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Motivation
The musculoskeletal system is essential for human movement. It is very versatile, allowing 
most people to walk, run, or dance seemingly effortlessly. These and other activities of daily 
living that most of us take for granted can be much more difficult to perform when disease 
compromises the functioning of the musculoskeletal system. The ability to perform more 
basic but very common activities of daily living such as walking, negotiating stairs, and 
getting up from a seated position in a pain-free manner, is important for many aspects of 
life, including general mobility, societal participation, and ultimately, quality of life. Indeed, 
besides pain, a reduced ability to move around independently is one of the most important 
reasons for patients to undergo orthopedic surgery (Wright et al. 1994). The work in this 
thesis focuses on walking and other related activities of daily living that are primarily 
performed by the lower limbs in different types of patients, spanning a range of diseases, 
levels of severity, and associated surgical interventions. From least severe to most severe, 
these include primary osteoarthritis of the hip, secondary osteoarthritis due to hip dysplasia, 
and sarcoma (a malignant tumor) in the lower limb. Patients suffering from any of these 
diseases present their own specific problems and have their own specific treatment options, 
which include conservative treatment and surgical interventions. Conservative treatment 
consists of, for example, pain medication and lifestyle advice to alleviate the symptoms 
as much as possible. However, when these treatment options are exhausted or undesired, 
surgical interventions to treat the disease are considered a more viable alternative. These 
interventions vary in their degree of effectiveness and complexity. One of the most 
ubiquitous is total hip arthroplasty (Charnley 1961). Although this operation is widely used 
and generally very successful at relieving pain and restoring mobility (Learmonth et al. 
2007), it is not completely clear to what degree the operation restores normal biomechanics 
during activities of daily living. This unclarity about the restoration of normal biomechanics 
is also true in the case of triple innominate osteotomy (Steel 1973), which is a more extensive 
surgical intervention to treat secondary osteoarthritis of the hip due to dysplasia. An even 
more extensive surgical intervention with a far less firmly established functional outcome 
is limb salvage surgery for osteosarcoma and soft-tissue sarcoma (Veth et al. 1995). Since 
each tumor is unique, each patient likewise represents a unique challenge for the orthopedic 
oncologist. Predicting the functional outcome of patients suffering from sarcoma is part of 
the decision-making process between lower limb amputation and limb salvage surgery, and 
is also important for informing the patient at the pre-operative stage. 
Musculoskeletal models and their validation
To study, to predict, and to eventually improve the outcomes of orthopedic interventions, 
musculoskeletal models are a useful tool (e.g., Delp et al. 1994b; Fluit 2015; Hicks et al. 
2007). Musculoskeletal models have the potential to aid in clinical decision making in 
several ways. These include, for example, predicting the effects of tendon transfers (Piazza et 
al. 2003; Reinbolt et al. 2009), joint replacement (Delp et al. 1994a; Piazza et al. 2001), and 
to predict patterns of bone-implant micromotions (van der Ploeg et al. 2012), which may 
cause aseptic loosening in primary joint replacements (Ulrich et al. 2008). Traditionally, 
musculoskeletal models are constructed based on anatomical measurements stemming 
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from one (Carbone et al. 2015; Klein Horsman et al. 2007) or several  (Duda et al. 1996; 
White et al. 1989) cadaver specimens. This is commonly called a generic model, which is 
simply scaled linearly to represent a subject based on anthropometric measurements, such 
as body length and weight. This way of working does not take into account the variability 
that is present in musculoskeletal geometry (Duda et al. 1996; White et al. 1989), which is 
particularly relevant when studying complex biomechanical problems. Therefore, subject-
specific models, for example based on extensive medical imaging data, are necessary to form 
an accurate representation of each subject’s anatomy (Lenaerts et al. 2009; Scheys et al. 2008; 
Taddei et al. 2012). Since a trend towards increased use of subject-specific models appears 
to be going on, the need increases to validate their subject-specific predictions (Lund et 
al. 2012). Some of the most critical predictions that need to be validated from the models 
are the muscle forces, since these ultimately dictate a given movement of the subject and 
the resulting loads on the joints. However, measuring muscle forces in vivo is not easy to 
do, since invasive measurements would need to be performed. Indirect measurements such 
as electromyography are a more viable alternative, but this technique has many inherent 
limitations, including the limited number of muscles that can be measured simultaneously, 
the inability to measure deep-lying muscles, and the fact that muscle activity from only a 
small area of a muscle can be measured. A more comprehensive validation technique is, 
therefore, highly desirable. Especially if musculoskeletal models are ever to be used on a 
broader scale, for example in assisting surgical planning in a clinical setting rather than in a 
research setting, the need to expand our knowledge of the construction of these models and 
the need for their validation is clear. This was recognized and made one of the primary focus 
points in the TLEMsafe project.
The TLEMsafe project
The work presented in this thesis was part of a large international research project called 
TLEMsafe (‘Twente Lower Extremity Model’ to be used for ‘safe’ surgery). This project 
aimed to research and improve the functional outcome of complex orthopedic surgical 
interventions by using state-of-the-art musculoskeletal models. The workflow of the project 
is shown schematically in Figure 1.1. The conceptual idea is that a highly personalized 
musculoskeletal model should be able to predict whether a patient would, for instance, 
be able to walk after an extensive orthopedic intervention on the lower limb. The original 
TLEM model, consisting of a full anatomical dataset of the lower limb based on a single 
cadaver specimen, was used as a starting point in the project (Klein Horsman et al. 2007). 
The generic TLEM was made subject-specific for each participating patient and healthy 
subject in the TLEMsafe project, based on anatomical data extracted from an MRI scan 
and functional measurements. The MRI scan was made at the Radboud University Medical 
Center, using a protocol that was specifically designed to allow for the easiest distinction of 
muscle boundaries (Scheys 2009). From the MRI scan, muscle volumes, bone geometries, 
joint rotation centers, and muscle attachment points were extracted by Materialise using 
Mimics (Materialise N.V., Leuven, Belgium). These subject-specific anatomical data were 
used by the University of Twente and AnyBody to create subject-specific musculoskeletal 
models in the AnyBody Modeling System (AnyBody A/S, Aalborg, Denmark). As input to 
the inverse-dynamics-based models, motion capture data and measurements of lower limb 
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Figure 1.1. The workflow of the TLEMsafe project for a patient suffering from hip dysplasia with high 
luxation. A) Pre-operative data are collected, including an MRI scan, motion-capture and strength 
tests. B) Patient-specific data (bone shapes, joint locations, muscle volumes and muscle attachment 
sites) are extracted semi-automatically from the MRI scan. C) A musculo-skeletal model is built spe-
cifically for this patient. D) The functional effects of several operative plans are predicted using the 
model. E) The most optimal surgical plan is executed as planned with the help of a navigation system. 
F) The optimal reconstruction has decreased the risk of complications and yielded an optimal func-
tional outcome.
strength were essential. These were collected at the Radboud University Medical Center, 
and a large part of them form the basis of the work presented in this thesis. Using a surgical 
pre-planning interface developed by the Warsaw University of Technology, participating 
surgeons were able to pre-plan several surgical scenarios (e.g., different bone resections, 
muscle transfers, surgical approaches) in the musculoskeletal models, and to choose the 
most optimal one in terms of functional outcome. The functional effects of each scenario 
were predicted by new musculoskeletal modeling algorithms, developed at the University 
of Twente (Fluit 2015). If desired by the surgeon, the pre-planned optimal surgical scenario 
could be loaded into a navigation system provided by Brainlab (Brainlab A/G, Munich, 
Germany) to allow for executing the surgery exactly as it was planned. This thesis is part of 
the TLEMsafe project and focuses on step A (Figure 1.1), collecting data of healthy subjects 
and patients as input for the construction of musculoskeletal models and their validation, 
and step F (Figure 1.1), measuring the functional outcome of interventions in an objective 
way. 
The rest of this introductory chapter first describes the knowledge gaps of the functional 
outcome of contemporary surgical treatment for several diseases of the musculoskeletal 
system (osteoarthritis of the hip, hip dysplasia, and sarcoma in the lower limb). These three 
diseases were chosen because they each represent specific levels of anatomical complexity, 
expected functional outcome, and differ in the expected subject specificity required from 
CB
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musculoskeletal models to model the functional outcome of their associated surgical 
interventions. This was intended to lead to more knowledge about which biomechanical 
aspects, and which aspects of functional outcome the project needed to focus on in terms 
of musculoskeletal validation. After introducing the diseases, this chapter introduces a 
new measurement technique for assessing muscle activity in the entire lower limb during 
walking. Besides providing the opportunity to obtain valuable insight on a fundamental level 
into the functioning of the musculoskeletal system, this technique could be used to validate 
musculoskeletal models in a pre-operative assessment of a patient who is a candidate for 
orthopedic surgery, or in quantifying and specifying the functional effects of orthopedic 
interventions in more detail.
Total hip arthroplasty for osteoarthritis
Osteoarthritis of the hip is a leading cause of disability. It is a more frequent cause of activity 
limitation than heart disease, cancer, or diabetes, is the second most frequently reported 
chronic condition, and the third leading cause of work limitation (Orthoworld Annual 
Report 2014). This disease is often treated by total hip arthroplasty (Figure 1.2). Almost 
21.000 total hip arthroplasties are performed each year in the Netherlands (Otten et al. 
2010); with the number of surgeries still increasing worldwide. From 2000 to 2009, it grew 
by 73% (123% for patients aged 45 to 64 years, 54% for ages 65 to 84 years) (Orthoworld 
Annual Report 2014). This indicates that the patients who undergo total hip arthroplasty 
are becoming younger at the time of surgery. This is partly due to the increased longevity 
of the implants, which allows the operation to take place at a younger age. Younger patients 
are generally more active than older patients, which infers that the demands that the total 
hip arthroplasty patient population places on the functional outcome of this intervention 
are higher than ever before. Fortunately, total hip arthroplasty is one of the most successful 
medical interventions in the world, and has even been called ‘The operation of the century’ 
                                                         
Figure 1.2. In total hip replacement, the proximal femur and the acetabulum are replaced by artificial 
parts. This typically relieves pain and restores range of motion, thereby increasing the quality of life 
of the patient.
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(Learmonth et al. 2007). The modern inception of the total hip arthroplasty has been 
performed since it was introduced by Sir John Charnley in the early 1960s (Charnley 1961). 
Since then, several improvements have been made in the design of the implants, such as 
improved materials for the cup liner and surface coatings for uncemented implants; and 
the surgical technique, such as minimally invasive approaches. Although the clinical results 
of total hip arthroplasty (such as relief of pain and restoration of range of movement), and 
radiographic placement have been researched in excruciating detail, most of this research has 
been performed using clinical scoring systems such as the Merle d’Aubigné and Postel score 
(D’Aubigne et al. 1954) and the Harris hip score (Harris 1969). Such scoring systems provide 
a convenient way of assessing the functional outcome, but they are inherently subjective, 
and do not include objective measurements of human functioning. As complementary tools 
to the scoring systems, quantitative measurement techniques such as gait analysis can be 
used to provide additional insight into the patient’s level of functioning after the operation 
(Lindemann et al. 2006; Nantel et al. 2009; Rosler et al. 2000). ‘Gait analysis’ is a term that 
encompasses any combination of the analysis of spatiotemporal, kinematic, and kinetic 
parameters. Spatiotemporal parameters include aspects such as walking speed, stride length, 
step length, and single and double support time (Perry et al. 2010). Kinematic parameters 
describe the motion of the body segments during the gait cycle, e.g., the frontal hip joint angle 
and the sagittal knee joint angle. Kinetic parameters are the forces, moments, and powers 
that are involved in the gait cycle. Although by ‘gait analysis’ authors commonly mean the 
analysis of walking (i.e. the gait cycle), the same analysis methodology can also be applied to 
other related activities of daily living such as stair negotiation and stepping over an obstacle. 
Regardless of the movement, this type of quantitative research into the functional outcome 
of total hip arthroplasty has been relatively scarce, and several discrepant findings have been 
reported in the literature. Although authors have attempted to summarize the published 
literature on walking (Ewen et al. 2012; Sinha et al. 2011), an extensive overview that also 
includes other functional movements (e.g., stair negotiation, stepping over an obstacle), 
takes into account factors such as differences in walking speed between study groups, and 
comparisons between the operated and the non-operated limb, has thus far been lacking. 
Triple innominate osteotomy and total hip arthroplasty for 
hip dysplasia
Hip dysplasia is congenital or developmental in nature. The disease is characterized by a 
shallow, obliquely-oriented acetabulum and a malposition of the proximal femur (Figure 
1.3). When such a joint is loaded, as is the case during activities of daily living, an increased 
rate of wear is experienced due to the relatively small weight-bearing area that has to 
carry the same body weight as any other healthy person (Hsin et al. 1996). As the disease 
progresses, the pain that the wear causes can severely limit patients in their daily activities. 
To address these problems, orthopedic surgeons have several options. In some patients, 
conservative treatment with pain medication and lifestyle advice is warranted, whereas in 
others with more advanced stages of the disease (including luxation of the hip), a total hip 
arthroplasty with femoral shortening may be the best option. In these most severely affected 
patients, the objectives of the surgery are to relieve pain, and to reduce as much as possible 
the biomechanical problems associated with the disease. These include restoring the limb 
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length discrepancy, the hip joint’s center of rotation and range of motion, and the force 
generating capacity of mainly the abductor muscles (Lai et al. 2001; Marangoz et al. 2010). 
Reports on the gait characteristics and post-operative muscle strength of these patients have 
been scarce, and most studies reported only spatiotemporal or kinematic gait parameters 
(Kyriazis et al. 2002; Marangoz et al. 2010).
Additionally, there are also patients who suffer from too much pain for conservative 
treatment, but who are too young for a total hip arthroplasty and who show no or low-
grade osteoarthritis (de Kleuver et al. 1997; Janssen et al. 2009). For those patients, triple 
innominate osteotomy is a surgical procedure that can offer a solution (Steel 1973; Tonnis 
et al. 1981). The aim of this type of surgery is to improve the acetabular coverage over the 
femoral head (Figure 1.3). The improved coverage spreads the forces of the body’s weight 
over a larger surface area, thereby reducing the local pressure, pain, and further joint 
degeneration. In spite of these seemingly great advantages, functional outcome is also an 
important factor to take into account when evaluating the results of the surgery, since the 
patients are generally young adults who enjoy an active lifestyle. Similarly to functional 
analyses in total hip arthroplasty, functional outcome of triple innominate osteotomy is most 
commonly measured with clinical scoring systems. Whereas clinical results of this operation 
are generally reported as ‘good’, ‘excellent’, or ‘improved compared to before the operation’ 
(de Kleuver et al. 1997; Hsin et al. 1996; Janssen et al. 2009), studies that use complimentary 
quantitative measurements such as gait analysis and measurements of residual muscle 
strength after the operation, are lacking. Since several treatment options exist for the group 
of patients eligible for triple innominate osteotomy, studies into the functional outcome of 
the operation would allow comparing it quantitatively to the outcome of other treatment 
options.
                     
Figure 1.3. Left: X-ray of a dysplastic hip, showing insufficient coverage. Middle: Post-operative X-ray 
of a triple innominate osteotomy. The area around the acetabulum has been osteotomized in three lo-
cations, allowing its rotation in the coronal plane, and improving the coverage over the femoral head. 
Right: X-ray of a successful triple osteotomy. The acetabulum provides enough coverage to relieve pain 
and this allows the patient to return to daily activities.
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Limb salvage surgery for sarcoma in the lower limb
Osteosarcoma and soft-tissue sarcoma are malignant tumors that occur most frequently 
in the lower limb (Figure 1.4). When these occur, (large) segments of bone and soft tissue 
need to be surgically removed to prevent the cancerous cells from spreading to other parts 
of the body. Amputation was often the only viable option until the 1980s, when limb salvage 
surgery came into more frequent use, combined with vastly improved staging techniques, 
chemotherapy, and reconstructive prostheses (Veth et al. 2003). Nowadays, the vast majority 
of patients (70-85%) that suffer from sarcoma can be treated with limb salvage surgery (Veth 
et al. 2003). The decision on whether to amputate or perform limb salvage surgery is based on 
several factors, such as tumor size, location, and the anticipated level of functional outcome 
(Robert et al. 2010). The expected functional outcome is, thus, an important aspect that 
is taken into consideration in the pre-operative decision making process. The importance 
of functional outcome is further highlighted by its strong relation to quality of life after 
the operation (Robert et al. 2010). However, it is not known how well surgeons are able to 
predict the functional outcome of limb salvage surgery. If they are not able to predict the 
functional outcome of limb salvage surgery, there may be a need for the development of 
tools (e.g., patient-specific musculoskeletal models) that can help the surgeon in his/her 
decision making process before the surgery. For instance, a personalized musculoskeletal 
model may be able to predict whether enough muscle strength will remain for the patient 
to be able to extend the leg and stand on it, or to estimate whether a patient can walk or not 
after the operation (Fluit 2015). 
Positron emission tomography
Positron emission tomography (PET) is an imaging technique with which the location of 
a tracer molecule in the body can be detected (Cherry et al. 2012) (Figure 1.5). The most 
commonly used PET tracer, and the one used in the work reported in this thesis, is the 
fluorinated analogue of glucose, [18F]-fluorodeoxyglucose (FDG). In this molecule, one of 
                                                     
                                                
Figure 1.4. MRI scan of a patient with osteosarcoma in the distal femur region (dark area). 
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the OH groups has been replaced by [18F]Fluorine. The chemical alteration does not affect 
the molecule’s ability to enter cells in the same way as regular glucose, but it does prevent 
the completion of its metabolic pathway. After phosphorylation, FDG-6-phosphate does not 
undergo glycolysis, and becomes trapped in the intracellular space (Shimada et al. 2009). 
This trapping property, combined with [18F]’s relatively long half-life of 110 minutes, makes 
it an ideal tracer to measure cumulative activity in the region of interest using PET. The FDG-
PET technique has many clinical applications, such as mapping metabolically active regions 
of the brain (Kirshner 2014) and detecting and staging cancerous tumors (Gallamini et al. 
2014). The common denominator in these applications is that the tissue of interest exhibits 
an increased uptake of glucose (and FDG) to generate ATP in the cells. This principle also 
applies to activated muscles; the FDG uptake is closely correlated with the exercise intensity. 
For example, Pappas et al. studied subjects who performed an elbow flexion exercise, and 
found that a fivefold increase in the lifted weight (from 2 pounds to 10 pounds) led to an 
increase in FDG uptake in the biceps brachii, by a factor of 4.94 (Pappas et al. 2001). This 
correlation between activation and FDG uptake is one of the cornerstones that makes FDG-
PET a suitable method to study muscle activity during exercise. Pappas et al. also found that, 
in contrast to common biomechanical assumptions, the level of activity within the muscle 
varied considerably (Pappas et al. 2001). This spatial variation enables the study of region-
specific activation of muscles, but also necessitates the use of three-dimensional analyses of 
the FDG uptake in muscles. Since Fujimoto et al. first started using the FDG-PET technique 
for measuring muscle activity during running in the late 1990s (Fujimoto et al. 1996), the 
technique has been applied to measure muscle activity during a range of activities including 
walking (Oi et al. 2003; Shimada et al. 2009; Shimada et al. 2007), cycling (Fujimoto et al. 
2003; Gondoh et al. 2009), and even double poling (Bojsen-Moller et al. 2010). 
The work in this thesis focuses on walking, since it is one of the most important activities 
of daily living. Knowledge about how each individual muscle contributes to walking can 
be useful for several purposes, including rehabilitation, medical education, and validating 
                               
Figure 1.5. Illustration of the fundamental principle of positron emission tomography. The PET scan-
ner detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide tracer, which 
is introduced into the body on a biologically active molecule. The three-dimensional images of the 
tracer’s concentration within the body are then reconstructed by computer analysis. 
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musculoskeletal models. However, until FDG-PET was first used for measuring muscle 
activity in the late 1990’s (Fujimoto et al. 1996), it was difficult to measure the muscle 
activities of all the muscles of the lower limb simultaneously, because existing measurement 
techniques (such as electromyography) suffered from limitations. FDG-PET holds several 
key advantages over electromyography. First, FDG-PET can measure the activity of all 
muscles in the lower limb simultaneously, whilst electromyography is limited by the number 
of applied electrodes. Second, deep-lying muscles can be measured more easily than with 
electromyography, as the latter requires insertion of invasive needle electrodes. Third, the 
activity in the entire muscle can be measured in three dimensions, whereas electromyography 
only provides information about a small muscle region, which might not be representative 
for the activity in the entire muscle (Hodson-Tole et al. 2013; Holtermann et al. 2005; Pappas 
et al. 2001). 
The problems associated with measuring muscle activity with electromyography have thus 
far only been partly overcome by authors who used FDG-PET. Several authors limited their 
analyses to measuring muscle FDG uptake in only one or a few discrete slices of the PET 
scan, rather than analyzing the entire muscle (Oi et al. 2003; Rudroff et al. 2014; Shimada 
et al. 2009; Shimada et al. 2007). Therefore, their results might not be representative for the 
activity of the entire muscle (Hodson-Tole et al. 2013; Holtermann et al. 2005; Pappas et al. 
2001; Staudenmann et al. 2009). Furthermore, they did not report muscle activity of the 
muscles that were not present in the discrete slices. As for asymmetries in activity between 
the muscles in the dominant and those in the non-dominant lower limb, some authors have 
examined these using FDG-PET (Rudroff et al. 2014). However, they only performed a slice-
based analysis on a limited number of muscles. Finally, although region-specific activation 
within muscles has been studied using FDG-PET, the literature in this area is limited in two 
ways: region-specific activation has only been reported during simple isometric contractions 
(Kalliokoski et al. 2007; Pappas et al. 2001), and studies that performed more complicated 
tasks such as cycling (Heinonen et al. 2012) or walking (Kindred et al. 2015) only reported 
glucose uptake heterogeneity of the entire muscle rather than distinguishing between areas 
of high and low uptake. In part, the limitations of the mentioned literature are due to the very 
labor-intensive manual work that is involved in measuring muscle glucose consumption 
from PET scans. Since PET scans of muscle activity do not contain anatomical information 
about the locations of muscles, the muscle regions-of-interest (of typically about a dozen 
muscles per slice) need to be drawn manually, referring to a concurrently made CT or MRI 
scan. This tedious manual contour-drawing process needs to be repeated hundreds of times, 
as scans of the entire lower limb typically consist of hundreds of slices. Then, the process 
would need to be repeated for each participant in the study. It is in this area where automatic 
muscle segmentation methods would have a tremendous benefit.
Aims and research questions
This thesis has two main aims. The first aim is to provide insight into the current status and 
challenges regarding functional outcome after the major orthopedic interventions described 
in this introduction. This aim is addressed in part I (chapters 2-4) of the thesis, guided by 
the following research questions:
17
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1) What is the current level of functional outcome after total hip arthroplasty, 
assessed with objective measurement methods, during gait and gait-related 
activities of daily living?
2) To what extent is the functional outcome in terms of gait and lower limb strength 
after triple innominate osteotomy and total hip arthroplasty with femoral shortening 
similar to healthy controls and comparable between the limbs?
3) Are orthopedic oncologists able to accurately predict the functional effects of 
limb salvage surgery in the lower limb?
The second aim is to explore the possibilities of FDG-PET in providing fundamental insight 
into the musculoskeletal system, and its potential as a supporting technique to help in solving 
some of the identified challenges surrounding functional outcome. This aim is addressed in 
part II (chapters 5-7) of the thesis, using the following research questions:
4) Which muscles in the lower limb are of primary importance during walking?
5) Are the muscles in the lower limb symmetrically active during walking?
6) Is muscle activity homogeneous or region-specific during walking?
7) Can FDG-PET be used to validate healthy subject-specific musculoskeletal 
models?
Outline
In chapter 2, we present a systematic review in which we mapped the differences between 
patients after total hip arthroplasty and healthy controls, and between the operated and 
non-operated limbs during gait and gait-related activities of daily living. In chapter 3a, we 
present a retrospective, controlled cohort study in which we investigated differences in gait 
and muscle strength between patients who had undergone triple innominate osteotomy 
and healthy controls, and between the operated and the non-operated leg. In chapter 3b, 
we examined the gait and strength of patients after total hip arthroplasty with femoral 
shortening for congenital hip dysplasia. In chapter 4, we investigated whether independent 
orthopedic oncologists were able to predict the functional effects of limb salvage surgery 
in the lower limb in a nationwide study.  In chapter 5, we used FDG-PET in combination 
with three-dimensional muscle segmentations to determine the contribution of each muscle 
of the lower limb to walking in healthy subjects. In chapter 6, we employed the FDG-PET 
technique to detect asymmetries in muscle activity between the dominant and the non-
dominant lower limb, and examined whether muscle activity is homogeneous throughout 
each muscle, or whether it is region-specific in healthy subjects. In chapter 7, we used 
advanced modeling techniques to generate subject-specific musculoskeletal models. The 
predicted muscle activities were compared to those previously obtained using FDG-PET. 
The thesis concludes with a summary and general discussion of the findings (chapter 8), 
in which we interpret the findings of this thesis, and provide directions for future research. 
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Abstract
Background: Differences in the performance of gait and gait-related activities of daily living 
are known to persist after total hip arthroplasty compared to healthy controls, but the 
specific underlying deficits (spatiotemporal, kinematics and kinetics) are not completely 
understood. This review aimed to map the differences between patients and controls, and 
between the operated and non-operated limbs during various activities of daily living.
Methods: A computerized search with broad search terms was performed in the MEDLINE 
database. Primary inclusion criteria were: primary osteoarthritis as indication, comparison 
with healthy controls or comparison between the operated and the non-operated limbs, and 
follow-up period at least six months after surgery. 
Results: The literature search yielded 2177 citations, of which 35 articles were included. 
Compared to controls, reductions were identified in the operated hip in sagittal range of 
motion, peak extension, sagittal power generation, abduction moment and external rotation 
moment. During stair ascent, these reductions did not become more apparent, although 
deficits in hip kinetics in all three planes were found. Walking speed and step length were 
reduced compared to controls at longer-term follow-up, but not at short-term follow-up.
Conclusions: The hip abduction moment deficit was present both in level walking and in stair 
ascent in total hip arthroplasty patients compared to controls. Reduced sagittal hip power 
generation and external rotation moment were also found, of which the clinical relevance 
remains to be established. Due to a low number of studies, many of the longer-term effects 
of THA on gait and gait-related ADL are not yet accurately known. 
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Introduction
Total hip arthroplasty (THA) is a surgical procedure commonly performed in patients with 
osteoarthritis. Even though THA is very successful in achieving its primary objective of 
relieving pain (Bennett et al. 2009), functional limitations may persist after surgery (Johanson 
et al. 1992; Laupacis et al. 1993). The ability to successfully perform common activities of 
daily living (ADL) is important for safe mobility, societal participation, and ultimately, 
quality of life. It is not surprising that besides pain, limitations in ADL (e.g., reduced ability 
to walk and to negotiate stairs) are important complaints in patients before THA (Wright et 
al. 1994). After THA, the ability to perform ADL generally improves (Foucher et al. 2008; 
Lamontagne et al. 2012; Shrader et al. 2009), but some activities such as stair climbing and 
rising from a chair may still be challenging (Foucher et al. 2008; Talis et al. 2008).
The outcome of THA is traditionally measured with clinical scoring systems such as the 
Merle d’Aubigné and Postel score (D’Aubigne et al. 1954) and the Harris hip score (Harris 
1969). These scoring systems are subjective, and do not include objective measurements 
of human functioning. Thus, in order to obtain a complimentary objective evaluation of 
function after hip surgery, it is necessary to employ quantitative measurement techniques 
such as gait analysis (Lindemann et al. 2006; Nantel et al. 2009; Rosler et al. 2000; Saleh et 
al. 1985). Such instrumented methods can also be employed to measure other ADL, such as 
stair negotiation, chair rising and sitting, and stepping over obstacles.
Walking after THA has been extensively investigated. Generally, walking is known to 
improve after THA, but does not reach a level that would be considered normal (Bennett et 
al. 2009; Bennett et al. 2006; Foucher et al. 2007; Perron et al. 2000). Ewen et al. summarized 
the findings of seven studies in this area in a review and meta-analysis, and found reductions 
in walking velocity, stride length, sagittal hip range of motion (RoM) and hip abduction 
moment, whilst hip flexion and extension moments were increased compared to healthy 
controls (Ewen et al. 2012). In spite of those comprehensive findings, many kinematic 
and kinetic parameters were not included. Moreover, several interesting studies have been 
published since and a number of relevant issues remained unaddressed. 
First, walking at self-selected comfortable speed arguably does not reflect a patient’s full 
motor capacity. Other functional tasks may be more suitable to test performance at higher 
capacity levels and thereby identify possible functional limitations. Other gait-related 
ADL (e.g., stair negotiation) may place different or higher demands on the operated limb 
compared to level walking (Aqil et al. 2013; Chamnongkich et al. 2012; Foucher et al. 2008; 
Lamontagne et al. 2012; Shrader et al. 2009). Yet, research into other ADL besides level 
walking has been scarce in patients who underwent THA (Aqil et al. 2013; Benedetti et al. 
2010; Chamnongkich et al. 2012; Foucher et al. 2008; Lamontagne et al. 2011a; Lamontagne 
et al. 2009, 2012; Lamontagne et al. 2011b; Majewski et al. 2005; Perron et al. 2003; Queen et 
al. 2013; Shrader et al. 2009; Stansfield et al. 2002; Talis et al. 2008; Vissers et al. 2011), and 
the findings have not previously been categorized, interpreted or summarized. 
Second, many studies comparing gait characteristics between THA patients and controls 
did not match walking speeds between the groups. As walking speed influences kinematic 
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and kinetic gait parameters (McCrory et al. 2001; Mockel et al. 2003; Perron et al. 2000), 
previously reported differences after THA might have in fact been epiphenomena of a 
reduced walking speed. Several recent papers, therefore, reported group comparisons at 
matched or imposed walking speeds, whereas other studies investigated differences in gait 
parameters between the operated and the non-operated limbs. The latter methodology may 
reveal compensatory strategies implemented by the non-operated limb. 
The primary goal of this review was to provide an overview of the differences in 
spatiotemporal, kinematic and kinetic parameters between patients who underwent THA 
more than six months ago and healthy controls, and between the operated and non-operated 
limbs of the patients during gait and gait-related ADL. The secondary goal was to define 
areas to be focused on in rehabilitation protocols as well as in future research. 
Methods
Eligibility criteria
Studies were eligible if they 1) included THA patients with primary osteoarthritis as 
the indication for surgery, 2) reported spatiotemporal and/or kinematic and/or kinetic 
parameters during gait or gait-related ADL, 3) compared the results with a control group 
of healthy subjects or compared the operated limb with the non-operated limb, and 4) had 
a follow-up period of at least six months post surgery. Our argument for the latter criterion 
was that most improvement in gait is generally reported to be achieved within that time 
frame, which was based on a preliminary literature search before the review was performed 
(Casartelli et al. 2013; Lavigne et al. 2010; Nantel et al. 2009; Perron et al. 2000; Rasch et 
al. 2010). Furthermore, most rehabilitation programmes end at six months or sooner, after 
which the rate of recovery is presumed to decrease (Nantel et al. 2009; Perron et al. 2000; 
Sicard-Rosenbaum et al. 2002).
Studies were excluded if the control group was not comparable with regard to age (within 
ten years). In addition, the language of the publication had to be English, Dutch or German. 
Furthermore, comments, guidelines, abstracts, protocols and review studies were excluded. 
Selection of studies was unconstrained regarding subject age and sex, type of implant used 
and surgical approach. 
Literature search
A computerized literature search was conducted in the MEDLINE database on July 8th, 
2013. The search strategy was based on medical subject headings (MeSH) terms, words in 
the title or abstract, and Boolean operators, and was phrased as follows: 
(Postoperative Period [MeSH] OR Posture [MeSH] OR Postural Balance [MeSH] OR 
Movement [MeSH] OR chair [tiab] OR sit [tiab] OR sitting [tiab] OR Stair [tiab] OR Gait 
[tiab] OR Stairs [tiab] OR obstacle [tiab] OR obstacles [tiab] OR barrier [tiab] OR barriers 
[tiab])   AND   (hip arthroplast*[tiab] OR Total Hip[tiab] OR Hip Replacement[tiab] OR 
29
Activities of Daily Living After Total Hip Arthroplasty: A Systematic Review
2
Hip Prosthesis[tiab] OR “Arthroplasty, Replacement, Hip”[Mesh]). 
These broad search terms were used to minimize the chance of missing relevant articles. 
Additionally, the reference lists of eligible articles were scanned for potentially relevant 
articles, missed by the computerized search. 
Selection procedure
The titles and abstracts of the studies found by the literature search and the scanning of 
reference lists were screened on possible eligibility for inclusion by SK, MM and GB. In the 
case of disagreement about inclusion, an independent reviewer, VW, was consulted. The 
study was discussed until complete consensus was reached.
Data extraction
A predefined data extraction form was used to aid in extracting data from included papers. 
This form included data fields of follow-up period, surgical approach, number of patients 
and controls, age of patients and controls, and reported outcome measures.
Primary outcomes
The primary outcome measures investigated in this review were spatiotemporal, kinematic 
and kinetic parameters during gait and gait-related ADL. If a parameter was reported in 
fewer than three studies, we chose not to include it in this review. Spatiotemporal parameters 
were walking speed, stride length, cadence, step length, stance duration, single support time, 
double support time, step width and cycle duration. Kinematic parameters comprised hip 
RoM in the sagittal plane, peak hip flexion and extension angles, hip RoM in the frontal 
plane, peak hip abduction and adduction angles, and pelvic tilt RoM. Kinetic parameters 
were peak hip flexion and extension moment, peak hip power generation and absorption 
in the sagittal plane, peak hip abduction and adduction moment, peak hip external and 
internal rotation moment, and total hip power generation.
Results
Study inclusion
The study screening and inclusion process are shown in Figure 2.1. Of the 35 included 
articles, 28 investigated gait and seven investigated stair negotiation. Sit-to-stand/stand-to-
sit and ramp ascent/descent were each investigated by one study. The study characteristics 
are listed in Table 2.1. Some studies performed subgroup analyses for patients operated on 
by different surgical approaches (Kiss et al. 2012; Varin et al. 2013), implant varus/valgus 
angles (Hodge et al. 1991), or follow-up times (Berman et al. 1991; Kiss et al. 2012; Lavigne 
et al. 2010). In those cases, the findings were split accordingly and treated as separate 
results. Some studies used data from the same patient cohort (e.g., Lamontagne et al. 2011a; 
Lamontagne et al. 2009), in which case the findings were combined. 
30
Chapter 2
Gait
Findings regarding gait are listed in Table 2.2 and Table 2.3.
Spatiotemporal characteristics
Generally, studies that allowed self-selected walking speed found it was lower in patients 
than in controls (Beaulieu et al. 2010; Bennett et al. 2008; Guedes et al. 2011; Leuchte et 
al. 2007; Loizeau et al. 1995; Mont et al. 2007; Perron et al. 2000; Talis et al. 2008) or not 
different between the groups (Berman et al. 1991; Casartelli et al. 2013; Lavigne et al. 2010 
(at 6m post-OR); Nantel et al. 2009; Sicard-Rosenbaum et al. 2002; Tanaka 1998; Tateuchi et 
al. 2011; Varin et al. 2013). Stride length was also either smaller (Beaulieu et al. 2010; Bennett 
et al. 2008; Hodge et al. 1991 (varus group); Loizeau et al. 1995; Perron et al. 2000), or similar 
to controls (Hodge et al. 1991 (valgus group); Nantel et al. 2009; Sicard-Rosenbaum et al. 
2002; Tateuchi et al. 2011). The results for all other spatiotemporal parameters tended to 
yield outcomes that did not differ between THA and control groups. Studies that compared 
the operated with the non-operated limb did not yield consistent results. 
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Figure 2.1. Flow chart of the literature search and study inclusion, according to PRISMA guidelines 
(Moher et al. 2009).
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Kinematics 
Hip RoM in the sagittal plane was reduced in almost all studies compared to healthy controls 
(Beaulieu et al. 2010; Bennett et al. 2008; Foucher et al. 2007; Kiss et al. 2012; Madsen et 
al. 2004; Perron et al. 2000; Varin et al. 2013) as well as compared to the non-operated 
limb (Benedetti et al. 2010; Kiss et al. 2012). Peak hip extension was consistently reduced 
compared to controls (Beaulieu et al. 2010; Bennett et al. 2008; Perron et al. 2000; Sander et 
al. 2011; Tanaka 1998; Varin et al. 2013). Peak hip flexion was most often similar to controls 
(Bennett et al. 2008; Kiss et al. 2012; Tanaka 1998; Tateuchi et al. 2011), but was reduced in 
some studies (Beaulieu et al. 2010; Kiss et al. 2012 (anterolateral group)). Pelvic tilt RoM was 
mostly not different between patients and controls (Beaulieu et al. 2010; Bennett et al. 2008; 
Kiss et al. 2012; Varin et al. 2013).
Kinetics
Peak hip abduction moment was reduced in almost all studies (Beaulieu et al. 2010; Foucher 
et al. 2007; Foucher et al. 2011; Mont et al. 2007; Perron et al. 2000; Varin et al. 2013), and 
peak hip external rotation moment was reduced across all reporting studies (Beaulieu et al. 
2010; Foucher et al. 2007; Foucher et al. 2011; Perron et al. 2000; Varin et al. 2013). Peak hip 
flexion moment did not differ between patients and controls in almost all studies (Foucher 
et al. 2007; Foucher et al. 2011; Hodge et al. 1991 (valgus group); Tanaka 1998; Tateuchi et 
al. 2011; Varin et al. 2013); the same was true for the extension moment (Foucher et al. 2007; 
Foucher et al. 2011; Hodge et al. 1991 (valgus group); Mont et al. 2007; Nantel et al. 2009; 
Tanaka 1998; Tateuchi et al. 2011; Varin et al. 2013). Peak sagittal hip power generation 
was either reduced (Perron et al. 2000; Tateuchi et al. 2011; Varin et al. 2013), or similar 
compared to controls (Nantel et al. 2009; Varin et al. 2013). Sagittal hip power absorption 
findings were ambiguous, being lower (Loizeau et al. 1995; Perron et al. 2000; Tateuchi et 
al. 2011), similar (Beaulieu et al. 2010; Varin et al. 2013) or higher (Nantel et al. 2009) than 
controls. 
Relation kinematics and kinetics with walking speed
Some studies matched walking speeds between patients and controls during the measurement 
(Hodge et al. 1991; Kiss et al. 2012) or in the analysis (Foucher et al. 2007; Foucher et al. 2011; 
Perron et al. 2000). In those studies, the previously identified reduction of sagittal hip RoM 
was found almost as consistently as when walking speed was not taken into consideration. 
Thus, the sagittal hip RoM deficit did not appear to be speed-related. With respect to gait 
kinetics, these studies yielded similar results to those described above. Particularly the 
reduced peak hip abduction moment and peak hip external rotation moment in the THA 
groups persisted in studies that matched walking speeds (Foucher et al. 2007; Foucher et al. 
2011; Perron et al. 2000). 
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Effects of follow-up time on outcome measures
To determine the influence of follow-up time on the outcome measures, we compared the 
studies with the shortest follow-up (six to nine months) to those with the longest follow-up 
(more than 24 months). Of the 23 studies in Table 2.2, eight studies had a follow-up period 
of six to nine months (Berman et al. 1991; Casartelli et al. 2013; Kiss et al. 2012; Lavigne et 
al. 2010; Leuchte et al. 2007; Madsen et al. 2004; Nantel et al. 2009; Vissers et al. 2011). In 
contrast, only one study included patients exclusively after 24 months (Bennett et al. 2008). 
Five other studies included patients at a range of follow-up periods, but with a mean of 24 
months or longer (Guedes et al. 2011; Hodge et al. 1991; Loizeau et al. 1995; Tanaka 1998; 
Tateuchi et al. 2011). Walking speed was not different from controls in most studies that had 
a short follow-up period, whereas it was lower than controls in most of the studies that had a 
follow-up of 24 months or longer. This coincided with a reduction in step length in the long-
term follow-up studies (Bennett et al. 2008; Tanaka 1998), which was generally not found in 
the short-term follow-up studies (Casartelli et al. 2013; Kiss et al. 2012 (anterolateral group); 
Lavigne et al. 2010). Cadence and sagittal hip RoM did not appear to depend on the follow-
up period: cadence was similar and sagittal hip RoM was reduced compared to controls both 
at short-term and at long-term follow-ups. Other parameters were too scarcely reported in 
one or both categories of follow-up to draw solid conclusions. Although walking speed was 
matched between groups in one short-term follow-up study (Kiss et al. 2012) and in one 
long-term follow-up study (Hodge et al. 1991), excluding them from the follow-up time 
comparison would not have yielded different results.
In studies that compared the operated with the non-operated limb, the findings in studies 
with long-term follow-up were inconsistent, or reported parameters different from those in 
studies with short-term follow-up, or the parameters were reported too scarcely in either or 
both follow-up categories to draw solid conclusions.
Stair negotiation and other gait-related ADL
Findings regarding stair negotiation and other gait-related ADL are listed in Table 2.4.
Stair ascent
In stair ascent, sagittal hip RoM was similar between patients and controls across all studies 
(Foucher et al. 2008; Lamontagne et al. 2011a; Lamontagne et al. 2011b; Queen et al. 
2013), but findings regarding its subcomponents (peak hip flexion and extension angles) 
differed. Queen et al. found higher flexion and lower extension (Queen et al. 2013), whereas 
Lamontagne et al. found an almost opposite result with similar flexion and increased 
extension angles (Lamontagne et al. 2011b). However, Lamontagne et al. also measured 
another cohort of patients and did not identify any differences in the sagittal plane peak 
angles in those patients (Lamontagne et al. 2011a; Lamontagne et al. 2009). In the frontal 
plane, hip RoM and peak hip abduction and adduction angles were mostly similar between 
groups (Lamontagne et al. 2011a; Lamontagne et al. 2011b; Queen et al. 2013). 
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In the patients, hip flexion moment was higher than controls (Foucher et al. 2008; 
Lamontagne et al. 2011b) or similar (Lamontagne et al. 2011a; Queen et al. 2013), and the 
extension moment was mostly similar to controls (Foucher et al. 2008; Lamontagne et al. 
2011b; Queen et al. 2013). Peak hip abduction moment was lower than controls (Foucher et 
al. 2008; Lamontagne et al. 2011a) or similar (Lamontagne et al. 2011b; Queen et al. 2013), 
and adduction moment was similar across all studies (Foucher et al. 2008; Lamontagne et 
al. 2011a; Lamontagne et al. 2011b; Queen et al. 2013). Peak internal rotation moment was 
mostly lower (Foucher et al. 2008; Lamontagne et al. 2011a) than controls, as was the total 
hip power generation (Lamontagne et al. 2011a; Lamontagne et al. 2009; Lamontagne et al. 
2011b). The operated limb had a lower peak hip internal rotation moment than the non-
operated limb (Benedetti et al. 2010). 
Stair descent
Peak hip flexion angle (Lamontagne et al. 2011a; Lamontagne et al. 2011b) and peak internal 
rotation moment (Lamontagne et al. 2011a; Lamontagne et al. 2009; Lamontagne et al. 
2011b) were most often reduced compared to healthy controls. Abduction and adduction 
moments were mostly similar to controls (Lamontagne et al. 2011a; Lamontagne et al. 
2011b; Queen et al. 2013). The operated limb had a shorter stance duration than the non-
operated limb (Benedetti et al. 2010).
Incline walking and sit-to-stand
Patients walked slower, and with reduced cadence on a ramp with 10° incline or decline 
(Stansfield et al. 2002). In sit-to-stand and stand-to-sit, sagittal hip RoM, peak hip flexion, 
hip extension moment and power generation were lower than in controls (Lamontagne et 
al. 2012).
Discussion
This review aimed to investigate the underlying deficits during gait and gait-related ADL in 
patients after THA. Similar to previous work (Ewen et al. 2012), we identified reductions in 
sagittal hip RoM and hip abduction moment, but additionally found reductions in peak hip 
extension, sagittal hip power generation, and peak hip external rotation moment in THA 
patients compared with controls. Most of these findings (sagittal hip RoM, hip abduction 
moment, hip external rotation moment) could not be attributed to a difference in walking 
speed, as they persisted in studies that matched walking speed between groups. During stair 
ascent, the identified impairments did not become more apparent, although deficits in hip 
kinetics in all three planes were found. In stair descent, differences with healthy controls 
were found less frequently. Other ADL beside walking and stair negotiation have scarcely 
been researched in THA patients.
The results from this review indicate that the gait of THA patients is different from healthy 
controls in several ways. In the sagittal plane, the reduction in hip RoM appeared to be 
due to the concomitantly reduced hip extension. The hip extension deficit may be caused 
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by increased passive resistance from the hip flexors (i.e. a flexion contracture), which is 
relatively prevalent in THA patients (Davis et al. 2007). Alternatively, it may be related to 
weakness of the hip extensor muscles. However, as we found no consistent reduction in 
extension moment in THA patients compared to healthy controls, this explanation seems 
less likely. 
Besides the kinematic differences, we also found that the peak sagittal hip power generation 
was reduced in most studies. Because of the timing of this peak in the pre-swing phase of 
gait (in which the hip is flexing), this indicates that the flexor muscles may contribute less 
to gait propulsion in THA patients than in controls. Differences between groups persisted 
even in studies where walking speed was matched (Perron et al. 2000), or where it was used 
as a covariate in the analysis (Beaulieu et al. 2010), thus indicating a ‘real’ reduction in hip 
flexor activity rather than it being an epiphenomenon of reduced walking speed. A strength 
deficit may underlie the lower flexor activity, as previous research found that, compared to 
controls, THA patients had significantly reduced hip flexor strength (Frost et al. 2006). It 
therefore seems that the hip flexors deserve more attention in rehabilitation, besides the 
commonly performed hip extensor and abductor strengthening exercises (Hesse et al. 2003; 
Okoro et al. 2013).
Frontal plane hip kinematics were investigated in only a few studies (Beaulieu et al. 2010; 
Bennett et al. 2008; Madsen et al. 2004; Varin et al. 2013). This is surprising since some of the 
clinically most relevant and frequently observed gait deviations in patients before and after 
THA (Trendelenburg and Duchenne gait) take place in the frontal plane. The reductions 
in peak hip adduction angle (Beaulieu et al. 2010; Varin et al. 2013) and hip abduction 
moment (Beaulieu et al. 2010; Foucher et al. 2007; Foucher et al. 2011; Mont et al. 2007; 
Perron et al. 2000; Varin et al. 2013) may indeed point to a Trendelenburg-type gait pattern. 
This may be due to persisting muscle weakness that patients had developed in the years 
before the surgery. This postulation is supported by Arokoski et al., who found significantly 
reduced hip abduction strength in hip osteoarthritis patients compared to healthy controls 
(Arokoski et al. 2002). An alternative explanation is damage to the abductor muscles 
inflicted during certain surgical approaches (e.g., lateral and anterolateral approaches). 
However, almost all reporting studies in this review found a reduced abduction moment 
in their patients, including studies that employed the posterior approach, which spares the 
abductor musculature (Jolles et al. 2006; Madsen et al. 2004). 
The reduced peak hip external rotation moment we identified might be due to the operative 
technique, as the external rotators are partly released in several approaches to the hip, 
including the common posterior approach (Madsen et al. 2004). However, the studies in 
which the external rotation moment deficit was found, used other approaches in their 
patients (Beaulieu et al. 2010; Foucher et al. 2011; Varin et al. 2013), or only used the 
posterior approach in a subset of their cohort (Foucher et al. 2007; Perron et al. 2000). Thus, 
the external rotator weakness appears to be independent of surgical approach, and may 
instead be persisting from before the surgery. This postulation is supported by Hakkinen 
et al. who found significantly reduced external rotator strength in the operated compared 
to the non-operated hip of patients before, and at 3, 6 and 12 months after hip resurfacing 
arthroplasty (Hakkinen et al. 2010). Further research is required to establish the origin and 
the clinical relevance of this finding. 
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Differences between the kinematics of the operated and non-operated limbs are an 
interesting area of study, because it allows compensatory inter-limb strategies to be 
identified. Such strategies are potentially harmful, as an asymmetric gait pattern may cause 
abnormal loading, which in turn could jeopardize the prosthesis’ fixation (McCrory et al. 
2001) or cause secondary complaints in other joints (Foucher et al. 2012). It therefore is 
surprising that only two studies investigated asymmetries in kinematics or kinetics between 
the operated and the non-operated hip (Benedetti et al. 2010; Kiss et al. 2012). Those studies 
found reduced sagittal RoM in the operated hip compared to the non-operated hip, for which 
compensatory strategies included increasing pelvic rotation, obliquity and tilt (Huang et al. 
2011; Kiss et al. 2012; Miki et al. 2004). The larger pelvic motions thereby allow maintenance 
of normal step length (Huang et al. 2011; Kiss et al. 2012; Wu et al. 2002), which is beneficial 
for maintaining walking speed, but their long-term consequences are unknown and in need 
of further study.
The importance of studying the effects of THA on the operated as well as the non-operated 
limb was underlined by Foucher et al. (2012), who found several significant and relevant 
differences compared to controls. These included increased abduction and extension 
moments in the knee contralateral to the operated hip, both before and after the operation 
(Foucher et al. 2012). The higher knee abduction moment in particular has been linked to 
the development (Hurwitz et al. 2000) and aggravation of knee osteoarthritis (Andriacchi 
et al. 2006; Miyazaki et al. 2002). These findings call for further investigations into gait re-
training and rehabilitation strategies that aim to establish gait symmetry. 
Interestingly, the literature did not provide clear indications for gait deviations to decrease 
with prolonged time post surgery. In fact, walking speed was similar to controls in most 
studies that had a short follow-up of six to nine months, whereas it was reduced, in parallel 
with reductions in step length, in most studies that had a relatively long mean follow-up of 24 
months or longer. Furthermore, the results for cadence or sagittal hip RoM were not different 
between short and long term follow-up periods. However, it is difficult to firmly establish the 
effects of time post surgery, as the comparison between short-term and long-term follow-up 
studies is hampered by the small number of studies in each group. Particularly, only a single 
study included patients exclusively after 24 months. Additionally, several gait parameters 
(peak hip abduction moment, peak hip external rotation moment) that were identified in 
this review as being reduced compared to healthy controls at follow-up times less than 24 
months were not or scarcely reported in the long-term follow-up studies. Future studies that 
investigate gait longitudinally at several follow-up times (including a follow-up of two years 
and more) should address these gaps.
In stair negotiation, we found several differences between patients and controls, but 
compared to level walking, the differences did not become magnified. In stair ascent, several 
differences with healthy controls were apparent in the kinetics of the hip in all three planes. 
In the sagittal plane, two studies found an increased hip flexion moment in THA patients 
(Foucher et al. 2008; Lamontagne et al. 2011b). This increase may be part of a strategy in 
which patients make their trunk lean forward during late stance, increasing their feeling of 
stability and relying less on their reduced hip abductor function (Foucher et al. 2008). In the 
frontal plane, the peak hip abduction moment was lower (Foucher et al. 2008; Lamontagne 
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et al. 2011a) or similar compared to controls (Lamontagne et al. 2011b; Queen et al. 2013). 
Thus, the reduced hip abduction moment in THA patients found in level walking was 
also found, albeit less consistently, in stair ascent. In addition to the lower hip abduction 
moment, the reduced internal rotation moment in THA patients (Lamontagne et al. 2011a; 
Lamontagne et al. 2011b) may be reflective of abductor weakness because, when the hip is 
flexed, most fibres of the gluteus medius and minimus act as internal rotators (Platzer 1999). 
In descent, peak hip flexion was found to be lower than healthy controls in two studies 
(Lamontagne et al. 2011a; Lamontagne et al. 2011b). This might be indicative of a particular 
strategy whereby the trunk inclination is reduced and the centre of mass is brought 
backward, so as to reduce the chance of falling forward (Lamontagne et al. 2011b). It might 
also be indicative of hip flexor muscle weakness. However, the peak hip flexion moment was 
not concurrently reduced in the THA patients in the studies that found reduced hip flexion 
(Lamontagne et al. 2011a; Lamontagne et al. 2011b), which argues against this postulation. 
Generally, previous research indicates that the hip joint moments required to negotiate stairs 
are similar or lower than those required for level walking (Kirkwood et al. 1999; Nadeau 
et al. 2003; Riener et al. 2002). This implicates that THA patients are not pushed further 
towards the limits of their capacity in stair negotiation than in level walking, which explains 
why differences with healthy controls did not become more apparent in stair negotiation 
than in level walking.
Chair rising and sitting were investigated in only one included study (Lamontagne et al. 
2012). Since these are common ADL in THA patients (Morlock et al. 2001), it is surprising 
that they have been investigated by so few studies. Lamontagne et al. (2012) and Talis et al. 
(2008) found that both rising and sitting are performed asymmetrically in THA patients. As 
discussed earlier, asymmetric movement and loading may increase the risk of developing 
secondary complaints in the contralateral limb. Increasing the strength of the primary 
muscles responsible for this movement in the operated limb (vastus and gluteus maximus 
muscles) and retraining THA patients to properly load the operated hip joint may help in 
improving the patients’ recovery (Lamontagne et al. 2012).
This review has some limitations. We examined only peak values for the kinematic and 
kinetic parameters. The absence of differences in peak values does not necessarily imply 
that the pattern as a whole is not different. Thus, a patient may still walk or negotiate stairs 
quite differently compared to a healthy peer. Furthermore, statistically significant results 
do not always imply clinical relevance. Lastly, the methodological quality of the included 
studies differed. For instance, in some of the studies that were included in this review, there 
might have been a reporting bias. It was often described unclearly which gait parameters 
were statistically compared between THA patients and controls, whilst only the statistically 
significant parameters were reported. 
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Conclusions
The available literature showed that THA patients had reduced sagittal hip RoM, peak hip 
extension, sagittal hip power generation, hip abduction moment, and peak hip external 
rotation moment during gait compared to controls. The lower hip abduction moment was 
also found during stair ascent, and appeared to be independent of the surgical approach. 
Stair ascent and descent did not magnify the deficits found during level walking. Research 
into other ADL (e.g., sit-to-stand transfers) has been scarce, even though THA patients 
perform such activities frequently and in a plausibly harmful asymmetric way. Walking 
speed and step length were reduced compared to controls at longer-term follow-up, which 
was not observed at short-term follow-up. However, given the low number of studies that 
had a follow-up of two years or longer, many of the longer-term effects of THA on gait and 
gait-related ADL are not yet accurately known, which indicates a need for more research. 
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Abstract
Background: In adult patients with developmental hip dysplasia, a surgical procedure (triple 
innominate osteotomy) of the pelvic bone can be performed to rotate the acetabulum in the 
frontal plane, establishing better acetabular coverage. Although common clinical hip scores 
demonstrate significant improvements after surgery, they provide only overall information 
about function. The purpose of this study was to quantify the long-term outcome of triple 
innominate osteotomy in more detail using gait analyses and muscle strength measurements. 
Methods: We performed gait analyses at self-selected walking speed as well as isometric 
hip and knee muscle strength tests in twelve women who had undergone a unilateral triple 
innominate osteotomy (age: 34±12y, time post surgery: 80±18m). We compared the results 
to reference values obtained from eight healthy peers (age: 33±10y). 
Results: The patients exhibited slight asymmetries in step length (smaller steps) and stance 
time (longer stance) as well as lower hip abduction moments in the operated limb in 
early stance compared to the non-operated limb. However, there were no differences in 
gait compared to healthy controls, even though the patients showed reduced bilateral hip 
abduction strength compared to controls. 
Conclusions: Our results indicate that the patients’ gait pattern had generally recovered 
very well, despite slight asymmetries in spatiotemporal parameters. Subtle deviations in 
hip abduction moments were observed during gait, whereas hip abduction strength was 
substantially reduced. Hence, the patients walked at a higher percentage of their maximal 
capacity. They may, therefore, be prone to fatigue and adopt compensatory gait strategies 
more quickly than healthy peers when walking long distances. 
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Background
Developmental dysplasia of the hip is characterized by a shallow, obliquely-oriented 
acetabulum and malposition of the proximal femur. Together, these anatomical deformations 
lead to an increased local load because of a decreased weight-bearing area (Hsin et al. 1996). 
This is painful for patients, can cause secondary osteoarthritis, and limits patients in their 
daily activities. To relieve the symptoms, a surgical procedure (Triple Innominate Osteotomy; 
TIO) can be performed (Steel 1973; Tonnis et al. 1981). In this surgery, the acetabulum is 
rotated in the frontal plane to increase its coverage over the femoral head (de Kleuver et 
al. 1997). This procedure reduces pain and further joint degeneration and, thereby, greatly 
improves the quality of life of patients (Faciszewski et al. 1993). In addition to pain relief 
and radiographic improvement, functional outcome is also important in determining the 
success of hip dysplasia surgery. 
Most patients who underwent TIO achieve good to excellent functional results based on 
clinical functional scores (de Kleuver et al. 1997; Guille et al. 1992; Nakamura et al. 1998). 
However, drawbacks of these scoring systems are that they are subjective (Learmonth et al. 
2007), may have ceiling effects (Wamper et al. 2010), and only provide information about 
the overall level of function. They do not allow one to assess which joints or muscle groups 
underlie functional abnormalities. Thus, in order to obtain a quantitative and objective 
evaluation of function after TIO, it is necessary to employ more detailed and quantitative 
measurement techniques such as gait analysis (Kolk et al. 2014; Lindemann et al. 2006; Nantel 
et al. 2009; Rosler et al. 2000). In addition to gait analysis, muscle strength measurements are 
valuable to assess the biomechanical properties of the operated limb (Lin et al. 2007). 
To our knowledge, there have been no reports on the impact of TIO at such a detailed 
functional level. The information obtained from gait analysis could provide a better 
assessment of the long-term effects of this surgery. It can be used to inform the, usually 
young-adult, patients about their expected walking ability after the operation (van 
Hellemondt et al. 2005). It also allows comparing the functional outcome of TIO surgery 
to that of other treatment options such as Ganz’s osteotomy (Ganz et al. 1988), for which 
gait analysis studies have been performed (Karam et al. 2011; Pedersen et al. 2006; Sucato 
et al. 2010). Several decrements (e.g., in walking speed and hip flexion pull-off power) after 
Ganz’s osteotomy have been found (Karam et al. 2011; Sucato et al. 2010). Since the surgical 
approach is slightly different between TIO (usually a modified Smith-Peterson approach) 
and Ganz’s osteotomy (usually either a classic Smith-Peterson or an abductor-sparing direct 
anterior approach), abnormalities in gait parameters after these respective operations may 
be related to the approach. Furthermore, the identification of specific gait and strength 
deficits might be useful for improving surgical techniques or postoperative rehabilitation 
protocols that may further enhance the functional outcome. 
This study aimed to investigate the long-term outcome of TIO in terms of biomechanics 
of gait and muscle strength. Specifically, our objectives were to determine deviations in (1) 
spatiotemporal parameters, hip joint angles and joint moments during gait, and (2) hip and 
knee muscle strength in patients who had undergone TIO between two and ten years ago. 
We compared the results between the operated and non-operated limb and between patients 
and healthy controls. 
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Methods
Participants
Twelve women who had undergone TIO and eight healthy women in the same age range 
participated in this study. The indication for TIO was symptomatic hip dysplasia with a 
spherical femoral head, and without major damage to the cartilage (van Hellemondt et al. 
2005). All patients were operated in the Sint Maartenskliniek, Nijmegen, The Netherlands 
by the same experienced surgeon. The surgical procedure (modified Tönnis osteotomy) has 
been described in detail (Kooijman et al. 1990). Patients between 18 and 70 years who had 
undergone a unilateral TIO between January 2003 and June 2010 were eligible for inclusion. 
This time window ensured that rehabilitation had been completed. Rehabilitation consisted 
of regular mobilization of the hip joint and strengthening exercises for the muscles of the hip 
region, and lasted for 3-12 months, depending on the patient’s individual speed of recovery. 
In total, 54 patients were screened, of whom 34 were eligible for inclusion. Of those, 18 
patients were willing to participate, and 12 were included after screening for exclusion 
criteria. We excluded patients that had any disease or other condition that could affect their 
gait, including severe hip pain, as well as patients with a Body Mass Index (BMI)>30 kg/
m2 because of difficulties in marker placement for gait analysis. Selection was unspecific 
regarding gender, but all 12 included patients were women. 
The study procedure was approved by the local ethical committee of the region Arnhem-
Nijmegen, the Netherlands (study code 2012/065). A written informed consent was obtained 
from each subject.
Clinical assessment
The participants were invited to the gait laboratory of the Radboud university medical center, 
Nijmegen, The Netherlands for a combined gait and muscle strength assessment session. We 
also obtained the Oxford (Dawson et al. 1996; Murray et al. 2007) (range 0-48) and Harris 
Hip Score (Harris 1969) (range 0-100) from the patients during a break in the session.
Gait analysis
The participants walked barefoot on an 8 m long walkway at self-selected comfortable 
walking speed. An integrated data collection was performed including three-dimensional 
motion capture with synchronized force plate recordings. A six-camera digital optical 
motion capture system (Vicon MX, Oxford, UK) was used to record the position of 35 retro-
reflective markers placed on the lower limb and torso (100 Hz). The standard Vicon Plug-
in-Gait marker set was used, with additional markers placed on the anterior side of the thigh 
and lower leg at 1/3 and 2/3 segment length, and on the fifth metatarsal head of the foot. Two 
custom-made force plates (AMTI, Watertown, MA, USA), embedded level in the laboratory 
floor measured ground reaction forces (1000 Hz) during the stance phase of the gait cycle. 
No specific instructions were given other than ‘walk naturally’ to prevent participants from 
targeting the force plates. Trials were repeated until six successful trials had been recorded, 
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where ‘successful’ was defined as a trial in which each foot cleanly struck one of the two 
force plates. The gait analysis data of one patient and one control subject had to be discarded 
due to technical problems, leaving a group of 11 patients and 7 controls available for the gait 
analysis part of the study.
Data analysis
Heel strike and toe off events were identified using thresholding of ground reaction force 
data (heel contact when F>20 N, toe off when F<20 N). Spatiotemporal parameters were 
subsequently calculated based on a combination of these events and the heel and toe marker 
position data.
A 21 degrees of freedom kinematic model (‘GaitLowerExtremityModel’, as available in the 
AnyBody Managed Model Repository 1.5.1) consisting of trunk, pelvis, thigh, shank, talus 
and foot segments was scaled to each subject based on the marker trajectories using the 
AnyBody Modeling System (version 5.3.1, AnyBody Technology A/S, Aalborg, Denmark). 
The marker trajectories were initially filtered with a 5 Hz 2nd order Butterworth low-pass 
filter. Force plate data were low-pass filtered at 12 Hz with a 2nd order Butterworth filter. 
The model was based on the kinematic part of the Twente Lower Extremity Model dataset 
(Klein Horsman et al. 2007). After this procedure, lower limb joint angles were obtained by 
solving the inverse kinematics using the optimized parameters. At each joint, ideal torque 
generators were added. The segment masses were scaled using common scaling laws (Winter 
1991), available in AnyBody. The model marker positions, segment lengths and knee joint 
axes were then optimized using a parameter optimization algorithm (Andersen et al. 2010). 
Finally, the kinematics and ground reaction forces were used as input for an inverse dynamic 
analysis (Damsgaard et al. 2006), in which joint moments were calculated in the local (ISB 
(Wu et al. 2002)) reference frames.
Our outcome variables of interest were spatiotemporal parameters, hip joint angles and 
moments in the sagittal and frontal planes. Each of these variables was averaged across trials 
to obtain subject ‘ensemble’ averages both for the operated and the non-operated limbs. 
The moments were normalized to the body weight (BW) and height (Ht) of the subject 
(%BW*Ht). In the sagittal plane, we determined the peak flexion and extension angles and 
moments. In the frontal plane, we used the adduction angle at 20% of the gait cycle in the 
analysis, since there was a peak in the angle at that particular phase of the gait cycle. Owing 
to the M-shaped curve of hip abduction moments during gait, we extracted two peak values, 
one in the first and one in the second half of the stance phase. For the healthy controls, we 
used the mean of the left and right limbs in the analyses.
Muscle strength
Isometric maximum voluntary contractions were recorded for hip abduction, and knee 
flexion and extension. Hip abduction strength was tested in side-lying position, with the 
tested hip at 0° flexion and 0° adduction, and the knee extended (Figure 3.1A). The non-
tested hip was flexed at 45°, and the knee was flexed at 90° in order to prevent the contralateral 
limb from contributing to the maximum strength effort. The end piece (soft Velcro strap) of 
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a force transducer was applied just proximal to the femoral epicondyles perpendicular to the 
limb, and the other end of the transducer was rigidly attached to the testing bench.  
For maximum knee flexion strength testing, subjects sat on the edge of a testing bench 
positioned close to a wall (Figure 3.1B). The knee and hip were flexed at 90°, and the end 
piece of the force transducer was applied just proximal to the malleoli. The other end was 
rigidly fixed to the wall, level with the end piece. During the contractions, manual pressure 
was applied by an assistant proximal to the top of the tested knee to prevent it from rising. 
Knee extension was tested in a custom-built chair with vertical backrest, with the knee and 
hip flexed at 90°, and with the end piece of the force transducer applied just proximal to the 
malleoli (Figure 3.1C). The subject was strapped to the chair to prevent the waist from rising.
Participants performed three maximum isometric contractions for four seconds each, 
separated by 30 seconds of rest. All subjects received the same verbal encouragements 
during the contractions to achieve maximum effort. The highest recorded maximal force 
was multiplied by the moment arm to the joint centre of the tested joint to obtain peak 
torque values. Raw data was low-pass filtered at 6 Hz with a 2nd order Butterworth filter and 
the peak torque was normalized by body weight. 
Statistical analysis
Student’s t-tests were used for comparing group characteristics, spatiotemporal parameters, 
kinematics and muscle strength tests between the patient and control groups. Paired 
samples t-tests were used for comparisons between operated and non-operated limbs. Hip 
joint moments during gait were tested with repeated-measures ANOVAs; one with phase of 
gait cycle (early and late stance) and limb (operated and non-operated) as within-subjects 
factors, and another with phase of gait cycle (early and late stance) as within-subjects factor 
and group (operated limb of patients and controls) as between-subjects factor. Post-hoc 
paired samples t-tests were used if the ANOVA indicated significant differences between the 
operated and the non-operated limb. The significance level was set at p≤0.05. For the muscle 
strength data, significance was set at p≤0.01 because of the number of t-tests performed 
(12). IBM SPSS Statistics 20.0.0.1 was used for all statistical analyses.
Results
Group characteristics
Descriptive characteristics of the patients who had undergone TIO and of the controls are 
shown in Table 3.1. No significant group differences were found for age, weight, height, 
or BMI. The participating patients were between 59 and 111 months post surgery. Their 
average Harris hip score was ‘good’ (84 points), and their average Oxford hip score was 
‘excellent’ (42 points).
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Spatiotemporal parameters
Spatiotemporal parameters are shown in Table 3.2. None of the parameters differed 
significantly between the groups. Within the patient group, the step length of the operated 
leg was 0.03 m smaller than that of the non-operated leg (p = 0.019), whereas the stance time 
was 1.2% longer (p = 0.039).
Kinematic gait parameters
The kinematics of the operated and non-operated limb did not differ significantly from 
controls (Figure 3.2A and 3.2C). There were also no differences between the operated and 
non-operated limbs.
                                
Figure 3.1. Experimental setup for muscle strength measurements. These were performed for (A) hip 
abduction, (B) knee flexion, and (C) knee extension. In all cases, the end piece (soft Velcro strap) of 
the force transducer was applied perpendicular to the limb, and the other end was rigidly attached to 
either a clinical testing bench, a wall, or a custom-built chair.
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Kinetic gait parameters
Hip abduction moments during stance are shown in Figure 3.2D. The operated limb had a 
different abduction moment pattern than the non-operated limb during the stance phase, as 
demonstrated by a significant phase x limb interaction effect (F1,10 = 5.78, p = 0.037); in early 
stance, the abduction moment in the operated limb was non-significantly lower than in the 
non-operated limb (p = 0.129), whereas in late stance it was non-significantly higher (p = 
0.192). The main effect of limb was not significant (F1,10 = 0.12, p = 0.742). The operated limb 
was not significantly different from controls (group: F1,16 = 0.00, p = 0.949; phase x group: 
F1,16 = 2.63, p = 0.125). 
Sagittal plane hip moments during stance are shown in Figure 3.2B. The hip flexion and 
extension moments generated by the operated limb of the patients were not different from 
the unaffected limb (limb: F1,10 = 0.03, p = 0.861, phase x limb: F1,10 = 1.51, p = 0.247). The 
operated limb did not differ from controls (group: F1,16 = 2.62, p = 0.125, phase x group: F1,16 
= 0.28, p = 0.601).
Muscle strength
Abduction strength was significantly lower than healthy controls in both the operated and 
the non-operated limb (Figure 3.3), whereas differences in knee flexion and extension 
strength between patients and controls did not reach significance. The operated and non-
operated limbs did not differ in any of the strength measurements.
Discussion
In this study, we found that patients who had undergone TIO (on average 80 months ago) 
did not have major abnormalities in their gait pattern compared to controls, but did exhibit 
subtle asymmetries between the operated and non-operated limbs. The operated limb had a 
smaller step length and longer stance time compared to the non-operated limb. In addition, 
the abduction moment pattern during the stance phase was significantly different between 
the operated and non-operated limbs. In terms of muscle strength, a bilateral abduction 
strength deficit was found. Muscle strength did not differ between the operated and the non-
operated limb for any of the tested joints. 
Interestingly, we found subtle asymmetries in hip abduction moments between the operated 
and non-operated limbs. This may represent a more cautious walking pattern, by enabling a 
more gradual transfer of the body’s centre of mass over the operated limb, thereby reducing 
the peak hip abduction moment in early stance. This does not seem to be related to a lack of 
hip abductor strength, as there was no difference in strength between the operated and non-
operated leg. The reduced step length and prolonged stance duration that we found in the 
operated limb, albeit rather small, may also point to an integral strategy in the frontal plane 
reflecting a more cautious walking pattern. 
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Compared to healthy controls, we found significantly reduced hip abduction strength in 
patients who had undergone TIO. Hip abductor weakness is a common finding in patients 
with hip dysplasia, frequently resulting in Trendelenburg’s sign during gait (Romano et 
al. 1996; Steel 1973). Hence, the persisting weakness that we found may be reflective of 
severe muscle atrophy that had developed over many years prior to surgery and that did 
not fully recover despite postoperative rehabilitation. Alternatively, our patient group may 
have been less physically active than the controls, resulting in poorer muscle strength. We 
indeed observed a general trend of muscle strength reduction in all the tests performed, but 
Table 3.1 Characteristics of patients after triple innominate 
osteotomy and controls
TIO patients
n = 12
Controls
n = 8
p*
Age (years) 34 (12) 33 (10) 0.910
Weight (kg) 66.8 (5.2) 66.2 (11.6) 0.894
Height (m) 1.67 (0.07) 1.72 (0.07) 0.343
BMI (kg/m2) 23.9 (2.4) 22.3 (3.0) 0.232
Time since surgery (months) 80 (18)
Operated limb L: 3, R: 9
Harris Hip Score 84 (15)
Oxford Hip Score 42 (5)    
Data are presented as mean (SD). * Student’s t-test for weight and BMI, 
Mann-Whitney U test for age and height.
Table 3.2 Spatiotemporal parameters of patients after triple innominate 
osteotomy and controls
TIO patients Controls p*
Walking speed (m/s) 1.32 (0.14) 1.34 (0.22) 0.752
Cadence (steps/min) 116.7 (5.5) 115.2 (13.1) 0.733
Step length operated limb (m) 0.66‡  (0.08) 0.69† (0.06) 0.386
Step length non-operated limb (m) 0.69‡  (0.05) 0.69† (0.06) 0.924
Stride length (m) 1.35 (0.12) 1.40 (0.11) 0.477
Stance duration operated limb (% of gait cycle) 61.2§ (2.1) 60.0† (1.5) 0.202
Stance duration non-operated limb (% of gait cycle) 60.0§ (2.0) 60.0† (1.5) 0.961
Data are presented as mean (SD). 
* Student’s t-test.
† Mean of both legs.
‡ Significantly different between operated and non-operated limb (paired t-test: p = 0.019).
§ Significantly different between operated and non-operated limb (paired t-test: p = 0.039).
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the pronounced weakness in hip abduction argues against an overall reduction in physical 
activity being the only responsible factor.
Our finding that hip abduction strength was substantially lower in patients compared to 
controls, whilst no main effect of group could be demonstrated for hip abduction moments 
during gait implies that the patients walked at a higher percentage of their maximum 
capacity. This may eventually result in gait pattern changes when patients become fatigued, 
as it has been shown that human gait is relatively sensitive to weakness in the hip abductor 
muscle group (van der Krogt et al. 2012). A gait pattern typical of abductor weakness 
(Trendelenburg’s sign) may then emerge, involving pelvic drop at the contralateral side. This 
increases hip joint stress in the operated hip due to a decrease in joint contact area (Westhoff 
et al. 2006), which may speed up the development of osteoarthritis in the operated hip. 
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Figure 3.2. Hip kinematics and kinetics of patients after triple innominate osteotomy and healthy con-
trols. Shown are (A) sagittal plane kinematics, (B) sagittal plane kinetics, (C) frontal plane kinematics, 
and (D) frontal plane kinetics. The kinematic data are normalized to full gait cycle (heel strike to ipsi-
lateral heel strike); the kinetic data are normalized to the stance phase of the gait cycle (heel strike to 
ipsilateral toe off). Standard deviations of the mean of the operated limb are shown at the time points 
that were tested statistically (maximum extension angle, maximum flexion angle, hip adduction angle 
at 20% of the gait cycle, maximum extension moment, maximum flexion moment, and maximum hip 
abduction moment in early and late stance). The shaded areas represent equal boundaries of ±1SE for 
controls. The horizontal bracket and star in (D) indicate the significant interaction effect between the 
operated and the non-operated limb during the stance phase.
65
Gait and Strength in Women After Triple Innominate Osteotomy
3a
The clinical results of TIO at comparable follow-up times are generally ‘good’, ‘excellent’, 
or ‘improved compared with before the operation’ (de Kleuver et al. 1997; Hsin et al. 
1996; Janssen et al. 2009), which is congruent with the results of our study. Hence, the 
functional status of our study population appears to be representative of the TIO group 
at large. To our knowledge, up to this point no studies have been published that employed 
gait analysis or maximum strength measurements to describe the functional outcome after 
TIO surgery. In contrast, results from gait analyses have been reported for patients after 
Ganz’s periacetabular osteotomy (Ganz et al. 1988), which conceptually is a rather similar 
procedure to the modified Tönnis osteotomy used here (Kooijman et al. 1990). Our findings 
that patients after TIO did not demonstrate major gait deviations compares well to previous 
results from patients after Ganz’s osteotomy. After that surgery, no statistically significant 
differences from controls could be demonstrated in sagittal hip joint kinematics and kinetics 
(Pedersen et al. 2004; Pedersen et al. 2006) or frontal plane kinetics (Sucato et al. 2010). 
Similarly, Karam et al. investigated spatiotemporal gait parameters before and one year after 
Ganz’s osteotomy (Karam et al. 2011) and found post-operative walking velocities, stride 
lengths and cadences very similar to our results. Thus, the relatively small differences in the 
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Figure 3.3. Maximum generated torque of patients who had undergone triple innominate osteotomy 
and controls. Peak torque values are given in Newton-meters, normalized to body weight. The error 
bars represent equal boundaries of ±1SD. x Indicates a statistically significant difference (p≤0.01).
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surgical approach between TIO and Ganz’s osteotomy (even if it was abductor-sparing, as 
in the case of Sucato et al. (2010) do not appear to play a major role in long-term functional 
outcome.
Our study has certain limitations. First, we invited 34 patients to participate in the study, 
but only 18 responded, out of which 12 patients could be included. The non-responders and 
excluded patients might have had more pain or functional limitations than those included. 
Moreover, since there were only women in our study population, the results might not apply 
to men who underwent TIO. Second, although the study groups were similar with regard to 
age, gender, height, weight and BMI, we did not take confounding factors into account such 
as general activity level or participation in sports. As such, it is possible that the patients were 
less active than the controls and that, therefore, they had less muscle strength around the 
hip and knee joints. Third, we did not perform gait and strength measurements before the 
surgery. Such analyses could reveal whether the deviations in gait observed post-operatively 
in this study stem from pre-operatively adopted gait patterns. Fourth, we did not adjust 
the geometry of the operated hip joint in the AnyBody model. The joint’s centre of rotation 
in our patients might have been slightly altered by the TIO, thereby influencing the joint 
moment calculations. 
Conclusions
This study showed that patients who underwent TIO generally recovered well from their 
operation with regard to gait, but did exhibit subtle asymmetries between the operated 
and non-operated limbs several years after surgery. Muscle strength deficits were found 
bilaterally in hip abduction. Although the differences observed in gait were subtle, they may 
become clinically important in young or active patients who engage in high-level activities 
over many years. Thus, in further research in this patient group it is recommended to focus 
on gait adaptations after prolonged walking.
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Chapter 3b
Gait and lower limb muscle strength in women with congenital 
hip dysplasia after total hip arthroplasty with femoral shortening
(abstract only)
Kolk, S., Rijnen, W.H., Verdonschot, N., Weerdesteyn, V.
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Abstract
Background: Congenital hip dysplasia may, in severe cases, lead to cranial migration of the 
femoral head. To alleviate the associated pain and walking problems, total hip arthroplasty 
with acetabular reconstruction and femoral shortening can be performed. The purpose of 
this study was to quantify the functional outcome of this procedure.
Methods: We performed gait analyses and isometric hip (abduction and extension) and knee 
(flexion and extension) muscle strength tests in seven women who had undergone a unilateral 
total hip arthroplasty with femoral shortening (39±13y, time post-surgery: 45±52m). They 
walked at self-selected walking speed and wore their own shoes, which corrected the residual 
leg-length discrepancy. Kinematic and kinetic data were captured with a three-dimensional 
motion capture system (Vicon MX) and force plates embedded level in the laboratory floor. 
The data were analyzed using AnyBody 5.3.1 (AnyBody Technology A/S). We compared the 
results to reference values obtained from seven healthy peers (31±10y). 
Results: Walking speed, cadence and step length were similar between patients and controls, 
but patients had a shorter single support phase on the operated side. The adduction angle 
in the operated limb was significantly larger than in the non-operated limb (Figure 3.4A). 
Kinetic deviations in the operated limb included lower hip abduction moments (Figure 3.4B; 
compared to controls), and a lower hip extension moment (compared to the non-operated 
limb). The operated limb had lower hip and knee muscle strength compared with controls in 
all directions, which was also true for hip strength on the non-operated side. The operated 
limb was weaker than the non-operated limb except for knee flexion.
Conclusions: Our results demonstrate that the patients had persisting gait deviations 
in the frontal plane with asymmetries between the operated and non-operated side. The 
observed gait deviations point to the occurrence of Trendelenburg’s sign to compensate for 
abductor weakness. This is supported by the reduced abductor muscle strength obtained 
in the isometric measurements. It is unknown if there is potential to improve in this area, 
because of plausible structural changes in the muscle tissue stemming from many years of 
functioning at non-optimal lengths. Our results may help in informing patients about their 
expected walking ability.
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Abstract
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this study was to quantify the functional outcome of this procedure.
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in the isometric measurements. It is unknown if there is potential to improve in this area, 
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Abstract
Background: Accurate predictions of functional outcome after limb salvage surgery (LSS) 
in the lower limb are important for several reasons, including informing the patient 
preoperatively and, in some cases, deciding between amputation and LSS. This study aimed 
to elucidate the correlation between surgeon-predicted and patient-reported functional 
outcome of LSS in the Netherlands. 
Methods: Twenty-three patients (between six months and ten years after surgery) and 
five independent orthopedic oncologists completed the Toronto Extremity Salvage Score 
(TESS) and the RAND-36 physical functioning subscale (RAND-36 PFS). The orthopedic 
oncologists made their predictions based on case descriptions (including MRI scans) that 
reflected the preoperative status. 
Results: The correlation between patient-reported and surgeon-predicted functional 
outcome was “very poor” to “poor” on both scores (r2 values ranged from 0.014 to 0.354). 
Patient-reported functional outcome was generally underestimated, by 8.7% on the TESS 
and 8.3% on the RAND-36 PFS. The most difficult and least difficult tasks on the RAND-36 
PFS were also the most difficult and least difficult to predict, respectively. Most questions 
had a “poor” intersurgeon agreement. 
Conclusions: It was difficult to accurately predict the patient-reported functional outcome of 
LSS. Surgeons’ ability to predict functional scores can be improved the most by focusing on 
accurately predicting more demanding tasks.
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Introduction
Limb salvage surgery (LSS) rather than amputation is the operation of choice in 70-85% of 
all malignant bone and soft tissue lower limb sarcomas (Gebhardt 2002; Veth et al. 2003). 
Since the oncological results for amputation and LSS in the surgical treatment of sarcomas 
are comparable (Ghert et al. 2005; Niimi et al. 2008), the decision to perform an amputation 
or LSS is based on the tumor size, the tumor location, patient preferences, the expected risk 
of complications and multiple reoperations, and the expected functional outcome (Ghert 
et al. 2005). If it is surgically possible, LSS is generally the preferred treatment, unless a 
poor functional outcome is expected. It has been shown that the functional outcome of 
LSS is superior to amputation, with the exception of below-knee amputation, which yields 
a similar function as limb salvage (Aksnes et al. 2008). The expected functional outcome of 
patients after LSS is thus an important part of the preoperative decision making process for 
the surgical treatment. 
Several known predictors of functional outcome include tumor size, location, grade, bone 
resection, muscle involvement, use of radiotherapy and motor nerve sacrifice (Davis et 
al. 2000). The functional outcome is predicted by the surgeon based on these parameters 
combined with his/her clinical experience. However, to the best of our knowledge, there 
are no reports about how well surgeons are able to actually predict functional outcome after 
LSS. Insight into the level of accuracy of these predictions is important for several reasons. 
First, accurate predictions of functional outcome are highly relevant in informing the patient 
preoperatively about the expected final functional outcome. Second, in some cases, the 
predictions are helpful in deciding between amputation or LSS. Third, information about 
the correlation between predicted functional outcome and patient-reported functional 
outcome provides valuable information for surgeons in training. 
In this study, we (1) aimed to establish whether orthopedic oncologists can accurately 
predict patient-reported functional outcome of LSS in the treatment of sarcoma in the lower 
limb in a selected group of patients. We also (2) examined whether there was a tendency to 
over- or underestimate patient-reported functional outcome. Additionally, (3) we sought to 
identify which items on the functional outcome scores were least difficult and which were 
most difficult to predict, and whether the surgeons agreed amongst themselves (interrater 
reliability) in their predictions. 
Materials and Methods
Patients
We selected patients who had undergone a LSS for a sarcoma in the lower limb from a 
database of orthopedic oncologic patients at the department of orthopedic surgery of the 
Radboud University Medical Center (RUMC), Nijmegen, The Netherlands. The database 
contained 216 patients who had undergone LSS or amputation for any type of tumor 
in the hip or knee region. We selected patients using the following inclusion criteria: 
follow-up at least six months after the surgery (before July 1, 2012) for patients without 
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adjuvant treatment and at least twelve months for patients with adjuvant treatment, a 
maximum follow-up of ten years (after February 1, 2003), and age between 18-70 years, 
and preoperative MRI-scans had to be available. The follow-up of at least six months was 
chosen because functional scores tend to plateau within that time frame (Davis et al. 2000; 
Davis et al. 1996). We excluded patients who had a bone tumor with an intact cortical bone, 
as almost no functional deficits were expected to occur in those patients. Patients who had 
suffered local recurrence or complications that required reoperation in the last six months 
before the study were excluded. A flow chart of the patient selection is shown in Figure 4.1. 
Twenty-four patients were eligible for inclusion in the study, of whom 23 were successfully 
contacted. All 23 patients were included in the study. The study procedures were approved 
by the local ethical committee of the RUMC. Written informed consent was obtained from 
all participants. 
Materials
To evaluate the functional outcome we used the Toronto Extremity Salvage Score (TESS) 
for the lower extremity and the RAND-36 physical functioning subscale (RAND-36 PFS). 
The TESS is a patient-reported questionnaire that has been specifically designed to measure 
the physical functional status of patients after limb-salvage surgery (Davis et al. 1996). It 
contains 30 questions, and the final score ranges from 0% to 100%, 100% being the highest 
achievable score. The RAND-36 PFS is intended to measure physical functioning in any 
patient cohort (van der Zee et al. 2012; van der Zee et al. 1996), which makes it more general 
than the TESS. Like the TESS, the RAND-36 PFS also is a patient-reported questionnaire. 
The RAND-36 PFS consists of ten questions, and the final score ranges from 0% to 100%, 
100% being the highest achievable score. The RAND-36 PFS is identical to the SF-36 PFS. 
In addition to the TESS and RAND-36 PFS, we also used the RAND-36 pain subscale to 
examine postoperative pain levels. The RAND-36 pain subscale contains two questions; one 
regarding the amount of pain and one regarding the hindrance experienced due to pain 
when performing everyday activities in the previous four weeks (van der Zee et al. 2012; van 
der Zee et al. 1996). The final score ranges from 0% to 100%, where 100% represents no pain. 
We did not employ the Musculoskeletal Tumor Society score (Enneking et al. 1993), as that 
score is not patient-reported, and includes the domains of pain and emotional acceptance, 
which would have been impossible to predict solely on the basis of case descriptions.
A case description of each patient was made, which reflected the preoperative status of the 
patient. It contained the patient’s age, sex, body mass index (BMI), tumor diagnosis, 
diagnostic MRI-scans, a description of the performed surgical procedure for tumor resection 
and reconstruction, whether the patient had received adjuvant pre- or postoperative chemo- 
or radiotherapy, and whether there were any complications from the surgery (a case example 
is shown in Figure 4.2). The information did not include follow-up time. If a reresection had 
been performed, the preoperative MRI scans from before the primary resection surgery 
were provided, rather than those made after the local recurrence. The case descriptions were 
distributed through a central electronic platform. Whenever bone was removed it was 
replaced by a tumor prosthesis and/or an allograft.
                                      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Original database
(n = 216) 
Suitable for inclusion 
(n = 25) 
No pre-operative MRI 
scan available 
(n = 65)
Too young (n = 20)
Too old (n = 19)
Date of surgery outside 
study range (n = 10) 
Tumor in the bone, 
intact bone cortex (n 
= 45)
Died (n = 22) 
No Limb-salvage 
surgery (n = 7) 
Recent (<6 months) re-
resection (n = 3) 
Missing surgery log 
(n = 1) 
Included (n = 23) 
Could not be 
contacted (n = 1) 
Figure 4.1. Flow chart of patient selection. Some patients fitted into multiple exclusion criteria (e.g., 
‘no pre-operative MRI scan available’ and ‘too old’); in such cases, the patient was counted as belon-
ging to the first of those exclusion criteria.
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Twenty-four patients were eligible for inclusion in the study, of whom 23 were successfully 
contacted. All 23 patients were included in the study. The study procedures were approved 
by the local ethical committee of the RUMC. Written informed consent was obtained from 
all participants. 
Materials
To evaluate the functional outcome we used the Toronto Extremity Salvage Score (TESS) 
for the lower extremity and the RAND-36 physical functioning subscale (RAND-36 PFS). 
The TESS is a patient-reported questionnaire that has been specifically designed to measure 
the physical functional status of patients after limb-salvage surgery (Davis et al. 1996). It 
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which would have been impossible to predict solely on the basis of case descriptions.
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diagnostic MRI-scans, a description of the performed surgical procedure for tumor resection 
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or radiotherapy, and whether there were any complications from the surgery (a case example 
is shown in Figure 4.2). The information did not include follow-up time. If a reresection had 
been performed, the preoperative MRI scans from before the primary resection surgery 
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Study procedures
The patients were interviewed about their current functional status in a structured telephone 
call (done by KC, an independent researcher who was not a medical doctor), consisting of 
the TESS, the RAND-36 PFS, and the RAND-36 pain subscale. Five independent orthopedic 
oncologists (JB, PD, PJ, JP, and MvdS), working in one of the other three Dutch orthopedic 
oncologic referral centers (other than the RUMC) participated in the study. They were asked 
to give a prediction of the total TESS score (one percentage for the total functional status 
of the patient without addressing all separate items), and a prediction of the ten individual 
items of the RAND-36 PFS, based on the case descriptions. They had never been involved in 
the treatment of the patients and were unaware of their patient-reported functional outcome. 
All orthopedic oncologists were experienced and specialized in orthopedic oncology. They 
were familiar with the employed functional scales, and were provided with a copy of the 
TESS questionnaire for reference.
Outcome measures and statistical analyses
Descriptive statistics were calculated and stated as mean ± standard deviation. We compared 
the patient-reported and surgeon-predicted TESS and RAND-36 PFS scores in three ways. 
First, Pearson correlations were calculated between the patients’ reported scores and 
individual surgeon predicted scores, as well as for the average scores of all the surgeons 
combined. The squared correlation coefficient, r2- (coefficient of determination), represents 
the variation in the values of the patient-reported outcome that can be explained by variations 
in the value of the surgeon-predicted outcome (Taylor 1990). An r2-value of 0.75-1.00 was 
Case 7: ♂ 37 years   
BMI: 23,74 (83kg / 1m872)
Indication: Malignant fibrous 
hystiocytoma left distal femur, pre-
treated with chemotherapy. An incision 
biopsy has been done on the left       
anterolateral side. 
Surgical treatment: Extra-articular
distal femur resection and 
reconstruction with tumour prosthesis.
Preoperative MRI: 
Top row: Transversal (T1 – FS)
Middle row: Transversal (T1)
Bottom row: Sagittal (T1)
Figure 4.2. Example case as given to the orthopedic oncologists. This is patient 7 in Table 4.1.
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interpreted as a “very good” prediction, 0.50-0.74 as “good”, 0.25-0.49 as “poor” and 0-0.24 
as “very poor”. The r2-values were considered the primary outcome measure.
Second, the mean differences and 95% confidence intervals (95% CI) between the patient-
reported scores on the TESS and RAND-36 PFS and the surgeon-predicted scores were 
calculated to reveal whether the predictions had a bias towards being too optimistic or 
pessimistic. 
Third, the agreement between patient-reported and the median surgeon-predicted answers 
to the separate questions of the RAND-36 PFS were examined using percent agreement and 
Gwet’s agreement coefficient (AC1). Compared with Cohen’s Kappa (Cohen 1960, 1968), 
Gwet’s AC1 has a more stable inter-rater reliability, and is less affected by prevalence and 
marginal probability (Wongpakaran et al. 2013). This allowed us to identify which questions 
were the least difficult and most difficult to predict. The intersurgeon agreement on each 
separate question was also calculated, using percent agreement and Gwet’s AC1. To calculate 
the intersurgeon agreement on the TESS, we used the intraclass correlation coefficient (ICC; 
absolute single measure/absolute agreement). Agreement coefficients below 0.40 were 
considered to represent a “poor” agreement; between 0.40 and 0.59 ‘fair’; between 0.60 and 
0.74 “good” and between 0.75 and 1.00 ‘excellent’, analogous to commonly used guidelines 
for interexaminer agreement (Cicchetti 1994). 
The associations between each separate variable (age, sex, BMI, pain, and time since surgery) 
and patient-reported TESS and RAND-36 were examined using univariate regression 
analyses to examine whether they were associated with the functional outcome scores.
Matlab R2011a (The Mathworks, Natick, MA, USA) and R version 3.0.2. (R Core Team 
2014) were used for the statistical analyses.
Results
Patients
The characteristics of all 23 patients are listed in Table 4.1. The age at the time of surgery 
was 39.9 ± 18.8 years, and the time after surgery was 47 ± 27 months. All patients were 
ambulatory and able to at least walk short distances without a walking aid. Two patients 
(cases 10 and 21) had undergone a reresection; this was mentioned in the case file. All other 
patients had not suffered from local recurrence or complications that required follow-up 
surgery. The mean patient-reported scores were: TESS 87.0 ± 12.1, RAND-36 PFS 73.3 ± 
18.7, and RAND-36 pain subscale 85.5 ± 24.7. 
Surgeon predictions – TESS
The surgeon-predicted scores and their correlations with the patient-reported scores of all 
five surgeons and the average predictions of all surgeons on the TESS are shown in Figure 4.3 
and in Table 4.2. The correlations with the patient-reported scores were “very poor” for all 
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surgeons, with the best correlation for surgeon 2 (r2 = 0.185). The TESS was underestimated 
for most patient cases (Figure 4.3); the mean underestimation ranged from 1.5 to 22.6 
percentage points (Table 4.2). The correlations with the patient-reported TESS formed by 
averaging all five surgeons’ predictions were “very poor” (r2 = 0.159) and underestimated 
patient-reported functional outcome by 8.7 (95% CI: 3.62-13.7) percentage points. The 
intersurgeon agreement on the TESS was “poor” with an ICC of 0.29 (95% CI: 0.10-0.53).
Surgeon predictions – RAND-36 PFS
The surgeon-predicted RAND-36 PFS scores and their correlations with the patient-reported 
scores are shown in Figure 4.4 and in Table 4.2. The correlations to the patient-reported 
scores were either “very poor” (surgeons 1, 4 and 5) or “poor” (surgeons 2 and 3). Surgeon 
3’s predictions had the highest correlation with the patient-reported scores (r2 = 0.354). 
The patient-reported RAND-36 PFS score was underestimated by all surgeons, except for 
surgeon 2 (5.4 percentage points overestimation) (Table 4.2). The average correlations with 
the patient-reported scores were “poor” (r2 = 0.255) and underestimated patient-reported 
functional outcome by 8.3 (95% CI: 0.64-16.0) percentage points.
In the analysis of the individual questions that make up the RAND-36 PFS, ‘Climbing 
several flights of stairs’ and ‘Walking more than a mile’ were the most difficult items to 
predict, with “poor” agreement coefficients (AC1) of 0.15 and 0.19, respectively, between 
surgeon-predicted and patient-reported scores (Table 4.3). ‘Walking one block’ and ‘Bathing 
or dressing yourself ’ were the least difficult items to predict, with ‘excellent’ agreement 
coefficients of 0.81 and 0.76, respectively, between surgeon-predicted and patient-reported 
scores. Similar to the overall RAND-36 PFS scores, most of its separate questions were 
underestimated; only two questions were overestimated (‘Bending, kneeling, or stooping’ 
and ‘Lifting or carrying groceries’).
Table 4.2 Patient-Reported and Surgeon-Predicted Mean TESS and RAND-36 PFS 
Scores and Coefficients of Determination for TESS and RAND-36 PFS Scores
TESS RAND-36 PFS
Mean scorea r2 Mean scorea r2
Patient-reported 87.0 (12.1) 73.3 (18.7)
Surgeon 1 75.6 (13.6) 0.167 50.9 (20.3) 0.142
Surgeon 2 83.6 (8.6) 0.185 78.7 (15.5) 0.336
Surgeon 3 82.5 (7.1) 0.096 70.2 (17.9) 0.354
Surgeon 4 85.5 (11.9) 0.014 72.2 (18.7) 0.081
Surgeon 5 64.3 (14.7) 0.088 52.8 (26.8) 0.118
Average of surgeons 78.3 (8.7) 0.159 65.0 (16.6) 0.255
a Scores are reported as mean (SD).
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On most questions of the RAND-36 PFS, the inter-surgeon agreement coefficient was “poor”, 
but there was a ‘fair’ agreement on ‘Bathing or dressing yourself ’ and ‘Moderate activities’, 
and a “good” agreement on ‘Vigorous activities’ and ‘Walking one block’ (Table 4.3). 
Other potential predictors
No correlations were found between the TESS or RAND-36 PFS and any of the potential 
predicting factors (Table 4.4). 
Discussion
This national survey aimed to investigate how well orthopedic oncologists are able to predict 
the patient-reported functional outcome of patients that had undergone LSS in the lower 
limb. We found “very poor” to “poor” correlations between patient-reported outcomes and 
surgeon-predicted outcomes on both the TESS and the RAND-36 PFS. The orthopedic 
oncologists tended to underestimate patient-reported functional outcome on both scales. 
The most difficult tasks on the RAND-36 PFS were also the most difficult to predict, whereas 
for the least difficult tasks it was easy to predict that these could be performed without 
substantial limitations by nearly all patients. The intersurgeon agreement on the RAND-36 
PFS questions was mostly “poor”, but was “good” for some of the most and least demanding 
tasks. None of the potentially predicting factors were related to the primary outcome 
measures.
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Figure 4.3. Scatter plots of patient-reported outcome and orthopedic tumor surgeon predictions on the 
Toronto Extremity Salvage Scale (TESS). The dashed lines indicate a hypothetical perfect correlation; 
if a patient case lies above or below this line, the functional outcome was overestimated or underesti-
mated, respectively.
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Our results indicate that it was difficult for the participating orthopedic oncologists to 
accurately predict the patient-reported functional outcome of limb salvage surgery. On 
the TESS for instance, the coefficients of determination (r2) between patient-reported and 
surgeon-predicted outcomes were lower than 0.20, indicating that less than 20% of the 
variance in TESS could be explained by the predictions made by the orthopedic oncologists. 
We did not expect such a poor predictive ability, considering the experience level of the 
orthopedic oncologists with limb salvage surgery. Several aspects may underlie this 
seemingly rather poor predictive ability. 
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Figure 4.4. Scatter plots of patient-reported outcome and orthopedic tumor surgeon predictions on 
the RAND-36 physical functioning subscale (RAND-36 PFS). The dashed lines indicate a hypothetical 
perfect correlation; if a patient case lies above or below this line, the functional outcome was overesti-
mated or underestimated, respectively.
Table 4.4 Coefficients of Determination Between Patient Characteristics 
and Functional Outcomes (TESS and RAND-36 Physical Functioning 
Subscale)
TESS RAND-36 PFS
r2 r2
Age 0.011 0.001
Sex 0.024 0.001
Body mass index 0.008 0.003
Pain (RAND-36 pain subscale) 0.042 0.079
Time since surgery 0.036 0.015
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First, each limb salvage patient presents a unique case in terms of anatomical involvement. 
Even in patients with the same type of tumor at a similar location, for instance the distal 
femur, final functional results can differ to a large extent. In part, this depends on the 
amount and precise location of soft tissue involvement, which may have been difficult 
to see from the limited set of MRI images in the case files. Moreover, patients are unique 
in terms of adaptive capacity. The adaptation of the patient to the new anatomical and 
sensorimotor situation plays a large role in the recovery of function (De Visser et al. 
2000). The amount of adaptive capacity may have been hard or impossible to estimate by 
the orthopedic oncologists from the case files. Second, we measured functional outcome 
with questionnaires, which are inherently subjective. Thus, the patients’ own perception of 
functioning may have played a large role in the functional outcome score. It might be that 
functional outcome measured by objective means, such as for example gait analysis, more 
closely reflects the orthopedic oncologists’ predictions. Third, in the case files, we mimicked 
as well as possible the information typically available preoperatively to the surgeon in a 
clinical setting, but the study design did not permit the independent surgeons to review the 
medical history of the patients, nor to perform a physical examination before the surgery. 
As such, predictions of patient-reported functional outcome in a ‘real’ clinical setting (e.g., 
including a physical examination) might be more accurate than those made in this study. 
Fourth, patients who had a bone tumor with an intact cortical bone were not included; 
the patient-reported functional outcome in those patients would potentially have been less 
difficult to predict than that in the patients with larger tumors. 
The poor predictive ability raises the question which other factors determine functional 
outcome in limb saving surgery, and to what degree. Davis et al. showed that large tumor 
size, deep lesions, high grade tumor, use of radiotherapy, bone resection, and motor nerve 
sacrifice are significantly related to increased disability on the TESS (Davis et al. 2000). In 
their study, those combined parameters were able to predict 20% of the variance in TESS 
score. This is in the same order of magnitude as the presently reported results, indicating 
that the surgeons were unable to ‘add’ predictive value on top of the given parameters in 
the case files. The rehabilitation protocol may also have an effect on functional outcome; 
Shehadeh et al. showed that adherence to a strict rehabilitation protocol after limb salvage 
surgery led to a relatively high level of functional outcome compared with other studies 
(Shehadeh et al. 2013). If we interpret our findings concurrent with those of Davis et al. 
and Shehadeh et al., it appears that still a large percentage of functional outcome cannot 
be predicted by the surgeon, nor by anatomical and surgery or adjuvant therapy-related 
factors, nor by rehabilitation protocols. Other factors that may play a significant role in the 
patient-reported functional outcome include the preoperative physical and mental state of 
the patient. For example, a patient who is highly motivated and athletic may recover to a far 
higher level of functioning than one who is less motivated and leads a sedentary lifestyle. 
From this perspective, one may intuitively expect a correlation between patient-reported 
functional outcome and age or BMI, but we did not find this (Table 4.4). Further studies are 
required to clarify the role each factor plays in patient-reported functional outcome after 
limb salvage surgery.
The orthopedic oncologists tended to underestimate patient-reported functional outcome 
on both the TESS and the RAND-36 PFS. Thus, it appears that the patients adapted to the 
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new anatomical and functional situation better than the surgeons predicted. It is possible 
that this is due to some surgeons being used to picturing a somewhat more pessimistic 
scenario to their patients so that the actual achieved functional result exceeds the patients’ 
expectations. However, we specifically instructed the surgeons to provide their most accurate 
predictions of patient-reported functional outcome, rather than to provide predictions that 
they would share with patients. As for clinical relevance, we did not set a specific threshold, 
but the underestimation of patient-reported functional outcome on both the TESS and the 
RAND-36 PFS was rather consistent, as demonstrated by the 95% confidence intervals that 
did not pass through zero.
Interestingly, we found that the ‘Walking one block’ question was the least difficult to 
predict, whereas the ‘Walking more than a mile’ question was one of the most difficult to 
predict (only ‘Climbing several flights of stairs’ was more difficult to predict). It appears 
that the ultimate level of function that is reached in patients is hard to predict, whereas it is 
easier to predict lower levels of function. Thus, surgeons’ ability to predict functional scores 
can be improved the most by focusing on accurately predicting more demanding tasks. 
Additional improvement might be gained by analyzing the prediction for the ‘Bending, 
kneeling, or stooping’ question. If the prediction for this question did not match with the 
patient-reported outcome, it was mostly overestimated (43.5% of cases). This overestimation 
breaks with the general trend to underestimate patient-reported functional outcome, and 
indicates that bending the knees is more difficult to do for patients than the median surgeon 
predicted.
The intersurgeon agreement on most RAND-36 PFS questions was “poor”, indicating 
that there was a high inter-surgeon variability in the predictions to the questions. Notable 
exceptions were ‘Walking one block’ and ‘Vigorous activities’, with “good” intersurgeon 
agreement. The prior arguably is the least difficult activity on the scale, whereas the latter 
represents the most demanding activities on the scale (including running, heavy lifting 
and strenuous sports). However, this does not imply that there was also a high agreement 
with the patient-reported outcome; ‘Vigorous activities’ had only a ‘fair’ agreement with 
the patient-reported score. ‘Walking one block’, on the other hand, was the only question 
that had both an ‘excellent’ agreement with the patient-reported score, as well as a “good” 
intersurgeon agreement. This might be due to the surgeons’ familiarity with predicting this 
basic level of functional outcome, or because being able to walk at least short distances is 
considered one of the criteria for attempting limb salvage surgery, and most patients indeed 
achieved that goal. 
This study has some limitations. First, the surgeons only predicted the total TESS score, 
instead of predicting each of the 30 questions that comprise the score. This was done because 
some questions were already present in the much shorter RAND-36 PFS, and to reduce 
the time it would take the surgeons to predict the 23 cases. Second, we used a translated 
version of the TESS which has not been validated in Dutch. However, as the TESS is the 
gold standard assessment tool after limb salvage surgery we decided to use it (Clayer et al. 
2012). The RAND-36 PFS has been validated in Dutch (van der Zee et al. 2012; van der 
Zee et al. 1996), and its results showed the same trend in the comparisons as the translated 
TESS. Third, we found a wide range of patient-reported functional outcome scores, 
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including in patients that had undergone similar surgery. Of course, each case is unique, 
but the perception of effort required to perform the activities in the questionnaires and 
the interpretation of the questions can vary between patients. Measuring actual functional 
outcome (e.g., in a movement laboratory or by observing patients in their home setting) 
could yield more knowledge of actual functioning, eliminate the subjectivity inherent in 
questionnaires, and establish the construct validity of the employed functional scoring 
systems. Fourth, the surgeons predicted the functional outcome based on a case description 
without being allowed to review the medical history of the patients or perform a physical 
examination. The time since surgery was also not provided, which might have negatively 
affected the predictions. This, however, does not explain the large differences found between 
predicted and patient-reported functional outcome nor does it explain the differences in 
predictions between surgeons. Furthermore, there was no correlation between the patient-
reported functional scores and the time since surgery (Table 4.4).
Conclusions
It was difficult for the participating orthopedic oncologists to accurately predict the patient-
reported functional outcome of limb salvage surgery. Patient-reported functional outcome 
tended to recover to a higher level than the surgeons predicted. The ultimate level of function 
that the patients reached was hard to predict, whereas it was easier to predict lower levels 
of function. Thus, surgeons’ ability to predict functional scores can be improved the most 
by focusing on accurately predicting more demanding tasks. Intersurgeon agreement to 
most questions was “poor”, indicating the high variability in the surgeons’ predictions, and 
possibly, treatment decisions. The poor predicting ability warrants research into objective 
tools to assist orthopedic oncologists in the decision making process. Such tools could 
include, for instance, computational musculoskeletal models that prospectively calculate 
whether enough muscle strength remains to perform activities of daily living.
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Abstract
Background: This study aimed to determine the contribution of each muscle of the lower 
limb to walking using positron emission tomography (PET) with [18F]-fluorodeoxyglucose 
(FDG). Furthermore, we compared our results obtained using volumetric analysis of entire 
muscles with those obtained using a more traditional approach considering the uptake in 
only one slice in each segment.
Methods: Ten healthy subjects walked on a treadmill at self-selected comfortable walking 
speed for 90 min, 60 min before and 30 min after intravenous injection of 50 MBq FDG. 
A PET/computerized tomography scan of the lower limb was made subsequently. The 
three-dimensional contours of 39 muscles in the left lower limb were semiautomatically 
determined from magnetic resonance imaging scans. After nonrigidly registering the 
magnetic resonance imaging to the computerized tomography scans we superimposed the 
muscle contours on the PET scans.
Results: The muscles with the highest median FDG uptake among all subjects were the 
soleus, gluteus maximus, vastus lateralis, gastrocnemius medialis, and adductor magnus. 
We found a wide range of FDG uptake values among subjects, including in some of the 
most important muscles involved in walking (e.g., soleus, gluteus medius, gastrocnemius 
medialis). Compared with the volumetric analysis, the single slice analysis did not yield an 
accurate estimate of the FDG uptake in many of the most active muscles, including the gluteus 
medius and minimus (overestimated) as well as all the thigh muscles (underestimated).
Conclusions: The distribution of FDG among the muscles varied between subjects, 
suggesting that each subject had a unique activation pattern. The FDG uptake as estimated 
from single slices did not correspond well to the uptake obtained from volumetric analysis, 
which illustrates the added value of our novel three-dimensional image analysis techniques. 
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Introduction
Walking is one of the most important activities of daily living. It is a complex orchestration of 
muscular contractions with the goal of moving the body forward while maintaining stance 
stability (Perry et al. 2010). Understanding the individual contributions of the muscles 
involved in walking is important for a variety of purposes (including rehabilitation, medical 
education and the validation of musculoskeletal models), but until a few decades ago, it was 
not possible to measure the contributions of all muscles of the lower limb to walking because 
of limitations of existing measurement techniques. 
Muscle activity during walking has been studied extensively using electromyography 
(EMG) (e.g., Burden 2010; Ericson et al. 1986; Inman et al. 1981). Although this method 
is convenient and noninvasive, it has several important limitations, as follows: deep-
lying muscles cannot be measured unless needle electrodes are inserted invasively, only a 
limited number of muscles can be measured at the same time, a reference contraction is 
required if muscles are to be compared with each other, and adipose tissue and crosstalk 
from other muscles are confounding factors (De Luca 1997; Staudenmann et al. 2010). [18F]-
fluorodeoxyglucose in combination with positron emission tomography (FDG-PET) does 
not suffer from these drawbacks. It can be used to estimate muscle activity in all muscles of 
the lower limb (including the deep-lying muscles) in one session. The working principle of 
FDG-PET is that exercising muscles take up glucose (and FDG) from the blood to replenish 
their expended energy. Using a concurrently made magnetic resonance imaging (MRI) or 
computerized tomography (CT) scan for anatomical reference, the muscles can be identified 
and their individual FDG uptake can be quantified.
FDG-PET has been used for studying several exercises (e.g., cycling (Fujimoto et al. 
2003; Gondoh et al. 2009), walking with a stride assistance system (Shimada et al. 2009a; 
Shimada et al. 2007), and simple flexion/extension exercises (Masood et al. 2014; Pappas 
et al. 2001; Rudroff et al. 2014)) since Fujimoto et al. first used it to analyze muscle activity 
during running (Fujimoto et al. 1996). Thus far, only a few studies have used FDG-PET 
for analyzing walking (Oi et al. 2003; Shimada et al. 2009b; Shimada et al. 2007). Oi et al. 
performed important work by comparing FDG uptake results with EMG and kinematic 
and kinetic studies, and demonstrating the concurrent validity of measuring the muscular 
activity of the lower limb with FDG-PET (Oi et al. 2003). Shimada et al. evaluated FDG 
uptake during walking with and without a stride assistance system (Shimada et al. 2007), 
and in older subjects compared with younger subjects (Shimada et al. 2009b). These studies, 
however, performed the quantification of the FDG uptake on one or only a few slices of the 
PET image. Thus, only a small portion of each muscle at a fixed cross-sectional level was 
analyzed. This raises the question whether analyzing such a small part provides an accurate 
representation of glucose uptake in the entire muscle. There are indications in the literature 
that muscle metabolism exhibits spatial heterogeneity. For instance, Pappas et al. found an 
inhomogeneous distribution of glucose uptake in the transverse direction and along the 
longitudinal axis of the biceps brachii after an elbow flexion exercise (Pappas et al. 2001). In 
the lower limb, Kalliokoski et al. demonstrated heterogeneous glucose uptake between the 
four quadriceps femoris muscles during a knee extension exercise (Kalliokoski et al. 2011). 
Besides the spatial heterogeneity, certain muscles may not even be included at the cross-
sectional level at which the slice is taken.
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With the advent of new MR image analysis techniques, it is now feasible to semiautomatically 
segment not just one or a few slices of muscles but entire muscles. To our knowledge, 
volumetric glucose uptake in entire muscles during walking has not yet been investigated. 
The purpose of this study was to quantify the activity of the muscles in the lower limb 
during walking, using FDG-PET scans and three-dimensional (3D) MRI segmentations. 
Furthermore, we aimed to determine whether the volumetric analysis would yield an 
appreciable benefit compared with analyzing only a single slice. 
Methods
Subjects
Ten healthy subjects participated in this study (Table 5.1). They had no history of major 
injury, had not undergone orthopedic surgery on the lower limb, and had no history of 
ailment related to carbohydrate metabolism or to cardiac or muscular disease. One of the 
inclusion criteria was being able to walk for at least 90 min without any difficulty. The 
subjects were recruited from the research staff and a database of volunteers available at our 
department. We specifically chose to include a wide variety of subjects in this study in terms 
of age (23-60 yr), sex (five men and five women) and anthropometry (1.60 - 1.95 m, 55.5 - 
91.7 kg). This was done because it was part of a larger research project that aimed to validate 
personalized musculoskeletal models of the subjects at a later stage (see e.g., Carbone et al. 
2012). The study procedures were approved by the ethical committee of the region Arnhem-
Nijmegen, the Netherlands. A written informed consent was obtained from each participant.
Protocol
The subjects walked on a treadmill at their own comfortable pace for 90 min, 60 min before 
and 30 min after injection with 53.6±1.8 MBq FDG (Figure 5.1). The walking speed was 
1.26±0.11 m/s. The PET/CT scan was started 30 min after finishing the last walking phase, 
which allowed the subject to be transported from the treadmill to the nuclear medicine 
department in a wheelchair, to void any excess radioactivity, and to position the subject in 
the PET/CT scanner. In addition to the PET/CT scan, an MRI scan had been taken a few 
Table 5.1 Participant characteristics
Number of participants 10
Sex (M:F) 5 : 5
Age (years) 40 (16)
Weight (kg) 74.8 (11.9)
Height (m) 1.75 (0.11)
BMI (kg/m2) 24.4 (2.3)
Walking speed (m/s) 1.26 (0.11)
Data are presented as mean (SD). 
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weeks earlier for anatomical reference. Before the PET/CT scan commenced, the subject’s 
legs were positioned on the table to reproduce as closely as possible their position as it 
was during the MRI scan using a ruler and a vacuum pillow that could be molded into the 
desired shape. Before the testing procedure, the subjects had to refrain from eating and 
drinking anything except water for at least six hours, and from participation in strenuous 
physical activity for two days. 
Tracer
FDG is a glucose analog, and as such, after entering the cell, FDG is phosphorylated into 
FDG-6-phosphate. However, FDG-6-phosphate is not a significant substrate for further 
metabolism. It is not converted into glycogen to any significant extent, and is not further 
metabolized in the glycolytic pathway. It thus becomes trapped within the cells, which is 
convenient from an imaging viewpoint (Cherry et al. 2012). It has a half-life time of 110 min.
Positron-emission tomography and CT scans
The PET/CT scans were made with a Biograph 40 mCT (Siemens AG, Erlangen, Germany) 
(Jakoby et al. 2011), in 3D mode, using an extended axial field of view of 216 mm. The PET 
scans lasted for four min per bed position. Eight to ten bed positions were acquired depending 
on the subject’s height. Thus, the scan time was 32-40 min. The scan region ranged from the 
feet to at least the iliac crest, with 50 mm overlap in the bed positions. The slice thickness 
was 2.0 mm. The PET images were reconstructed with the TrueX algorithm (with a spatially 
varying point spread function) and the incorporation of time-of-flight measurements (Ultra-
HD PET). Image reconstruction was performed using three iterations, 21 subsets, a matrix 
size of 512×512 and voxel spacing of 1.6 mm. After reconstruction, filtering was performed 
with a 3D Gaussian filter kernel with a full width at half maximum of 3.0 mm. The CT 
images used for attenuation correction were reconstructed with the B19f convolution kernel 
and a slice thickness of 5.0 mm, whereas the CT images used for anatomical reference were 
reconstructed with the B31f convolution kernel and slice thickness of 2.0 mm to correspond 
with the slice thickness of the PET images. 
00:00:00
Start walking
00:00:00 - 00:55:00
Pre-injection walking phase
01:00:00
FDG injection
01:02:00 - 01:30:00
Post-injection walking phase
01:30:00 - 02:00:00
Prep. phase before scan
02:00:00
Start PET scan
Figure 5.1. Timeline of the study protocol. The treadmill was stopped after 55 min of walking, to al-
low time for the subject to sit down and to insert the catheter for injection of FDG in a vein of the left 
forearm. The preparation phase before the scan consisted of transportation of the subject to the de-
partment of nuclear medicine in a wheelchair, and careful positioning of the subject on the scan table.
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Magnetic resonance imaging scans
MRI scans were made with a Magnetom Skyra (Siemens AG, Erlangen, Germany) at 3 Tesla 
and with a 400 mm transaxial field of view. The feet and ankles were placed in a head/neck 
coil containing 20 elements; the other areas of the lower limb were scanned with body phased 
array coils containing 18 elements combined with a spine array coil containing 32 elements 
that was embedded in the table. The scan protocol was specifically designed to yield optimal 
distinction between muscle boundaries (based on Scheys et al. 2009). The settings were as 
follows: T1 weighted image (repetition time/echo time, 450-545/9 ms) with turbo spin echo; 
number of excitations, 3; two echoes per excitation; 92-195 echo trains per slice; matrix size, 
512×512; no gap between slices; and in-plane resolution, 1.0×1.0 mm. Parallel imaging was 
not used, and there was no inversion pulse at the front end of the sequence. The hip, knee, 
and ankle regions were scanned with a 3.0 mm slice thickness, and the long bone regions in 
between were scanned with 8.0 mm slice thickness. This was done to obtain a higher level 
of detail in the areas where most muscles originate or insert. Six imaging stacks that covered 
the ankles (1), lower legs (1), knees (1) , thighs (2), and hip region (1) were used. An overlap 
of at least two 3.0 mm slices was used to allow proper “stitching” of the image stacks into a 
single integrated scan.
Image analysis
To obtain FDG uptake values of each individual muscle, several sequential steps were 
performed using Mimics (Materialise N.V., Leuven, Belgium), Matlab 2012b (The 
Mathworks, Natick, MA, USA) and Insight Segmentation and Registration Toolkit 4.5.2 
(ITK) (Kitware Inc., Clifton Park, NY, USA).
1) Three-dimensional regions-of-interest (ROI) were drawn manually around 
the muscles of the left lower limb of one of the subjects from the axial images. The 
boundaries of the ROI thus reflected the muscle boundaries. In total, 39 muscles 
were segmented in this way (Table 5.2 and Figure 5.2). The resulting segmentation 
of the muscles in the lower limb will henceforth be called “atlas”. 
2) The atlas was used to semiautomatically segment the muscles in the left lower 
limb of the other nine subjects in Mimics. The workflow was as follows: (1) create 
an initial crude mask containing all the muscles using a threshold on the voxel 
intensities, (2) remove strong gradients from the mask, (3) remove remaining 
undesired structures (fat and bones) using pen strikes on approximately every 
fifth slice as user input, (4) register the atlas to the subject automatically using an 
algorithm based on nonrigid registration, and (5) in an automatic postprocessing 
step, the transformed segmentation was combined with the voxel intensity 
information from the MRI scan to obtain the muscle ROI of the subject. The muscle 
ROI were thoroughly checked and manually corrected by a researcher where 
necessary. Hence, this step produced a segmentation of all muscles of the left lower 
limb for each subject. 
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3) The MRI scan and its corresponding ROI were subsequently registered onto 
the CT scan using ITK. The registration results were again thoroughly checked and 
manually corrected by a researcher where necessary.
4) The ROI were exported per muscle as Digital Imaging and Communications 
in Medicine (DICOM) mask files. The DICOM file format is a standard method 
for transferring images and associated information between devices and software 
manufactured by various vendors, including those used in this study. 
5) The ROI DICOM files and the subject’s PET scan (obtained directly from the 
PET scanner in DICOM format) were opened in Matlab 2012b and multiplied using 
a custom algorithm. In the algorithm, the ones (reflecting the muscle’s position) 
and zeros (surrounding area) in the ROI DICOM files were multiplied with the 
PET scan (gray values reflecting the FDG uptake in Bq/mL). The algorithm also 
extracted the rescale slope and intercept values from the PET DICOM headers, 
which were used to correct the FDG uptake values of the PET scan (in Bq/mL) for 
decay time since the start of the scan. 
We emphasize that the PET DICOM files from which we extracted the FDG uptake values 
were obtained directly from the Biograph 40 mCT, and that they were thus not “morphed” 
or modified in any other way. Furthermore, we only analyzed the left lower limb in this 
study. 
                             
Figure 5.2. A: MRI scan with three-dimensional muscle ROI. B: PET scan with three-dimensional 
muscle ROI. C: Frontal view of a PET scan with muscle ROI. D: MRI and PET scan slices of the hip, 
thigh, and lower leg regions with muscle ROI as used in the slice-based analysis.
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Analysis of volumetric uptake
The FDG uptake values per muscle were evaluated primarily with the volumetric %FDG 
uptake value. To obtain this value, we first calculated the volumetric mean standardized 
uptake value (SUV) of each muscle. The mean SUV reflects the average FDG uptake in a 
muscle, normalized by body mass and injected activity. 
In this equation, the numerator is the mean radioactivity count from all the voxels in the 
muscle divided by the muscle volume. The denominator reflects the total injected activity 
divided by the total body mass. The SUV was corrected for decay between the injection and 
the start of the scan. Because the SUV is normalized by the muscle volume, small muscles 
can exhibit similar or higher SUV values than large muscles, even though the large muscles 
plausibly exert much more force and/or perform much more work during gait. Therefore, 
we multiplied each muscle’s SUV by its volume. The resulting value was expressed as a 
percentage of the sum of the product of each muscle’s SUV times its volume, yielding %FDG 
uptake as our primary outcome measure: 
where i is the index of the muscle and j is a summation index that includes all 39 muscles. 
The %FDG uptake values thus reflect the amount of FDG in each muscle relative to the total 
amount of FDG in the muscles of the limb.
Analysis of volumetric versus slice-based uptake
To allow comparison of our volumetric analysis with the commonly used method in the 
literature of analyzing single slices, the %FDG uptake values were calculated both for entire 
muscles, and at three discrete slice heights, as follows: 3 cm above the femoral head, 50% 
of the distance between the joint space of the knee and the top of the femoral head, and at 
30% of the distance between the joint space of the knee and the tip of the lateral malleolus. 
These slice heights were based on commonly used slice heights in the literature for this type 
of study (Oi et al. 2003; Shimada et al. 2009a; Shimada et al. 2009b; Shimada et al. 2007; 
Tashiro et al. 1999). The percentage difference between the methods was calculated using 
the following formula:
where i is the index of the muscle. We did not want to choose either the volumetric or the 
slice-based data to be the “reference value”, therefore, this unbiased version of the percentage 
difference was used. The comparison between methods was made only among the five 
most active muscles in each segment (based on the %FDG uptake values observed in the 
volumetric analysis) because differences in these muscles were considered the most relevant. 
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Sensitivity study
To examine the sensitivity of our results with regard to the effects of errors in identification 
of muscle boundaries, we took an offset of the muscles on the PET images by 1 mm (both 
dilated and eroded). We chose 1 mm because this is the pixel size on the MRI on which the 
original muscle ROI were drawn. To perform the sensitivity study, we created 3D models of 
the muscles as triangulated surfaces (Sterolithography (STL) file format). Then, we computed 
new muscle masks from these STL. The dilated and eroded STL were then multiplied by the 
PET data (step 5 as described earlier) to yield a new set of results. The results in terms of 
%FDG uptake were virtually insensitive to this manipulation; the differences between the 
original, dilated, and eroded results were in the order of mere tenths of percents (0.0%-0.7%). 
This was true for all muscles, including the very smallest, where the offset of 1 mm had a 
relatively large effect in terms of volume (in the order of 30%-50%). This lends confidence 
that our method of volumetrically extracting %FDG uptake values from semiautomatically 
processed scans was sufficiently accurate.
Results
Example PET and MRI scans with muscle ROI are shown in Figure 5.2. 
Volumetric %FDG uptake
The muscles with the highest median %FDG uptake over all subjects were the soleus 
(17.1%), gluteus maximus (7.1%), vastus lateralis (5.8%), gastrocnemius medialis (5.6%) 
and adductor magnus (5.4%) (Figure 5.3). In general, the larger muscles had higher %FDG 
uptake, whereas the smaller muscles had lower uptake (Table 5.2). 
In the hip region, besides the gluteus maximus, the gluteus medius and minimus also had 
high %FDG uptake (4.4% and 2.2%, respectively). The uptake in the gluteus medius, in 
particular, varied widely between subjects (2.5%-19.5%). The iliacus and psoas had lower 
%FDG uptake than the gluteal muscles (2.0% and 1.4%, respectively), and the uptake also 
varied less between subjects (1.2%-3.0% and 0.8%-1.7%, respectively).
In the thigh, the vastus lateralis (5.8%), adductor magnus (5.4%), vastus intermedius (4.3%) 
and vastus medialis (4.2%) had the highest median uptake. The FDG uptake in these muscles 
was relatively similar between subjects compared with that in the gluteal muscles. 
In the lower leg, the soleus was by far the most active muscle (17.1%). The uptake in 
this muscle varied widely between subjects (8.8%-40.5%). The gastrocnemius medialis 
(5.6%) and tibialis anterior (4.8%) also exhibited a high median uptake. The uptake in the 
gastrocnemius medialis varied widely between subjects (1.9%-13.7%). The gastrocnemius 
lateralis had a much lower median uptake (1.9%) than the gastrocnemius medialis, and it 
also varied less (1.0%-4.6%).
The %FDG uptake data of all muscles in all subjects are available in Appendix 5.1.
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Table 5.2 %FDG uptake values obtained with the volumetric and the single 
slice method
Muscle
Volume 
(mL)
%FDG
(volumetric)
%FDG
(single slice)
SUV (g/mL)
(volumetric)
SUV (g/mL)
(single slice)
Gluteus maximus 892 7,1% 8,1% 0,58 0,67
Gluteus medius 330 4,4% 8,8% 0,86 1,09
Gluteus minimus 86 2,2% 5,4% 1,56 1,92
Iliacus 184 2,0% 2,1% 0,78 0,69
Psoas 161 1,4% 1,0% 0,68 0,73
Pectineus 55 0,5% 0,80
Piriformis 30 0,5% 2,9% 1,07 1,43
Obturator internus 47 0,5% 0,86
Tensor fasciae latae 62 0,5% 0,2% 0,58 0,91
Obturator externus 26 0,3% 0,84
Quadratus femoris 33 0,3% 0,80
Gemellus inferior 5 0,1% 0,94
Gemellus superior 3 0,0% 0,94
Vastus lateralis 700 5,8% 4,6% 0,64 0,63
Adductor magnus 509 5,4% 3,3% 0,75 0,62
Vastus intermedius 457 4,3% 3,3% 0,75 0,71
Vastus medialis 480 4,2% 2,3% 0,68 0,74
Rectus femoris 260 1,9% 1,0% 0,58 0,57
Adductor longus 164 1,8% 0,6% 0,66 0,80
Semimembranosus 250 1,7% 1,2% 0,64 0,66
Biceps femoris caput longum 218 1,6% 1,8% 0,57 0,56
Adductor brevis 92 1,5% 1,16
Sartorius 135 1,4% 0,6% 0,64 0,69
Semitendinosus 187 1,2% 1,0% 0,54 0,55
Biceps femoris caput breve 99 0,8% 0,2% 0,65 0,74
Gracilis 85 0,6% 0,5% 0,59 0,57
Soleus 594 17,1% 18,8% 2,34 2,29
Gastrocnemius medialis 256 5,6% 5,7% 2,31 2,57
Tibialis anterior 141 4,8% 5,7% 3,20 3,54
Gastrocnemius lateralis 108 1,9% 2,1% 1,14 1,43
Tibialis posterior 106 1,5% 1,2% 1,24 1,27
Extensor digitorum longus 48 1,5% 1,7% 2,57 2,72
Flexor hallucis longus 72 1,2% 1,20
Extensor hallucis longus 41 1,2% 2,39
Peroneus longus 57 1,0% 1,5% 1,22 1,34
Flexor digitorum longus 44 0,8% 0,7% 1,37 1,56
Peroneus brevis 53 0,7% 1,04
Popliteus 20 0,4% 1,37
Plantaris 7 0,1% 1,55
Table is sorted by %FDG (volumetric). All volumes, SUV and %FDG values are presented as median values. 
Some muscles were not present in the slices at the discrete slice heights (based on the literature) that we 
analyzed, therefore there are no %FDG and SUV values for those muscles. 
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Volumetric SUV
The muscles in the lower leg tended to exhibit greater SUV than those in the hip or thigh 
regions (Appendix 5.2); the mean SUV of all the muscles in the lower leg over all subjects 
was 2.04 g/mL, whereas it was 1.12 g/mL in the hip and 0.76 g/mL in the thigh. The tibialis 
anterior (3.20 g/mL), extensor digitorum longus (2.57 g/mL), extensor hallucis longus 
(2.39 g/mL), soleus (2.34 g/mL) and gastrocnemius medialis (2.31 g/mL) had the highest 
SUV overall. Several muscles that had high %FDG uptake, such as the gluteus maximus 
and the vastus lateralis, had comparatively low median SUV of 0.58 g/mL and 0.64 g/mL, 
respectively.
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Figure 5.3. FDG uptake in the muscles in the left lower limb of all ten subjects. The boxplot shows the 
median, 25th and 75th percentiles, and the full range of uptake values (i.e. no values were considered 
outliers). The psoas was only partly segmented, because its uppermost cranial aspect was outside the 
scan area. Therefore, the muscle’s uptake in this figure is lower than it is in reality. 
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The SUV data of all muscles in all subjects are available in Appendix 5.2.
Differences between volumetric and single slice analyses
There were large differences between the %FDG uptake as measured volumetrically 
compared with the %FDG uptake measured using the single slice technique. The differences 
of the five muscles in each segment that had the largest %FDG uptake are shown in Figure 
5.4. 
In the hip region, the %FDG uptake in the gluteus medius and minimus was severely 
overestimated when only a single slice was analyzed (between 45.7% and 80.4% and 
between 65.9% and 123.5%, respectively), whereas the uptake in the psoas tended to be 
underestimated (between -95.0% and 13.8%).
In the thigh, the %FDG uptake was underestimated when analyzing only a single slice in 
all muscles shown in Figure 5.4. The underestimation was most severe in the rectus femoris 
(between -90.8% and -32.1%). 
In the lower leg, we did not find consistent under- or overestimation in %FDG uptake, but 
the ranges of differences between methods were roughly similar to those observed in the 
hip and thigh. The gastrocnemius lateralis had a particularly wide range of between -53.9% 
(underestimation) and 56.2% (overestimation).
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Figure 5.4. Differences in %FDG uptake between volumetric and slice-based analyses in the five most 
active muscles in each segment. In the plot, a positive/negative percentage indicates that the %FDG 
uptake was overestimated/underestimated by analyzing only a single slice. The psoas was only partly 
segmented in the volumetric analysis, because its uppermost cranial aspect was outside the scan area. 
Thus, the muscle’s uptake was lower in the volumetric analysis than it was in reality, and the tendency 
of the slice-based method to underestimate that muscle’s uptake would be even larger than it is pre-
sently.
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Discussion
This study aimed to determine muscular activity during walking using a volumetric analysis 
of glucose uptake in entire muscles. The muscles with the highest median %FDG uptake were 
the soleus, gluteus maximus, vastus lateralis, gastrocnemius medialis and adductor magnus. 
We found a wide range of %FDG uptake values between subjects, including in some of the 
most important muscles involved in walking (e.g., soleus, gluteus medius, gastrocnemius 
medialis). Compared with the volumetric analysis, the single slice analysis did not yield an 
accurate estimate of the %FDG uptake in many of the most active muscles, including the 
gluteus medius and minimus (overestimated) and all the thigh muscles (underestimated). 
The soleus and the gastrocnemius medialis were among the muscles that had the highest 
median uptake of FDG of the muscles in the lower limb, both in terms of %FDG uptake 
and SUV. As these muscles are both plantarflexors, this is consistent with literature stating 
that the generation of plantarflexion torque is key to forward propulsion and to prevent the 
body from falling forward while walking (Liu et al. 2006; Perry 1974; Winter 1983). The 
gluteus maximus and vastus lateralis also had high %FDG uptake values. These muscles 
are two of the primary hip and knee extensors, respectively. As such, they play a crucial 
role in providing support in the first half of stance (Pandy 2001; Winter 1980). The vastus 
lateralis took up more FDG than the vastus intermedius and medialis because of its larger 
volume. Combined, the median uptake of all three vasti was 14.3%, which demonstrates 
their importance in the walking motion. 
The adductor magnus, much to our surprise, was one of the most active muscles during 
walking (median 5.4% FDG uptake). The adductor magnus also had the second highest 
SUV (0.75 g/ml) of the thigh muscles, indicating that its high %FDG uptake was not merely 
due to its large volume (509 mL). Although the temporal activation pattern of the adductor 
magnus during walking has been reported (using EMG) (Green et al. 1970), the quantitative 
activity of this muscle has remained understudied (Anderson et al. 2003). The consistently 
high %FDG uptake we observed in this muscle across subjects suggests that this muscle 
performs more work or exerts more force than commonly presumed. Previous work most 
often designated the hip abductors as the primary muscles controlling the hip in the frontal 
plane (e.g., Anderson et al. 2003; Liu et al. 2006; Perry 1974), with the adductors only 
tending to participate during the transfer phases between stance and swing (Perry et al. 
2010). Therefore, we had expected that the largest hip abductor (gluteus medius, 4.4% FDG 
uptake) would be more active than any of the adductor muscles. Indeed, the gluteus medius 
had a higher median SUV (0.86 g/mL) than the adductor magnus (SUV=0.75 g/mL), but 
the adductor magnus had a larger volume, resulting in higher %FDG uptake. This result 
demonstrates the added value of the FDG-PET technique in revealing the activity of an entire 
muscle during gait, which would have been difficult to do with traditional measurement 
techniques (e.g., surface EMG) that measure only a small part of the muscle. Although other 
studies that used FDG-PET did analyze the FDG uptake in the hip adductors (Oi et al. 
2003; Shimada et al. 2009b; Shimada et al. 2007), they examined the hip adductors only as a 
muscle group rather than differentiate between the muscles that comprise the group. 
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Like the adductor magnus, the gluteus minimus was surprisingly active. In spite of its small 
size (86 mL) compared with the functionally similar gluteus medius (330 mL), our results 
suggest that it made a large contribution to hip abduction and stabilization, as it took up 
roughly 50% of the FDG relative to the gluteus medius (Table 5.2). The gluteus minimus also 
had the highest SUV amongst all the muscles in the hip region (1.56 g/mL). This is in line 
with Oi et al., who found the SUV of the gluteus minimus during walking was the highest 
amongst the three gluteal muscles (Oi et al. 2003). 
The iliacus and psoas are two muscles that flex the hip but have been difficult to examine 
with traditional methods (e.g., surface EMG) because of their anatomical position deep in 
the body. Although some authors have used intramuscular EMG to record the activity of 
these muscles, quantitative data about their contribution to walking have remained scarce 
(e.g. Andersson et al. 1997; Perry et al. 2010). In this study, we found that the %FDG 
uptake values of the iliacus and psoas were 2.0% and 1.4%, respectively. Even when added 
together, our data suggest that the activity of these muscles is rather low in normal walking 
compared to the ankle plantarflexors and dorsalflexors, hip extensors and abductors, and 
knee extensors and flexors. This is in agreement with Perry, who stated that the iliacus plays 
a small role in normal walking, although walking faster or slower increases its importance 
(Perry et al. 2010).
The large differences between subjects in %FDG uptake values in some muscles could 
indicate that each subject activated his/her muscles in a unique fashion. This notion is 
supported by previous studies that used surface EMG; Arsenault et al. found large and highly 
significant intersubject differences in the normalized (to maximum voluntary contraction) 
signal amplitude among healthy subjects, for instance in the soleus, rectus femoris, vastus 
medialis and tibialis anterior (Arsenault et al. 1986). Yang and Winter (Yang et al. 1984) and 
Winter and Yack (Winter et al. 1987) found intersubject coefficients of variation that are in 
the same order of magnitude as ours (Appendix 5.1). Given that we specifically chose to 
include subjects with a wide range of body types in this study, several factors could explain 
the variance in %FDG uptake, for instance, age. Subject 8 provides an illustration of the 
effect that a relatively high age (60 yr) might have had. The soleus had the highest uptake of 
all muscles and in all subjects except subject 8 (Appendix 5.1). That subject concurrently had 
the highest %FDG uptake in the gluteus maximus amongst all subjects. Thus, this subject 
might have shifted from exerting ankle plantarflexion torque to exerting more hip extension 
torque to achieve forward progression. In addition, this subject had the lowest psoas and 
iliacus activity of all subjects as well as the second lowest summed activity in the quadriceps 
of all subjects. These combined findings suggest an “elderly walking pattern”; they match 
exactly a redistribution pattern of joint torques observed by DeVita and Hortobagyi in 
elderly subjects when compared with that in younger subjects (DeVita et al. 2000). However, 
we did not observe the same pattern in any of the other three relatively old subjects (age 55-
60 yr), so other factors (e.g., general physical fitness level) may also influence the degree to 
which each muscle is active during walking.
The volumetric and single slice analyses yielded systematically discrepant results in some 
of the muscles that were most active during walking (e.g., gluteus medius, vastus lateralis). 
Moreover, the muscles in which no systematic discrepancy was found (e.g., gastrocnemius 
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lateralis, iliacus), still exhibited a rather large range (from -53.9% to 56.2% and from -18.9% 
to 37.5%, respectively) around the “ideal” 0% difference. These findings illustrate the added 
value of analyzing entire muscles rather than only single slices on the quantification of 
%FDG uptake values. For this comparison, we took slices taken at discrete heights on the 
basis of the literature (Oi et al. 2003; Shimada et al. 2009a; Shimada et al. 2009b; Shimada 
et al. 2007; Tashiro et al. 1999). It may be argued that other slice heights might resemble 
the results more closely as obtained in the volumetric analysis. Therefore, in an additional 
sequence of assessments, we also examined the effects of taking slices at different heights but 
we were unable to find a single slice height in each segment that accurately represented the 
volumetric FDG uptake in all subjects. 
Limitations
Our study has some limitations. First, the muscle segmentation might have some errors 
despite extensive examination of the intermediate and end results. Despite the fact that the 
MRI scan protocol was specifically designed for imaging muscle boundaries, the boundaries 
of some muscles were difficult to distinguish. However, the sensitivity analysis indicated that 
the effects of these possible errors on the volumetric %FDG uptake were small. Second, we 
had no control condition such as similar measurements of FDG uptake after a resting period. 
This could have revealed whether the baseline FDG uptake was similar between muscles and 
subjects. Unfortunately, it remains difficult to extend this type of experiment with control 
measurements because of ethical issues regarding the radiation dose. Third, the comfortable 
walking speed was unique for each subject and this might have influenced the %FDG uptake 
values. The intensity level of the protocol might also have been experienced differently by 
different subjects, although none of the subjects indicated that it was too intense or asked to 
have the speed of the treadmill reduced. We deliberately chose comfortable walking rather 
than a fixed walking speed to prevent subjects from being “forced” to walk at an unnatural 
pace; consequently, this might lead to unnatural muscle FDG uptake. 
Another limitation inherent to studies that use FDG-PET to determine muscle activity, is the 
unknown relation between FDG uptake and the actual work performed or force exerted by a 
muscle. Muscle cells can use various substrates, including internal glycogen and triglyceride 
stores and plasma free fatty acids and glucose. The relative importance of these substrates 
depends on factors such as the intensity of the exercise (Romijn et al. 1993), the remaining 
muscle glycogen stores (Wahren et al. 1971), and the fiber type composition of the muscle 
(Henriksen et al. 1990). In our study, the exercise intensity was constant and rather low and 
the muscle glycogen stores were likely not depleted as a result. Thus, plasma glucose uptake 
likely remained constant (Romijn et al. 1993) in our study. The fiber type composition might 
have an influence on FDG uptake; muscles that have a high proportion of Type I fibers 
tend to be more metabolically active during exercise (Heinonen et al. 2012). The concurrent 
validity, however, of studying walking by FDG-PET compared with EMG and kinematic and 
kinetic studies has previously been shown by Oi et al. (Oi et al. 2003). The present results 
corroborate these findings, as the %FDG uptake in several known prime movers of gait (e.g., 
soleus, gluteus maximus, vasti, gastrocnemius medialis) was high, which also corresponds 
well with the literature on contributors to joint torques and powers (Anderson et al. 2003; 
Liu et al. 2006; Winter 1983). 
112
Chapter 5
Conclusions
The volumetric analysis of FDG uptake in the muscles of the lower limb yielded an extensive 
overview of the most active muscles during walking. The most active muscles in terms of 
%FDG uptake generally corresponded well with literature that used other methods such as 
inverse dynamics and EMG. Several muscles (adductor magnus, gluteus minimus) that were 
difficult to measure with traditional methods (e.g., surface EMG), because of their large size 
or their deep-lying position in the body, were found by FDG-PET to be very active during 
gait. The FDG uptake as measured in single slices did not correspond well to the FDG uptake 
obtained by volumetric analysis, which strongly illustrates the added value of our novel 
image analysis techniques. We intend to use these data to validate musculoskeletal models 
of these healthy subjects. In the future, it might be possible to analyze the gait of patients 
with orthopedic or neurological deficits, or to enable the construction of patient-specific 
rehabilitation protocols. To enable such next steps in patient populations, the protocol may 
need to be shortened. The innovative FDG-PET method as described in this chapter will 
assist in future steps toward a better understanding of musculoskeletal behavior of healthy 
subjects and patients.  
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Appendix 5.1: %FDG
Subject
1 2 3 4 5 6 7 8 9 10 median min max CV
H
ip
 re
gi
on
Gluteus maximus 4,1% 4,6% 7,2% 6,7% 7,0% 11,5% 7,9% 11,6% 7,4% 6,7% 7,1% 4,1% 11,6% 0,33
Gluteus medius 2,5% 2,5% 4,0% 3,0% 5,5% 4,8% 4,3% 19,5% 6,1% 4,5% 4,4% 2,5% 19,5% 0,88
Gluteus minimus 1,1% 0,6% 1,5% 1,2% 3,9% 3,0% 2,8% 4,8% 6,2% 1,2% 2,2% 0,6% 6,2% 0,71
Iliacus 1,3% 1,5% 2,0% 2,1% 2,3% 3,0% 2,6% 1,2% 2,7% 1,3% 2,0% 1,2% 3,0% 0,32
Psoas 1,1% 1,0% 1,4% 1,3% 1,6% 1,7% 1,7% 0,8% 1,7% 1,5% 1,4% 0,8% 1,7% 0,24
Pectineus 0,5% 0,5% 0,8% 0,8% 0,4% 0,5% 0,8% 0,4% 0,7% 0,4% 0,5% 0,4% 0,8% 0,30
Piriformis 2,7% 0,4% 1,1% 0,5% 0,2% 0,3% 0,5% 1,4% 0,6% 0,3% 0,5% 0,2% 2,7% 0,94
Obturator internus 2,0% 0,3% 0,9% 1,4% 0,5% 0,7% 0,4% 0,3% 0,5% 0,4% 0,5% 0,3% 2,0% 0,76
Tensor fasciae latae 0,3% 0,4% 0,4% 0,4% 0,5% 0,6% 0,6% 0,9% 0,5% 0,3% 0,5% 0,3% 0,9% 0,36
Obturator externus 0,5% 0,4% 0,3% 0,3% 0,3% 0,4% 0,4% 0,2% 0,2% 0,3% 0,3% 0,2% 0,5% 0,34
Quadratus femoris 0,2% 0,2% 0,4% 0,2% 0,3% 0,5% 0,5% 0,2% 0,7% 0,3% 0,3% 0,2% 0,7% 0,49
Gemellus inferior 0,1% 0,0% 0,0% 0,1% 0,1% 0,1% 0,1% 0,1% 0,1% 0,1% 0,1% 0,0% 0,1% 0,49
Gemellus superior 0,2% 0,0% 0,0% 0,0% 0,0% 0,1% 0,1% 0,0% 0,1% 0,1% 0,0% 0,0% 0,2% 0,81
Sum hip region 16,5% 12,4% 20,1% 18,0% 22,5% 27,3% 22,7% 41,3% 27,3% 17,3%
Th
ig
h 
re
gi
on
Vastus lateralis 3,6% 3,8% 6,7% 6,4% 6,4% 7,6% 7,4% 3,8% 4,7% 5,3% 5,8% 3,6% 7,6% 0,28
Adductor magnus 4,0% 3,6% 5,7% 5,3% 5,4% 6,9% 5,7% 3,7% 5,5% 3,6% 5,4% 3,6% 6,9% 0,23
Vastus intermedius 2,5% 3,0% 5,9% 4,6% 4,9% 6,0% 5,4% 2,8% 4,0% 3,2% 4,3% 2,5% 6,0% 0,31
Vastus medialis 2,4% 2,3% 5,4% 4,7% 4,2% 5,3% 4,2% 2,7% 4,2% 3,2% 4,2% 2,3% 5,4% 0,29
Rectus femoris 1,5% 1,3% 2,1% 1,8% 1,9% 2,0% 2,8% 1,0% 2,4% 2,0% 1,9% 1,0% 2,8% 0,27
Adductor longus 1,2% 1,2% 1,5% 5,1% 1,2% 2,2% 2,1% 3,9% 3,5% 1,1% 1,8% 1,1% 5,1% 0,61
Semimembranosus 2,6% 1,2% 1,7% 1,7% 1,3% 3,6% 1,8% 1,2% 2,7% 2,8% 1,7% 1,2% 3,6% 0,40
Biceps femoris caput longum 1,2% 0,9% 1,4% 1,9% 1,4% 1,9% 1,8% 0,8% 2,1% 2,3% 1,6% 0,8% 2,3% 0,32
Adductor brevis 2,0% 1,4% 1,2% 1,6% 1,0% 1,3% 1,3% 3,4% 1,9% 1,7% 1,5% 1,0% 3,4% 0,40
Sartorius 0,6% 1,0% 1,5% 1,4% 1,1% 1,5% 1,6% 4,4% 1,4% 0,8% 1,4% 0,6% 4,4% 0,71
Semitendinosus 1,2% 1,0% 1,2% 1,3% 1,3% 1,1% 0,9% 0,6% 1,6% 1,8% 1,2% 0,6% 1,8% 0,27
Biceps femoris caput breve 0,4% 0,7% 0,9% 0,8% 1,2% 1,0% 1,2% 0,5% 1,4% 0,5% 0,8% 0,4% 1,4% 0,39
Gracilis 0,3% 0,6% 0,7% 0,8% 0,6% 0,6% 0,7% 0,6% 0,6% 0,6% 0,6% 0,3% 0,8% 0,19
Sum thigh 23,5% 22,0% 36,0% 37,2% 31,8% 40,9% 36,8% 29,5% 35,9% 29,0%
Lo
we
r l
eg
Soleus 39,5% 40,5% 17,3% 17,0% 15,2% 13,5% 21,2% 8,8% 11,5% 21,5% 17,1% 8,8% 40,5% 0,53
Gastrocnemius medialis 5,1% 1,9% 8,6% 6,6% 13,7% 4,8% 4,0% 4,9% 6,1% 9,9% 5,6% 1,9% 13,7% 0,51
Tibialis anterior 7,0% 5,0% 4,6% 6,4% 7,1% 2,9% 2,8% 3,7% 5,2% 4,4% 4,8% 2,8% 7,1% 0,32
Gastrocnemius lateralis 2,3% 1,0% 4,0% 1,3% 1,4% 1,8% 1,7% 4,6% 2,0% 3,1% 1,9% 1,0% 4,6% 0,52
Tibialis posterior 1,1% 1,7% 3,4% 1,2% 1,1% 2,9% 2,0% 1,2% 4,7% 1,3% 1,5% 1,1% 4,7% 0,59
Extensor digitorum longus 0,7% 4,6% 1,2% 3,4% 1,1% 0,9% 1,6% 1,7% 1,8% 1,3% 1,5% 0,7% 4,6% 0,66
Flexor hallucis longus 0,6% 4,6% 0,7% 0,7% 1,2% 1,4% 2,3% 1,2% 0,8% 1,8% 1,2% 0,6% 4,6% 0,78
Extensor hallucis longus 1,5% 1,9% 0,8% 1,7% 1,0% 0,8% 0,8% 1,0% 1,3% 1,4% 1,2% 0,8% 1,9% 0,32
Peroneus longus 0,5% 2,6% 1,2% 4,4% 0,7% 0,8% 1,1% 0,6% 1,0% 3,2% 1,0% 0,5% 4,4% 0,82
Flexor digitorum longus 0,2% 0,9% 0,7% 0,4% 1,5% 0,9% 1,5% 0,6% 0,9% 0,4% 0,8% 0,2% 1,5% 0,55
Peroneus brevis 0,8% 0,6% 0,8% 1,4% 1,2% 0,5% 0,6% 0,3% 0,5% 4,8% 0,7% 0,3% 4,8% 1,15
Popliteus 0,5% 0,3% 0,4% 0,2% 0,5% 0,4% 0,5% 0,4% 0,7% 0,4% 0,4% 0,2% 0,7% 0,35
Plantaris 0,2% 0,1% 0,1% 0,1% 0,1% 0,1% 0,4% 0,2% 0,1% 0,1% 0,1% 0,1% 0,4% 0,62
Sum lower leg 59,9% 65,6% 43,8% 44,8% 45,8% 31,8% 40,5% 29,2% 36,7% 53,6%
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Appendix 5.2: SUV (g/mL)
Subject
1 2 3 4 5 6 7 8 9 10 median min max CV
H
ip
 re
gi
on
Gluteus maximus 0,44 0,48 0,63 0,58 0,58 0,70 0,53 1,40 0,65 0,56 0,58 0,44 1,40 0,41
Gluteus medius 0,76 0,63 0,84 0,79 1,23 0,87 0,72 5,74 1,43 1,05 0,86 0,63 5,74 1,10
Gluteus minimus 1,72 0,74 1,07 0,82 3,42 1,55 1,56 6,67 4,41 1,21 1,56 0,74 6,67 0,85
Iliacus 0,60 0,71 0,69 0,87 0,85 0,96 0,69 0,94 1,07 0,58 0,78 0,58 1,07 0,20
Psoas 0,54 0,60 0,80 0,93 0,76 0,60 0,71 0,65 0,87 0,55 0,68 0,54 0,93 0,18
Pectineus 0,67 0,81 0,79 0,97 0,70 0,91 0,62 1,23 0,90 0,66 0,80 0,62 1,23 0,22
Piriformis 8,18 1,13 1,30 1,34 0,83 1,02 0,73 4,43 0,93 0,86 1,07 0,73 8,18 0,83
Obturator internus 4,18 0,74 1,17 2,80 0,74 1,10 0,77 0,90 0,82 0,67 0,86 0,67 4,18 0,62
Tensor fasciae latae 0,38 0,46 0,61 0,59 0,57 0,62 0,50 1,12 0,68 0,46 0,58 0,38 1,12 0,32
Obturator externus 1,73 0,82 0,80 1,08 0,79 1,10 0,69 0,80 0,86 0,91 0,84 0,69 1,73 0,16
Quadratus femoris 0,61 0,66 0,87 0,86 0,78 1,13 0,69 0,97 0,83 0,62 0,80 0,61 1,13 0,20
Gemellus inferior 1,02 0,78 0,82 1,09 0,85 1,29 0,79 1,24 1,09 0,69 0,94 0,69 1,29 0,23
Gemellus superior 2,05 0,57 0,73 0,86 0,96 1,28 0,93 1,15 1,06 0,76 0,94 0,57 2,05 0,24
Sum hip region 1,76 0,70 0,86 1,04 1,01 1,01 0,76 2,09 1,20 0,74
Th
ig
h 
re
gi
on
Vastus lateralis 0,46 0,47 0,66 0,71 0,62 0,70 0,60 0,73 0,66 0,48 0,64 0,46 0,73 0,15
Adductor magnus 0,81 0,55 0,70 0,87 0,69 0,82 0,62 0,87 0,94 0,60 0,75 0,55 0,94 0,19
Vastus intermedius 0,52 0,55 0,74 0,78 0,75 0,79 0,66 0,89 0,75 0,55 0,75 0,52 0,89 0,16
Vastus medialis 0,45 0,52 0,72 0,76 0,61 0,76 0,65 0,99 0,71 0,52 0,68 0,45 0,99 0,21
Rectus femoris 0,41 0,46 0,61 0,59 0,58 0,71 0,56 0,63 0,77 0,47 0,58 0,41 0,77 0,17
Adductor longus 0,65 0,60 0,64 2,51 0,68 0,91 0,61 3,76 1,49 0,52 0,66 0,52 3,76 0,86
Semimembranosus 0,93 0,51 0,61 0,59 0,53 0,72 0,52 0,66 0,95 0,68 0,64 0,51 0,95 0,21
Biceps femoris caput longum 0,52 0,42 0,55 0,59 0,56 0,61 0,52 0,59 0,66 0,61 0,57 0,42 0,66 0,12
Adductor brevis 1,58 1,32 0,80 1,53 0,89 0,95 0,66 3,95 1,87 1,00 1,16 0,66 3,95 0,71
Sartorius 0,38 0,52 0,72 0,70 0,58 0,77 0,57 3,05 0,80 0,52 0,64 0,38 3,05 0,88
Semitendinosus 0,65 0,43 0,59 0,56 0,52 0,74 0,50 0,52 0,65 0,51 0,54 0,43 0,74 0,16
Biceps femoris caput breve 0,45 0,46 0,66 0,64 0,76 0,78 0,61 0,74 1,01 0,50 0,65 0,45 1,01 0,24
Gracilis 0,38 0,47 0,60 0,62 0,54 0,64 0,58 0,87 0,64 0,49 0,59 0,38 0,87 0,19
Sum thigh 0,63 0,56 0,66 0,88 0,64 0,76 0,59 1,40 0,92 0,57
Lo
we
r l
eg
Soleus 6,88 7,03 2,36 2,42 1,93 1,10 2,31 2,32 1,77 2,66 2,34 1,10 7,03 0,64
Gastrocnemius medialis 2,27 0,76 2,47 1,59 3,54 1,05 0,90 3,33 2,60 2,34 2,31 0,76 3,54 0,50
Tibialis anterior 5,07 4,34 2,75 4,14 3,55 1,10 1,07 3,43 2,96 2,37 3,20 1,07 5,07 0,41
Gastrocnemius lateralis 1,42 0,82 1,58 0,73 0,87 0,84 0,81 4,23 1,81 1,55 1,14 0,73 4,23 0,76
Tibialis posterior 1,05 1,55 1,93 1,22 1,12 1,26 1,09 1,51 3,23 0,97 1,24 0,97 3,23 0,45
Extensor digitorum longus 2,55 6,62 1,92 4,87 2,76 1,11 1,16 2,95 1,73 2,60 2,57 1,11 6,62 0,64
Flexor hallucis longus 1,19 6,98 1,01 1,11 1,22 0,87 1,93 1,50 1,08 2,55 1,20 0,87 6,98 0,95
Extensor hallucis longus 4,18 4,67 1,38 3,28 2,43 1,07 1,05 3,28 2,16 2,34 2,39 1,05 4,67 0,50
Peroneus longus 1,11 3,18 1,69 5,20 1,24 0,85 0,86 1,15 1,20 4,01 1,22 0,85 5,20 0,74
Flexor digitorum longus 0,98 1,67 1,57 0,94 1,41 1,24 1,46 1,32 1,57 1,18 1,37 0,94 1,67 0,17
Peroneus brevis 0,99 1,26 1,27 2,30 0,97 0,95 0,83 1,01 1,07 3,63 1,04 0,83 3,63 0,62
Popliteus 2,24 1,09 1,13 0,88 1,77 1,30 1,35 2,66 2,56 1,38 1,37 0,88 2,66 0,41
Plantaris 1,65 0,58 0,98 0,67 1,97 0,97 2,05 3,05 1,77 1,44 1,55 0,58 3,05 0,53
Sum lower leg 2,43 3,12 1,69 2,26 1,91 1,05 1,30 2,44 1,96 2,23
Mean all muscles 1,61 1,46 1,07 1,39 1,18 0,94 0,88 1,98 1,36 1,18
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Chapter 6
Symmetry and spatial distribution of muscle glucose uptake in 
the lower limbs during walking measured using FDG-PET
(Submitted)
Kolk, S., Klawer, E.M.E., Visser, E.P., Lobeek, D., Schepers, 
J., Verdonschot, N., Weerdesteyn, V. 
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Abstract
Background: This study aimed to elucidate whether muscle activity (in terms of glucose 
uptake) between the legs can be considered symmetrical during walking. Furthermore, 
we aimed to determine whether the [18F]-fluorodeoxyglucose (FDG) was distributed 
heterogeneously throughout each muscle, and if so, whether areas of high uptake would be 
clustered. 
Methods: Ten healthy participants walked on a treadmill at self-selected comfortable 
walking speed for a total of 90 minutes, 60 minutes before and 30 minutes after intravenous 
injection of 50 MBq FDG. Thereafter, a PET/CT scan of the lower limb was acquired. Three-
dimensional muscle contours of 78 (=39x2) muscles of the left and right lower limb were 
semi-automatically determined from MRI scans. After non-rigid registration, those muscle 
contours were used to extract FDG uptake from the PET scans.
Results: Large asymmetries were observed in the lower leg muscles (e.g., median absolute 
asymmetry index of 42% in the gastrocnemius medialis) and in the gluteus minimus (30% 
asymmetry) and gluteus medius (15% asymmetry), whereas the uptake in the thighs was 
relatively symmetrical between the limbs (<6% asymmetry). These were not related to limb-
dominance nor to inter-limb differences in muscle volume. The FDG distribution was not 
distributed normally; most voxels had a relatively low SUV, and a minority of voxels had a 
relatively high SUV. The voxels with higher FDG uptake were distributed heterogeneously; 
they were clustered in virtually all muscles.
Conclusions: The findings in this study challenge the common assumption of symmetry in 
muscle activity between the limbs in healthy subjects. The clustering of voxels with high 
uptake suggests that even in this prolonged repetitive task, different spatial regions of 
muscles contribute differently to walking than others.
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Introduction
Walking involves a complex integration of muscular contractions with the goal of maintaining 
stance stability and forward progression. Walking in healthy persons has traditionally been 
assumed to be a symmetrical motion, either from assumption or for convenience of data 
collection and analysis (Sadeghi et al. 2000). This assumption may be considered reasonable, 
as most healthy persons walk without a limp or other visible evidence of asymmetry. 
However, several studies have found that the legs and individual muscles do not necessarily 
behave symmetrically during gait. For instance, asymmetries in kinematics (Gundersen et 
al. 1989; Maupas et al. 1999) and muscle activation (Arsenault et al. 1986a; Ounpuu et al. 
1989) have been reported. A better understanding of these asymmetries is important, for 
instance in determining ranges of normal (healthy) asymmetry, beyond which a patient with 
a certain pathology is considered to be truly asymmetrical. Also, asymmetry is an important 
consideration in validating musculo-skeletal models, which generally assume that healthy 
persons walk with equal activity levels in muscles in both legs (Ackermann et al. 2010; 
Anderson et al. 2001).
To assess muscle activation patterns, researchers typically utilize surface electromyography 
(EMG). This method is convenient and noninvasive, but has disadvantages such as a 
limited number of muscles that can be measured simultaneously, the need for a reference 
contraction if muscles are to be compared with each other, inability to measure deep-lying 
muscles and deep-lying aspects of superficial muscles, and confounding factors such as 
crosstalk and adipose tissue (De Luca 1997; Staudenmann et al. 2010). In most surface EMG 
applications, the electrodes are placed in discrete locations on the skin superficial to the 
muscle. The resulting EMG data are generally considered to reflect the activity of the muscle 
as a whole. However, it is known (e.g., from multi-channel EMG studies) that the spatial 
activity of muscle regions can be heterogeneous (Hodson-Tole et al. 2013; Kalliokoski et 
al. 2007; Kinugasa et al. 2011; Laaksonen et al. 2013; Pappas et al. 2001; Staudenmann et 
al. 2009). For example, during standing, the gastrocnemius medialis was found to be more 
active in the distal region than in the proximal region (Hodson-Tole et al. 2013). Moreover, 
the activity level of muscle regions can shift depending on exercise intensity, as was found in 
the gastrocnemius medialis in an isometric plantar flexion exercise at varying contraction 
levels (Kinugasa et al. 2011). Finally, it is known from positron emission tomography (PET) 
studies, that the overall heterogeneity of glucose uptake in muscles varies depending on the 
exercise intensity; the heterogeneity decreasing with increasing exercise intensity (Heinonen 
et al. 2012). Region-specific activation may influence the magnitude and direction of forces 
that are applied to tendons (Rahemi et al. 2014), which may, for instance, have relevance in 
the study of injury mechanisms or muscle diseases. Insight into region-specific activation 
could also be useful for validating musculo-skeletal models, which often contain multiple 
musculo-tendon actuators per muscle, each of which with its own specific calculated 
activation level during a given activity (e.g., walking, stair negotiation or other activities of 
daily living).
Positron emission tomography with [18F]-fluorodeoxyglucose (FDG) is a technique that 
can be used to assess glucose uptake in entire muscles during activity in both limbs, as 
well as region-specific differences in glucose uptake within muscles. This technique is based 
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on the principle that contracting muscles take up glucose (and FDG) from the blood to 
replenish their expended energy. Although muscle cells can use various substrates (e.g., 
internal glycogen and triglyceride stores, plasma free fatty acids), the plasma glucose uptake 
is likely constant in a low intensity exercise such as walking (Romijn et al. 1993). Several 
authors have already used FDG-PET to investigate muscle activity during walking (Kindred 
et al. 2015; Kolk et al. 2015; Oi et al. 2003; Shimada et al. 2009; Shimada et al. 2007), but 
asymmetries between muscles in the left and right legs, and region-specific activation within 
muscles have not yet been studied. In part, this may have been due to the analyses of the 
FDG uptake data being limited to single slices of the PET scan, instead of taking the uptake 
in the entire muscle into account. Using three-dimensional MRI segmentation techniques, 
the added value of analyzing the uptake in the entire muscles was shown in previous work 
from our group (Kolk et al. 2015).
This study’s aims were threefold. First, we aimed to elucidate whether muscle activity (in 
terms of glucose uptake) between the legs can be considered symmetrical during walking. 
Second, we aimed to determine whether the FDG uptake was heterogeneous throughout 
each muscle. Third, in case the uptake would be heterogeneous, we aimed to investigate 
whether muscle regions that exhibited high uptake would be clustered.
Methods
The subjects, protocol and scans have been described in detail previously (Kolk et al. 2015), 
and will therefore be described only briefly.
Subjects
Ten healthy subjects with no history of major injury, orthopedic surgery on the lower limb, 
ailment related to carbohydrate metabolism, or cardiac or muscular disease participated in 
this study. There were five men and five women, age 23-60 years, height 1.60 m to 1.95 m, 
weight 55.5 kg to 91.7 kg. The dominant limb was determined to be the limb used to kick 
a ball (Chapman et al. 1987; Seeley et al. 2008). All procedures were approved by the local 
ethical committee and written informed consent was obtained from all participants.
Protocol
The protocol consisted of 90 minutes of walking on a treadmill at self-selected comfortable 
pace; 60 minutes before and 30 minutes after injection with 53.6±1.8 MBq FDG. The injected 
activity was low since the scans were made in 3D mode and through the use of time-of-flight 
technology on a latest generation PET scanner (Jakoby et al. 2011). When walking ceased, 
subjects rested for 30 minutes, and then a PET/CT scan of the lower limb was acquired. The 
subjects had refrained from eating and drinking anything except water for at least six hours, 
and from participating in strenuous physical activities for two days before the session.
123
Symmetry and Heterogeneity of Glucose Uptake During Walking
6
Positron-emission tomography and CT scans
The PET and CT scans were made with a Biograph 40 mCT (Siemens AG, Erlangen, 
Germany), from the feet to at least the iliac crest. The slice thickness of the PET scan was 2.0 
mm, and image reconstruction was performed with a matrix size of 512x512 and voxel size 
of 1.6 x 1.6 mm. The images were filtered using a 3D Gaussian filter with a kernel width of 3 
mm full width at half maximum. The CT images were used both for attenuation correction 
(reconstruction with 5.0 mm slice thickness, B19f convolution kernel), and anatomical 
reference (reconstruction with 2.0 mm slice thickness, B31f convolution kernel).
Magnetic resonance imaging scans
The MRI scans were acquired with a Magnetom Skyra (Siemens AG, Erlangen, Germany) 
at 3 Tesla. The slice thickness was 3.0 mm in the hip, knee and ankle regions, and 8.0 mm in 
the long bone regions in between, such that a higher level of detail was available in the areas 
where most muscles originate or insert. The scan parameters (TR/TE: 450-545/9 ms) were 
set to achieve optimal visibility of muscle boundaries (Kolk et al. 2015; Scheys 2009). 
Image analysis
The end goal of the image analysis phase was to extract FDG uptake values from each of 
78 muscles (39 muscles in both limbs, see Kolk et al. 2015) from the PET scans. To achieve 
this, three-dimensional regions-of-interest (ROIs) that reflected the muscle boundaries 
were needed. Several sequential steps were taken using Mimics (Materialise N.V., Leuven, 
Belgium), Matlab 2012b (the Mathworks, Natick, MA, USA) and the Image Segmentation 
and Registration Toolkit 4.5.2 (ITK) (Kitware Inc., Clifton Park, NY, USA).
1) Using the MRI scan of the left lower limb of the first of the healthy subjects, 
39 muscles were segmented manually on the axial slices in Mimics. These ‘stacked’ 
two-dimensional boundaries of each muscle formed three-dimensional ROIs. This 
complete segmentation will henceforth be referred to as ‘atlas’.
2) The muscles in the left lower limb of the other nine subjects were semi-
automatically segmented in Mimics, using the atlas of muscle ROIs and an 
algorithm based on non-rigid registration of the MRI scans. More detail can be 
found in (Kolk et al. 2015). The resulting muscle segmentations were thoroughly 
checked and manually corrected where necessary. 
3) The MRI scans and muscle ROIs of the left lower limb of all ten subjects 
were mirrored to their respective right lower limb, again with an algorithm based 
on non-rigid registration. Since the orientation of both limbs was not always 
perpendicular to the axial direction of the scan, and the fact that left-to-right 
anatomical differences might exist, the left and right limbs were treated as separate 
entities. Therefore, segmentation of the muscles of the right limb was checked and 
corrected again where necessary.
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4) The MRI scan and the muscle ROIs were registered onto the CT scan, using 
ITK. The muscle ROIs were manually checked and corrected where necessary, this 
time using the CT scan as the anatomical reference. Since the CT and PET scans 
were taken with the subject lying on the table in the same position, no further 
adjustment of muscle ROIs was necessary once the muscle ROIs properly reflected 
the muscle contours on the CT scan.
5) The muscle ROIs were exported as DICOM (Digital Imaging and 
Communications in Medicine) mask files.
6) The DICOM mask files and the PET DICOM files (which were obtained 
directly from the PET scanner) were loaded into Matlab. Then, the ones (reflecting 
the muscle’s location) and zeros (all surrounding areas) in the DICOM mask files 
were multiplied with the PET scan (containing grey values reflecting the FDG 
uptake in Bq/mL). The FDG uptake values were corrected for decay time since the 
start of the scan using the rescale slope and intercept values extracted from the 
DICOM headers.
An important note is that the PET DICOM files from which we extracted the FDG uptake 
values were obtained directly from the Biograph 40 mCT; they were not ‘morphed’ or altered 
in any way. 
Analysis of asymmetry
To analyze the amount of asymmetry between the dominant and non-dominant lower 
limbs, we used the absolute symmetry index (ASI) and the symmetry index (SI) (Becker et 
al. 1995; Furlong et al. 2015; Herzog et al. 1989; Schoeman et al. 2013). The equations for the 
SI and ASI of muscle i are: 
Where SUV is the mean Standardized Uptake Value of that muscle (Kubota et al. 1985; 
Lucignani et al. 2004). The SUV reflects the normalized, mean FDG uptake in a muscle, and 
is given by the following formula for muscle i:
We corrected the SUV for radioactive decay between the injection and the start of the scan. 
Since the SUV is normalized by the muscle volume, and volume differences might exist 
between muscles in the dominant and the non-dominant lower limb, these could have 
influenced the SUVs. Therefore, we also multiplied the SUV by the muscle volume, and 
refer to this value as the absolute uptake value (AUV).
The SI provided a measure for analyzing whether systematic differences existed in uptake 
between the dominant and the non-dominant limb, whereas absolute values of SI indicated 
the degree of non-directional asymmetries. Only the five largest muscles (in terms of 
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volume) in each segment (pelvis, thigh, lower leg) were analyzed, since in previous work, 
those muscles were found to provide the largest contributions to walking (Kolk et al. 2015). 
Hence, in total we considered 30 muscles (15 on each side) for the analyses.
Heterogeneous uptake
Heterogeneity in uptake within muscles was examined using the skewness of the FDG 
uptake. The skewness provides a measure for the symmetry of the probability distribution, 
which for this study was an advantage over the coefficient of variation, which only provides 
a measure for the spread of the distribution (the coefficients of variation have been reported 
previously (Kolk et al. 2015)). If the distribution has equally long and thick tails to the 
left and to the right, the skew is zero. If the most frequently occurring FDG uptake values 
clustered at the lower end of the distribution and the tail pointed towards the higher scores, 
the skewness was positive, and vice versa for negative skew (Field 2013). 
Clustering
To examine the degree to which voxels with high SUVs were clustered in a given muscle, 
we first classified the voxels that were amongst those with the highest five percent uptake 
as being ‘hot’ voxels, and the other voxels (i.e. 95 percent of the voxels) as ‘cold’ voxels. We 
then calculated for each hot voxel with how many hot voxels it shared a border (number of 
hot neighbors – NHN). This calculation was also done for determining the number of hot 
voxels that bordered each cold voxel. The calculation in both cases was performed using a 
custom algorithm written in Matlab that detected the 6-point connectivity of the voxel. The 
average number of hot neighbors per hot voxel was then divided by the average number of 
hot neighbors per cold voxel. Since there were 19 times (=95/5) less hot voxels than cold 
voxels, the denominator was multiplied by 19. This yielded a dimensionless index we will 
call the ‘cluster index’. The cluster index of muscle i is given by:
The numerator reflects the average number of hot voxels m per hot voxel h. The denominator 
reflects the average corrected number of hot voxels n per cold voxel c. A cluster index of 0 
would correspond to a situation where there is a homogeneous spread of the hot voxels 
throughout the muscle, whereas a higher cluster index value would indicate a tendency for 
hot voxels to cluster.
Statistical analysis
The distributions of the SUV and AUV values of each of the 30 muscles were tested for 
normality with Kolmogorov-Smirnov tests. Since about half of these tests indicated that 
data were not normally distributed, we used non-parametric tests (Wilcoxon matched-pair 
signed-rank) for all comparisons between muscles of the dominant and the non-dominant 
limb. The significance level was set at p ≤ 0.05.
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Results
Inter-limb asymmetries
There were large asymmetries in uptake between all muscles in both limbs, as indicated by 
the absolute symmetry indices (ASI) (Table 6.1). These differences were most pronounced 
in the lower leg, where median ASI values between 12% (soleus, tibialis posterior) and 42% 
(gastrocnemius medialis) were found. For individual subjects, differences up to 98% were 
found (tibialis anterior). In the hip region, the gluteus minimus and medius exhibited the 
largest asymmetry (median ASI of 30% and 15%, respectively). The uptake in the thighs was 
relatively symmetrical between the limbs; median ASI were 10% or lower in all muscles. 
All but one subjects had at least one asymmetry that was larger than 25% (Table 6.1, last 
column). 
With regard to the direction of these asymmetries, SUVs were not significantly different 
between the dominant and the non-dominant limb in 14 out of 15 muscles (Table 6.2). The 
median symmetry indices were smaller than 25% in all muscles, and smaller than 10% in 
12 out of 15 muscles (Figure 6.1). Similar to the SUV-based comparisons, when inter-limb 
muscle volume differences were taken into account (AUV), none of the 15 muscles exhibited 
significant systematic differences in AUV between the dominant and the non-dominant 
limb (Table 6.2). 
Table 6.1 Absolute Symmetry Indices of SUV for muscles of the lower limb 
during walking
Muscle ASI
Number of subjects 
>25% ASI
Subject numbers 
>25% ASI
Gluteus maximus 5% (0% - 49%) 1 8
Gluteus medius 15% (1% - 86%) 2 5, 8
Gluteus minimus 30% (1% - 64%) 6 2, 5, 7, 8, 9, 10
Iliacus 8% (2% - 18%) 0 -
Psoas 8% (2% - 25%) 1 5
Adductor magnus 6% (1% - 13%) 0 -
Vastus lateralis 8% (0% - 9%) 0 -
Vastus intermedius 3% (0% - 15%) 0 -
Vastus medialis 3% (0% - 19%) 0 -
Rectus femoris 3% (1% - 72%) 1 9
Soleus 12% (0% - 65%) 3 2, 4, 9
Gastrocnemius medialis 42% (3% - 93%) 7 1, 3, 4, 5, 7, 9, 10
Gastrocnemius lateralis 28% (3% - 73%) 6 1, 2, 4, 8, 9, 10
Tibialis posterior 12% (3% - 82%) 4 1, 2, 3, 5
Tibialis anterior 39% (3% - 98%) 6 2, 3, 4, 8, 9, 10
ASI: Absolute Symmetry Index. Values are given as median (range).
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Heterogeneity of FDG uptake
The SUVs of the individual voxels within muscles tended to be concentrated at the lower 
end of the histograms, with a tail towards the higher SUVs, as indicated by the median 
skewness values that were higher than zero in all muscles, and higher than one in 10 out 
of 15 muscles (Figure 6.2). Example histograms of muscles with low (0.5), typical (1.4) and 
high (2.1) skewness are shown in Figure 6.3G, H, and I, respectively. The adductor magnus 
had the highest median skewness (2.8 and 2.5 for the dominant and non-dominant limbs, 
respectively), as well as the widest range of skewness values between subjects (ranging from 
1.2 to 10.6 in the dominant limb). In addition, the gluteal muscles also exhibited relatively 
large skewness values. The tibialis anterior was the only muscle that was hardly skewed at 
all (median skewness 0.3 in the dominant limb and 0.2 in the non-dominant limb). From 
Figure 6.2 it is also evident that there were large inter-subject differences in the skewness 
values in the vast majority of muscles, with the exception of the quadriceps muscles and the 
tibialis anterior.
Clustering of FDG uptake
In all muscles, voxels with high FDG uptake tended to cluster together rather than being 
distributed heterogeneously. This is indicated by the cluster index, which was higher than 
one for all muscles (Figure 6.4). The clustering was most pronounced in the adductor 
magnus, soleus, tibialis posterior and non-dominant gluteus minimus, with median cluster 
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Gluteus maximus
Gluteus medius
Gluteus minimus
Iliacus
Psoas
Adductor magnus
Vastus lateralis
Vastus intermedius
Vastus medialis
Rectus femoris
Soleus
Gastrocnemius medialis
Gastrocnemius lateralis
Tibialis posterior
Tibialis anterior
Symmetry Index (%)
Symmetry Index Dominant − Non−Dominant Limb
Figure 6.1. Box plot of the symmetry index, which shows the differences in uptake between the mus-
cles in the dominant and the non-dominant lower limb. On each box, the central mark is the median, 
the edges of the box are the 25th (q1) and 75th (q3) percentiles, the whiskers extend to the most extreme 
data points not considered outliers, and outliers are plotted individually. Points are drawn as outliers 
if they are larger than q3 + 1.5*(q3 – q1) or smaller than q1 – 1.5*(q3 – q1).
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indices of two or more. Clustering was relatively low in the quadriceps muscles, as indicated 
by the median cluster indices of 1.3-1.8, and this observation was consistent across subjects. 
In contrast, the degree of clustering varied widely between subjects in most of the other 
muscles.
The locations of clustered areas also varied greatly between subjects for any given muscle. 
For example, the stretch of clustering that is visible in Figure 6.3B and C in the cranial, 
medial aspect of the soleus was present in four subjects, whereas the other six subjects had 
clustered areas elsewhere, or the clustered areas were smaller and more scattered throughout 
the muscle. Hence, we found clustering of high FDG uptake, but could not identify any 
consistent intra-muscular pattern of FDG uptake in any of the 15 muscles amongst the 10 
healthy subjects included in this study. 
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Gluteus Minimus
Iliacus
Adductor Magnus
Vastus Lateralis
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Non−dominant
Figure 6.2. Skewness of the FDG uptake distribution in the muscles in the dominant and the non-
dominant lower limb. A skewness of zero would indicate a normal, Gaussian distribution, whereas 
higher skewness values such as observed in the figure indicate that the most frequently occurring FDG 
uptake values clustered at the lower end of the distribution and the tail pointed towards the higher 
scores. On each box, the central mark is the median, the edges of the box are the 25th (q1) and 75th (q3) 
percentiles, the whiskers extend to the most extreme data points not considered outliers, and outliers 
are plotted individually. Points are drawn as outliers if they are larger than q3 + 1.5*(q3 – q1) or smal-
ler than q1 – 1.5*(q3 – q1).
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Figure 6.3. A-C: Three-dimensional rendering of the soleus muscle for three subjects, including mar-
ked ‘hot’ voxels in blue. The X, Y and Z-coordinates reflect the anterior-posterior, left-right and distal-
proximal directions, respectively. They are shown in the DICOM patient coordinate system. D-F: Slice 
of the soleus muscle taken at 2/3 of its height, with colors indicating the uptake value (SUV, i.e. g/
mL). The soleus in the middle was the largest; this subject was male, whereas subjects 4 and 8 were 
females. G-I: Histograms of the distribution of the entire muscle’s FDG uptake across the spectrum of 
uptake values. The histogram that corresponds with the lowest skewness value (on the left) is rather 
bell-shaped, whilst the other two clearly are not.
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Discussion
This study aimed to determine asymmetries in FDG uptake between muscles in the 
dominant and the non-dominant lower limb, as well as to determine heterogeneities in FDG 
uptake within muscles during walking, using three-dimensional MRI-based whole-muscle 
segmentations. Large inter-limb differences in uptake were found in the lower leg muscles 
and in the gluteus medius and gluteus minimus (differences up to 98% were found), whereas 
the uptake in the thighs was relatively symmetrical between the limbs. FDG uptake was not 
systematically higher in the dominant or the non-dominant limb in any muscle, including 
when inter-limb muscle volume differences were taken into account. The skew of the SUVs 
was to the right almost exclusively, indicating that most voxels had a relatively low SUV, 
and that a minority of voxels had a relatively high SUV. Rather than being homogeneously 
distributed in the muscle, the voxels with high SUV tended to cluster in virtually all muscles, 
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Figure 6.4. Clusterindices per muscle. A clusterindex of zero would indicate a homogeneous distribu-
tion of the ‘hot’ voxels of FDG across the muscle, whereas higher values are indicative of a clustering 
effect. On each box, the central mark is the median, the edges of the box are the 25th (q1) and 75th (q3) 
percentiles, the whiskers extend to the most extreme data points not considered outliers, and outliers 
are plotted individually. Points are drawn as outliers if they are larger than q3 + 1.5*(q3 – q1) or smal-
ler than q1 – 1.5*(q3 – q1).
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the clustering being strongest in the adductor magnus, the ankle plantar flexors, and the 
gluteus medius and minimus.
Considering that the subjects were healthy, our finding that there were large asymmetries 
in muscle FDG uptake between the limbs in several muscles was unexpected. According 
to traditional assumptions and a substantial body of literature (for overview, see Sadeghi 
et al. 2000), gait in the absence of disease has been supposed and found to be symmetrical. 
However, this notion is still under debate (Sadeghi et al. 2000), and the body of evidence 
supporting some asymmetry is also substantial. For example, in a large retrospective study 
(182 subjects), peak hip and knee flexion and adduction moments during walking exceeded 
10% asymmetry in more than half of the participants (Lathrop-Lambach et al. 2014). Similar 
studies that looked at spatiotemporal parameters, kinematics, and ground reaction forces 
also found significant asymmetries in these parameters (Gundersen et al. 1989; Herzog et al. 
1989; Maupas et al. 1999). There are also studies that found asymmetries in muscle activity 
using EMG (Arsenault et al. 1986a; Ounpuu et al. 1989). Nevertheless, in the present study, 
the asymmetries in terms of glucose uptake of more than 25% and even 50% that we found 
in many muscles, particularly in the lower leg, were larger than in any literature. 
A first possible explanation for the large asymmetries could be limb dominance, but 
the direction of the asymmetries in uptake varied widely between subjects and was not 
consistently pointing towards the dominant or the non-dominant limb in any muscle. A 
second explanation for a muscle being more active in one limb than in the contralateral limb, 
would be that it is compensating for similarly asymmetric co-activation in an antagonist 
muscle. Yet, we did not observe such a trend in the uptake data, and there were several 
subjects who actually showed an opposite effect. A third possible explanation for the large 
inter-limb asymmetries is that the muscles in either the dominant or the non-dominant limb 
would have different degrees of work efficiency. However, if this were the case, it would have 
been likely that a given muscle would consistently show a higher degree of efficiency (and 
thus, lower uptake) in either the dominant or in the non-dominant lower limb across subjects, 
which was not observed. Finally, a fourth explanation is that a very active muscle could be 
compensating for reduced activity in another muscle that has a similar functional role. For 
example, high activity in one of the plantar flexors (e.g., soleus) could be accompanied by a 
lower activity in the other plantar flexors (mainly medial and lateral gastrocnemius). Such a 
trend was not observed; subjects who had a high AUV in the soleus generally also had a high 
uptake in the medial and lateral gastrocnemius, and vice versa. Hence, it remains difficult to 
explain the large asymmetries, and this warrants further research using other methods (e.g., 
EMG and kinematic and kinetic gait analysis) in conjunction with the FDG-PET technique. 
Interestingly, the distribution of the SUVs across the voxels comprising each muscle did 
not follow a Gaussian curve, but was instead skewed to the right in almost all muscles. This 
indicates that there was a relatively large number of voxels which exhibited an SUV that 
was substantially lower than the mean SUV of the entire muscle. This high degree of skew 
is in line with Heinonen et al., who used FDG-PET to examine the heterogeneity of glucose 
uptake in the quadriceps during exercise at different intensity levels (Heinonen et al. 2012). 
Albeit in a different task (cycling), it was found that the heterogeneity of glucose uptake 
in the quadriceps was relatively high at low exercise intensity levels, and that it decreased 
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with increasing exercise intensity levels (30%, 55% and 75% of maximum VO 2). Since level 
walking at comfortable speed is generally considered a low intensity exercise, the high 
degree of skew that we observed is in line with this literature (Heinonen et al. 2012). The 
fact that skewness might be related to the intensity level of the activity opens the question 
whether it may be related to the fiber type composition of the muscle. This does not appear 
to be the case; the soleus has a very high type I fiber percentage of 87.7% (Johnson et al. 
1973) and exhibited an average degree of skew. Similarly, the rectus femoris, which has a 
very low type I fiber percentage of 38.1% (and, consequently, a high type II fiber percentage 
of 61.9%) (Johnson et al. 1973), also exhibited only an average degree of skew. The adductor 
magnus and tibialis anterior, however, have lower percentages of type I fibers than the soleus 
(58.4% and 73.1%, respectively (Johnson et al. 1973)), yet these exhibited the most (adductor 
magnus) and least (tibialis anterior) skewed distributions. 
The voxels with high uptake of FDG were clustered instead of being distributed 
homogeneously throughout the muscle, especially in the adductor magnus, the ankle plantar 
flexors, and the gluteus medius and minimus. This suggests that most of the work during 
walking is performed by limited regions within muscles. Since comfortable level walking 
is an aerobic activity, and since it is known that the different types of muscle fibers are 
organized in regions of different composition rather than being homogeneously distributed 
(Chanaud et al. 1991), the observed regional uptake differences could be due to regional 
differences in muscle fiber types. In conjunction, due to the size principle, the recruitment 
of motor units (MUs) in theory causes region-specific muscle activation when a certain 
specific demand is placed on the muscle (Hodson-Tole et al. 2013; Holtermann et al. 2005). 
In simple tasks (e.g., isometric exercises), this phenomenon of region-specific activation 
has been confirmed using modern techniques such as multi-channel electromyography 
(Holtermann et al. 2005; Staudenmann et al. 2009), MRI (Kinugasa et al. 2011) as well as 
FDG-PET (Kalliokoski et al. 2007; Pappas et al. 2001). Our results are in line with these 
findings and suggest that, also in a more complex task (walking), region-specific differences 
in muscle activation exist in almost all muscles. 
Rather than forming consistent patterns across subjects, the spatial distribution of FDG 
uptake in the muscles was very variable. Typically, three or four subjects could be grouped 
into one category of regional uptake (e.g., cranial, medial aspect in the soleus such as in 
Figure 6.3B and C), but no consistent patterns were observed across all subjects in any 
muscle. It is known that activation of anatomical regions within a muscle can be related 
to a specific functional task that needs to be performed (Brown et al. 2007; Hodson-Tole 
et al. 2013), or to mechanical demands (Higham et al. 2008) or force direction demands 
(Staudenmann et al. 2009). It also seems to be the case here that different spatial regions of 
muscles contribute differently to walking than others. Again, this warrants further research 
as to how and why these specific patterns differ between individuals and how they affect the 
walking pattern.   
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Limitations
This study has some limitations. First, the inter-subject variation in SUVs was high in 
some muscles, and the current sample size was too small to attribute this to any particular 
characteristic of these healthy subjects such as age, body mass index or general fitness level. 
However, high inter-subject variability in muscle activation during walking has been shown 
to exist with techniques such as EMG as well (Arsenault et al. 1986b; Winter et al. 1987; 
Yang et al. 1984). Second, our experimental protocol did not include a control condition 
such as resting. Therefore, it was not possible to assess whether the observed intra-muscular 
heterogeneities in FDG uptake were attributable to the walking task or (partly) due to varying 
levels of resting metabolism within muscles. Extending the protocol was not allowed by the 
medical ethical board at our hospital due to ethical constraints regarding the radiation dose 
to these healthy subjects. The board initially denied the study and we had to reduce the dose 
of the CT scan to be allowed to perform the study. Furthermore, our measurement protocol 
did not include gait analysis. This would have allowed us to test our visual observation that 
the healthy subjects walked symmetrically. Third, our walking time was long (90 minutes), 
which has two disadvantages. One is in transitioning from research on healthy subjects 
to clinical applications, as patients may change their gait during the prolonged walking 
task due to pain or fatigue in certain muscles. The other disadvantage is that FDG-PET is 
a cumulative measurement that provides no temporal information. Therefore, activation 
of different regions within each muscle may have shifted during the task, which makes 
interpretation of the region-specific uptake results difficult. Future work could focus on 
examining region-specific FDG uptake in a simpler, more controlled task, or it could focus 
on combining FDG-PET with multi-channel electromyography, such that changes in MU 
recruitment can be tracked over time and coupled with the FDG-PET results. 
Conclusions
The volumetric analysis of FDG uptake in both lower limbs after walking showed that muscle 
activity (in terms of glucose uptake) was symmetrical in the thigh muscles, whereas it was 
highly asymmetric in the lower leg and gluteal muscles in many subjects. These findings 
challenge the common assumption of symmetry between the limbs in healthy subjects. 
Practically all of the inter-subject differences disappeared when the results were averaged 
across subjects, which underlines that averaging individual subject data stemming from both 
limbs may preclude asymmetries from being noticed or reported. Studies that have the goal 
of validating muscle activation levels using subject-specific musculoskeletal models, will 
need to be cautious that muscle activity for the most active muscles during the activity (e.g., 
lower leg and gluteal muscles for walking) needs to be validated for each subject and each 
limb individually. As for the FDG distribution within muscles, there was a majority of voxels 
that had an SUV that was lower than the mean SUV, and there was a minority of voxels with 
a relatively high SUV in almost all muscles. Those ‘hot’ voxels tended to cluster rather than 
being spread homogeneously throughout the muscle, but those clusters were not located 
in consistent locations in a given muscle across subjects. The inconsistent locations of ‘hot’ 
clusters highlights the added value of performing a three-dimensional analysis of uptake 
rather than examining uptake in only a single slice for each muscle. Future research could 
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focus on revealing the relation of active versus resting FDG uptake levels, on measuring 
kinematics and kinetics while the exercise is performed, and on combining the cumulative 
FDG-PET measurement with a temporal-sensitive method such as multi-channel EMG. 
Using FDG-PET to measure muscle activity remains an exciting new technique, which has 
the potential to further improve our understanding of muscle contributions during exercise 
in many ways, including in detecting differences in muscle activity levels between subjects, 
between limbs, and between regions within muscles.
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Abstract
Background: Validation of musculoskeletal models represents a crucial challenge to gain the 
necessary confidence for clinical applications, such as surgical planning and decision making 
in orthopedics. Electromyography and, recently, near infrared spectroscopy have been used 
as convenient and non-invasive techniques for indirect validation of models. However, they 
can be applied only to a small number of superficial muscles. Positron emission tomography 
(PET) combined with the radioactive tracer [18F]-fluorodeoxyglucose (FDG) is a novel 
approach that allows measuring the muscular activity of all muscles of the lower extremity, 
including the deep muscles, in a single session. 
Methods: In this study, we used FDG-PET for validation of subject-specific musculoskeletal 
models, comparing the measured glucose uptake %FDG with the predicted metabolic 
energy consumption %Em for all the muscles of the lower extremity. 
Results: When analyzing each individual subject, good to very good correlations were 
found between %FDG and %Em (Spearman’s ρ = 0.87±0.04, Pearson’s r = 0.77±0.10). 
Higher correlations were found when analyzing results averaged over ten healthy subjects 
(Spearman’s ρ = 0.96, Pearson’s r = 0.91). Correlations were slightly higher for subject-
specific models compared to generic models, but this was not significant (p = 0.17). 
Conclusions: We conclude that FDG-PET should be considered as a complimentary 
validation tool to electromyography.
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Introduction
Recent improvements in medical imaging techniques and increase of computational power 
have allowed estimating subject-specific parameters of musculoskeletal (MS) geometry 
(Carbone 2016; Hausselle et al. 2014; Scheys et al. 2009) and muscle-tendon (MT) architecture 
(Carbone 2016; Hainisch et al. 2012; van Campen et al. 2014) in a semi-automatic way. Since 
the use of MS models in clinical applications such as surgical planning and decision making 
in orthopedics (Cohen et al. 2003; Reinbolt et al. 2009; Taddei et al. 2012) is increasing, 
extensive validation of model predictions is crucial (Lund et al. 2012; Prilutsky et al. 2002).
In-vivo measurement of muscle and joint reaction forces requires special tools, such as use 
of optic-fiber technique (Finni et al. 2000), in situ buckle-type force transducers (Gregor 
et al. 1991), or instrumented joint replacements (Bergmann et al. 2001; Fregly et al. 2012). 
For these reasons, direct validation of MS models is inherently difficult, costly and ethically 
problematic to perform.
Comparison of electromyography (EMG) measurements with predicted muscle forces 
represent a more common example of indirect validation of MS models (Asadi Nikooyan 
et al. 2011; Giroux et al. 2013). Next to EMG, measurement of local oxygen consumption 
of muscle tissue, reflecting the energy consumption process, through near infrared 
spectroscopy (NIRS) has been proposed as a validation tool for musculoskeletal models 
(Praagman et al. 2006; Praagman et al. 2003). Although both EMG and NIRS are convenient 
and non-invasive techniques for indirect validation of MS models, they share important 
limitations such as the limited number of muscles that can be measured at the same time, 
the lack of information on deep-lying muscles, and the fact that adipose tissue and crosstalk 
from other muscles are important confounding factors.
Positron emission tomography (PET) combined with the radioactive tracer [18F]-
fluorodeoxyglucose (FDG) is a novel technique that can be used to measure the intensity of 
carbohydrate metabolism in muscle tissue (Kemppainen et al. 2002). Unlike EMG and NIRS, 
FDG-PET can be used to estimate activity in all muscles of the lower extremity, including 
the deep muscles, in a single session (Kolk et al. 2015). Recently, FDG-PET has been 
successfully used to measure the intensity of muscular activity of the lower extremity during 
aerobic exercises such as walking (Oi et al. 2003; Shimada et al. 2007), running (Fujimoto 
et al. 1996; Fujimoto et al. 2000; Tashiro et al. 1999), and cycling (Gondoh et al. 2009). It 
has been shown that FDG-PET is able to distinguish the relative contributions of individual 
muscles to joint moments (Masood et al. 2014; Pappas et al. 2001), and to show differences 
between subjects with different age or physical conditions (Fujimoto et al. 2003; Kolk et al. 
2015; Rudroff et al. 2013; Shimada et al. 2009). Hence, it can be used to indirectly measure 
the functional differences in the muscle recruitment process. Oi et al. (2003) compared FDG 
uptake results with EMG and kinematic and kinetic studies and demonstrated the validity 
of measuring the muscular activity of the lower extremity with FDG-PET. Therefore, FDG-
PET seems to be a promising tool for validation of MS models.
In this study, we used FDG-PET for validation of comprehensive musculoskeletal 
models. We compared the activity of all muscles of the lower extremity during walking, 
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previously measured on ten healthy subjects using FDG-PET (Kolk et al. 2015), with the 
metabolic energy consumption predicted by ten subject-specific models, based on MRI and 
dynamometry data (Carbone 2016). Moreover, we aimed to determine whether subject-
specific models provided better predictions than generic models when compared to FDG-
PET measurements.
Methods
TLEMsafe healthy subjects dataset
A dataset of ten healthy subjects (five males, age 40.1±15.7 years, height 174.9±11.1 cm, 
weight 74.8±11.9 kg, BMI 24.4±2.3 kg/m2, fat percentage 27.8±5.8%) was obtained at the 
Radboud University Medical Center in Nijmegen, the Netherlands. For each subject, an MRI 
scan of the lower extremity was obtained (3T, T1-weighted axial spin echo (SE), voxel size 
of 1.0*1.0*3.0 mm for pelvis, knee and ankle region, and 1.0*1.0*8.0 mm for the remaining 
upper and lower leg) (Figure 7.1A) using a Siemens 3T MAGNETOM® Skyra (Siemens AG, 
Munich, Germany). Then, 3D motion data (Vicon®) with synchronized custom built force 
plate data (AMTI, Watertown, MA, USA) were recorded during walking trials at a level 
walkway (Figure 7.1B). Thirty-five optical markers were placed according to the Vicon® 
Plug-in-Gait model (Vicon®, 2002), with ten additional markers placed on the right and left 
thigh, shank, medial femoral epicondyle, medial malleolus and fifth metatarsal head of the 
foot. For each subject, three gait trials at comfortable walking speed (CWS) were selected. 
Subsequently, for each subject, an extensive set of isometric and isokinetic torques during 
maximal voluntary contractions were measured using a Biodex Dynamometer (Biodex 
Medical Systems) (Figure 7.1C) for ankle plantar/dorsiflexion, knee flexion/extension, hip 
flexion/extension and hip abduction/adduction.
   
Figure 7.1. TLEMsafe healthy subjects’ dataset. A. MRI scan of the lower extremities. B. Healthy sub-
ject wearing reflective markers and wireless EMG sensors during a recording session of 3D motion 
analysis and force plate data. C. Measurement of isometric and isokinetic torques during maximal 
voluntary contraction using a Biodex Dynamometer (Biodex Medical Systems).
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FDG-PET volumetric analysis
Each subject walked on a treadmill at the same CWS measured in the gait lab for 90 minutes, 
60 minutes before and 30 minutes after injection with FDG. Then, thirty minutes after 
finishing the last walking phase, a PET/CT scan was obtained using a Biograph 40 mCT 
(Siemens AG, Erlangen, Germany) in 3D mode, using an extended axial field of view of 
216 mm and slice thickness of 2.0 mm, with the subject’s legs positioned on the table to 
reproduce as closely as possible their position as during the MRI scan.
Muscle volumes of the left lower extremity were semi automatically segmented from MRI 
scans and subsequently registered onto the corresponding PET/CT scan, in order to obtain 
FDG uptake values for each individual muscle (Figure 7.2). Finally, %FDG uptake values 
were calculated to reflect the amount of FDG accumulated in each muscle relative to the 
total amount of FDG in all muscles of the lower extremity. More details about the FDG-PET 
protocol and medical imaging analysis, and complete results of the study are presented in 
(Kolk et al. 2015). Study procedures were approved by the ethical committee of the region 
Arnhem-Nijmegen, The Netherlands, and written informed consent was obtained from 
each subject.
Musculoskeletal models
Modeling was performed using the Twente Lower Extremity Model 2.0 (Carbone et al. 
2015) implemented in the AnyBody Modeling System™ ver. 6.0.3 (AnyBody Technology 
A/S, Aalborg, Denmark) (Figure 7.3). TLEM 2.0 represents a comprehensive MS geometry 
dataset including medical images (CT and MRI) and segmented bone and muscle volumes 
(Figure 7.3A and 3B). The model consisted of 12 body segments, 11 joints and 21 degrees-
                               
Figure 7.2. FDG-PET volumetric analysis: A. MRI scan with segmented muscle volumes. B. Segmen-
ted muscle volumes registered onto the PET scan. C. Frontal view of a PET scan with registered muscle 
volumes. D. MRI and PET scan slices of the hip, femur and tibia regions, with the registered muscle 
volumes.
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of-freedom (Figure 7.3C). To accurately describe the functionality of the MS system, each 
leg contained in total 55 MT parts whose mechanical effect was described by 166 three-
elements Hill-type MT elements (Zajac 1989) (Figure 7.3D).
For each subject, a generic and a subject-specific model was created:
Generic model
The TLEM 2.0 model was scaled using linear scaling laws, based on the relative position of 
the measured optical markers using a parameter optimization algorithm (Andersen et al. 
2010).
Figure 7.3. TLEM 2.0 dataset. From left to right: A. CT and MRI scans. B. Bone surfaces, muscle volu-
mes, and subcutaneous fat and skin volumes segmented from MRI and CT scans. C. TLEM 2.0 model 
implemented in the AnyBody Modeling System™ ver. 6.0.3 (AnyBody Technology A/S, Aalborg, Den-
mark), anterior and posterior view. It consisted of 12 body segments: HAT (Head, Arm and Trunk), 
pelvis, and right and left femur, patella, tibia, talus and foot. The fibula was considered as one unit in 
combination with the tibia. The model comprised 11 joints: L5S1 and left and right hip, knee, patella/
femur, talocrural and subtalar. The L5S1 and hip joints were modeled as a ball-and-socket, defined by 
a rotation center and three orthogonal axes. The knee, talocrural and subtalar joints were defined as a 
hinge, with a fixed rotation center and axis. The patella could rotate with respect to the femur around a 
rotation axis with a fixed rotation center. The patellar tendon was defined as a non-deformable element 
that connected the patella to the tibia. Thus, without introducing an extra Degree of Freedom (DOF), 
the orientation and position of the patella depended solely on the knee flexion angle. The orientation 
and position of the center of mass of the pelvis with respect to a 3D global frame, together with the 
joint rotations of the L5S1, hip, knee, talocrural and subtalar joints, resulted in a model with 21 DOFs. 
D. Schematic representation of three-elements Hill-type muscle-tendon element (Zajac 1989). The 
MT element consists of an active muscle, represented by a contractile element CE in parallel with a 
passive element PE, in series with an elastic tendon T, modelled as a nonlinear spring. Lf is the muscle 
fiber length, LT is the tendon length, γ is the pennation angle between the muscle fiber and the tendon. 
LMT is the total length of the MT element, which is equal to the sum of tendon length LT and muscle-
fiber length Lf adjusted by pennation angle γ (i.e. LMT = LT + Lf cos γ). Force in the tendon FMT is equal 
to the summed force in the muscle fibers FM adjusted by pennation angle gamma (i.e. FMT = FM cos γ).
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Subject-specific model
Personalized MS geometry of the 10 healthy subjects were obtained from the MRI scan 
of each subject, using the TLEM 2.0 dataset as a starting template (Carbone 2016). Then, 
muscle volumes were semi-automatically segmented from MRI using Mimics (Materialise 
N.V., Leuven, Belgium), and functional scaling was applied to MT parameters, in order to 
find the best possible match between the strength profile measured during dynamometry 
measurements and the maximal torque predicted by the model (Carbone 2016) (Figure 7.4).
Simulations
For each subject and each gait trial, inverse dynamic analysis and static optimization 
problems were solved to calculate the MT forces necessary to reproduce the measured gait 
trials, based on the recorded 3D motion analysis and force plate data. The muscle recruitment 
problem was solved minimizing the sum of the cubes of muscle activations at each time 
step (Crowninshield et al. 1981), using a normalization factor based on the muscle volume 
according to (Happee et al. 1995). In total, 10 healthy subjects * 3 gait trials * 2 models = 60 
simulations were performed and analyzed in this study.
For each MT element, the mechanical power was calculated as:
where         represents the predicted MT force, and        represents the lengthening velocity 
of the MT element, calculated as the first derivative of the total length of the MT element. 
Then, the metabolic power of each MT element was calculated based on the efficiency on 
the contractile element as:
assuming an efficiency µ = 25% for concentric muscle work (De Haan et al. 1989) and µ 
= -120% for eccentric work (Asmussen 1953), as previously used by Voigt et al. (1995), 
in order to reflect the thermodynamic fact that muscle work is irreversible, and that even 
negative muscle work requires positive combustion. Metabolic power was then integrated 
over a complete gait cycle in order to calculate metabolic energy consumption. Metabolic 
energy consumption Em of each muscle was calculated as the sum of each corresponding MT 
element. For each subject, the average metabolic energy consumption over 3 gait trials at 
CWS was calculated. %Em values were calculated to reflect the amount of Em in each muscle 
relative to the total amount of Em in all muscles of the left lower extremity. For each subject, 
the average metabolic energy consumption over 3 gait trials at CWS was calculated. One-
tailed Wilcoxon rank sum tests (α = 0.05) were performed to test if subject-specific models 
predicted a significantly lower energy consumption compared to generic models.
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Analysis
For each muscle, the %FDG uptake values measured through the PET/CT scans were 
compared with the metabolic energy consumption %Em predicted by the generic and subject-
specific models, with respect to the complete lower extremity and for the pelvis, upper 
leg and lower leg regions. Correlations between %FDG and %Em were assessed using two 
metrics: the Spearman’s rank correlation coefficient ρ, to assess how well their relationship 
could be described using a monotonic function, and the Pearson product-moment 
correlation coefficient r, as a measure of their linear correlation. Spearman’s ρ and Pearson’s 
r were calculated for each individual subject and for the average %FDG and %Em per muscle 
calculated over all ten healthy subjects, with respect to the complete lower extremity, and for 
the pelvis, upper leg and lower leg regions separately. One-tailed Wilcoxon rank sum tests 
(α = 0.05) were performed to test if subject-specific models showed a significantly higher 
correlation with %FDG compared to generic models.
Results
The average metabolic power Pm during the gait cycle was equal to 3.82±0.44 W/kg for 
generic models and 3.73±0.48 W/kg for subject-specific models, which were not significantly 
different (p = 0.13).
Qualitatively, the predicted %Em metabolic energy consumption, and the measured %FDG 
uptakes corresponded well (Figure 7.5). Quantitatively, the muscles in the lower leg 
consumed most of the metabolic energy (%Em equal to 48.1±3.4% and 46.2±4.4% for generic 
and subject-specific models, respectively), which was similar to the FDG-PET data (%FDG 
equal to 45.2±11.1%) (Table 7.1). The subject-specific models showed higher %Em in the 
pelvis region than in the upper leg (30.8±4.9% and 23.1±3.8%, respectively), whereas this 
was the other way around in the FDG-PET data (%FDG equal to 22.6±7.7% and 32.3±5.9% 
in the pelvis and upper leg region, respectively) and in the generic models (%Em equal to 
24.5±3.4% and 27.4±3.4% in the pelvis and upper leg region, respectively). 
Figure 7.4. Ten subject-specific musculoskeletal models of the lower extremity, based on MRI and 
dynamometry measurements. 
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7Many similarities were found between the muscles with the highest %FDG uptake and the muscles with the highest %Em metabolic energy consumption (Table 7.2); The Soleus was 
consistently the most consuming muscle (%FDG equal to 20.6%, %Em equal to 20.1% and 
21.7% for generic and subject-specific models, respectively), followed by the Gastrocnemius 
Medialis, the Gluteal muscles and the Adductor Magnus. The %Em of the Gastrocnemius 
Medialis was consistently overestimated by the models (17.0% and 10.0% for generic and 
subject-specific models, respectively) compared to %FDG (6.6%). Between the Gluteal 
muscles, the Gluteus Maximus and Gluteus Minimus showed consistent results, while the 
Gluteus Medius had a relatively large %Em (7.5% and 9.1% for generic and subject-specific 
models, respectively) compared to %FDG (5.7%). The Tibialis Anterior and the Vasti 
muscles exhibited a much smaller %Em compared to %FDG, while the Iliopsoas and the 
Rectus Femoris showed a larger %Em compared to %FDG. The detailed results of %FDG 
uptake and %Em metabolic energy consumption of all muscles for all ten healthy subjects are 
available in Appendix 7.1-7.5.
Figure 7.5. Qualitative comparison of distribution between muscles of: A. %FDG uptake, based on 
PET volumetric analysis, and B. %Em metabolic energy consumption, predicted using subject-specific 
musculoskeletal models (anterior, posterior and lateral view). Color of muscles is proportional to the 
%FDG and %Em values. Results are averaged over ten healthy subjects.
Table 7.1 Distribution of %FDG uptake and %Em metabolic energy consumption be-
tween pelvis, upper and lower leg
%FDG %Em - Generic Model %Em - Subject-specific Model
mean std min max mean std min max mean std min max
Pelvis 22,6% 7,7% 12,4% 41,3% 24,5% 3,4% 16,1% 27,6% 30,8% 4,9% 20,7% 37,2%
Upper leg 32,3% 5,9% 22,0% 40,9% 27,4% 3,4% 24,3% 34,4% 23,1% 3,8% 15,6% 29,3%
Lower leg 45,2% 11,1% 29,2% 65,6% 48,1% 3,4% 40,8% 55,1% 46,2% 4,4% 38,3% 54,6%
%FDG uptake based on PET volumetric analysis, %Em metabolic energy consumption predicted using generic and subject-spe-
cific musculoskeletal models. Results are averaged over ten healthy subjects.
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Good correlation was found between the %FDG uptake values and %Em metabolic energy 
consumption (Table 7.3). When analyzing each individual healthy subject, good to very good 
correlations were found for generic models (mean ρ = 0.88±0.04, mean r = 0.74±0.09) and 
for subject-specific models (mean ρ = 0.87±0.04, mean r = 0.77±0.10) and for the complete 
lower extremity, but the difference was not significant (p = 0.17). Very good correlations 
were found for the pelvis region (mean ρ = 0.85±0.10 and mean r = 0.71±0.15 for generic 
models, mean ρ = 0.84±0.05 and mean r = 0.78±0.13 for subject-specific models) and lower 
leg (mean ρ = 0.71±0.12 and mean r = 0.85±0.07 for generic models, mean ρ = 0.71±0.12 
and mean r = 0.88±0.08 for subject-specific models), while poor correlation was found for 
the upper leg (mean ρ = 0.24±0.22 and mean r = 0.24±0.26 for generic models, mean ρ 
= 0.20±0.31 and mean r = 0.18±0.27 for subject-specific models). Correlation values were 
higher when analyzing %FDG and %Em results averaged over the ten healthy subjects (ρ 
= 0.91 and r = 0.84 for generic models, ρ = 0.96 and r = 0.91 for subject-specific models) 
(Figure 7.6, Table 7.3). On the level of segments, very good correlations were found for the 
Table 7.2 Comparison between the %FDG uptake and %Em metabolic energy consump-
tion of the ten muscles showing the highest %FDG uptake values
%FDG %Em - Generic Model %Em - Subject-specific 
Model
mean std min max mean std min max mean std min max
Soleus 20.6% 11.0% 8.8% 40.5% 20.1% 3.1% 14.5% 25.0% 21.7% 5.3% 11.0% 27.9%
Gluteus Maximus 7.5% 2.5% 4.1% 11.6% 4.1% 1.5% 1.3% 5.6% 6.9% 2.5% 3.3% 10.9%
Gastrocnemius Medialis 6.6% 3.4% 1.9% 13.7% 17.0% 1.3% 15.2% 19.9% 10.0% 5.9% 2.4% 19.1%
Gluteus Medius 5.7% 5.0% 2.5% 19.5% 7.5% 1.6% 5.1% 9.3% 9.1% 1.6% 5.8% 10.8%
Vastus Lateralis 5.6% 1.5% 3.6% 7.6% 5.4% 2.5% 1.2% 9.8% 1.4% 1.5% 0.3% 4.2%
Adductor Magnus 4.9% 1.1% 3.6% 6.9% 2.4% 0.8% 1.1% 3.6% 3.7% 1.9% 0.9% 7.8%
Tibialis Anterior 4.9% 1.6% 2.8% 7.1% 2.3% 1.0% 1.3% 4.9% 2.1% 1.0% 1.1% 4.2%
Vastus Intermedius 4.2% 1.3% 2.5% 6.0% 0.4% 0.2% 0.1% 0.7% 1.5% 1.9% 0.0% 4.9%
Vastus Medialis 3.9% 1.1% 2.3% 5.4% 1.7% 0.7% 0.5% 3.0% 2.0% 1.6% 0.3% 5.7%
Gluteus Minimus 2.6% 1.9% 0.6% 6.2% 3.7% 0.5% 2.8% 4.4% 3.6% 1.5% 1.3% 6.0%
%FDG uptake based on PET volumetric analysis, %Em metabolic energy consumption predicted using generic and subject-
specific musculoskeletal models. Results are averaged over ten healthy subjects.
Table 7.3 Spearman’s rank correlation ρ and Pearson product-moment correlation r 
between %FDG uptake and %Em metabolic energy consumption
Mean values of the correlations between %FDG and %Em
calculated for each of the ten healthy subjects 
Correlations between the %FDG 
and %Em values averaged over ten 
healthy subjects
Generic Subject-specific Generic Subject-specific
ρ r ρ r ρ r ρ r
mean std mean std mean std mean std
Pelvis 0.85 0.10 0.71 0.15 0.84 0.05 0.78 0.13 0.91 0.83 0.95 0.92
Upper leg 0.24 0.22 0.24 0.26 0.20 0.31 0.18 0.27 0.26 0.35 0.15 0.27
Lower leg 0.71 0.12 0.85 0.07 0.71 0.12 0.88 0.08 0.89 0.87 0.89 0.95
Lower extremity 0.88 0.04 0.74 0.09 0.87 0.04 0.77 0.10 0.91 0.84 0.96 0.91
%FDG uptake based on PET volumetric analysis, %Em metabolic energy consumption predicted using generic and subject-
specific musculoskeletal models. 
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pelvis region (ρ = 0.91 and r = 0.83 for generic models, ρ = 0.95 and r = 0.92 for subject-
specific models) and lower leg (ρ = 0.89 and r = 0.87 for generic models, ρ = 0.89 and r = 0.95 
for subject-specific models), but poor correlation was found for the upper leg (ρ = 0.26 and 
r = 0.35 for generic models, ρ = 0.15 and r = 0.27 for subject-specific models).
Discussion
In this study, we used FDG-PET to indirectly validate muscle energy consumption 
predictions during walking made by generic and subject-specific MS models. The validity of 
FDG-PET to measure muscular activity during walking has been previously demonstrated 
by (Oi et al. 2003), however to our knowledge this is the first time that MS model predictions 
have been compared with FDG-PET data. In general, high correlations were found between 
the measured %FDG uptake and the predicted %Em metabolic energy consumption, 
giving more confidence on the validity of the model outcomes when it comes to relative 
contributions of muscles to walking. 
Almost 50% of the predicted %Em metabolic energy was consumed by muscles in the lower 
leg, in particular the Soleus and the Gastrocnemius, in accordance with the %FDG uptake 
values, confirming the key role of the ankle plantarflexors during walking (Liu et al. 2006; 
Winter 1983). Moreover, the fact that a deep and relatively small muscle like the Gluteus 
Minimus appeared among the most consuming muscles during gait, according to both 
%FDG and %Em and as previously indicated by Oi et al. (2003), shows the advantages of 
FDG-PET compared to EMG, which allows to measure only the superficial muscles.
High correlations were found between %FDG uptake and %Em metabolic energy 
consumption in the pelvis region and the lower leg, while poor correlation was found in the 
upper leg. This result may be dependent on the task analyzed, since %FDG uptake values 
during gait showed small variability between muscles within the upper leg (Kolk et al. 2015). 
Results are likely to be different for more demanding task such as running or stair climbing.
                     
Figure 7.6. Linear correlation between %FDG uptake, based on PET volumetric analysis, and %Em 
metabolic energy consumption, predicted using generic and subject-specific musculoskeletal models. 
and  values were averaged over ten healthy subjects. Linear trend lines are based on Pearson product-
moment correlation coefficient r.
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Unlike the FDG-PET results, the models predicted larger %Em metabolic energy consumption 
in the pelvis region, in particular the Gluteal and Iliopsoas muscles that provide stability to 
the hip joint during gait. They also predicted a smaller consumption in the upper leg, in 
particular in the Vasti muscles compared to the Rectus Femoris, probably due to the fact 
that the model includes a 1 degree-of-freedom knee joint that requires less muscle-induced 
stability. A thorough understanding of these kinds of features of the models remains very 
important to be able to explain their outcomes, and in order to further improve their 
predictions. 
Subject-specific models used in this study predicted more realistic MT forces and muscle 
activity during gait compared to generic models (Carbone 2016). These differences 
resulted in slight improvements in the predicted metabolic power consumption and in the 
correlation between %FDG uptakes and %Em metabolic energy consumption. However, it 
was not possible to statistically prove the significance of these improvements, probably due 
to the fact that FDG-PET is not accurate enough to detect the improvements of personalized 
models for healthy subjects and for relatively simple tasks such as walking. Differences 
between generic and subject-specific models are likely to be magnified for more strenuous 
activities such as running, climbing stairs or getting up from a chair, and when analyzing 
patients affected by musculoskeletal pathologies, where larger differences in MS geometry 
and MT parameters are expected.
On average, predicted metabolic power Pm (3.82 W/kg for generic models and 3.73 W/kg 
for subject-specific models) was lower than the measured values found in literature (4.67 
W/kg) (Inman et al. 1981). However, Pm depended exclusively on the predicted mechanical 
power of the muscles of the lower leg, while the measured metabolic power consumption 
based on the oxygen uptake, included the contribution of the muscles of the upper body 
and the resting metabolism. Moreover, the precise relation between metabolic energy 
consumption and predicted muscle forces is unknown. We assumed the same efficiency 
for all the muscles, whereas uptake of the glucose into a muscle depends on many factors, 
including the fiber types (Henriksen et al. 1990). Hence, it is possible that the different fiber 
composition in the muscles of the lower extremity (Johnson et al. 1973) affects the efficiency 
and energy consumption of muscles. FDG-PET results provides precious information 
to better understand the functional differences in the muscle energy consumption and 
recruitment process, and should be used to improve the static optimization criteria used in 
MS models, for example introducing energy-based cost functions as suggested by Praagman 
et al. (Praagman et al. 2006).
The main limitation of the FDG-PET results is that they depend on the quality of the 
medical images used and on the segmentation accuracy. Errors in muscle segmentation 
would directly affect the glucose uptake measurement, however Kolk et al. (Kolk et al. 2015) 
showed that the method used in this study had a small sensitivity to this kind of errors. 
Compared to EMG, FDG-PET results have a cumulative nature, therefore the measured 
glucose uptake represents an accumulation of all the muscle metabolic activity during 
the task and cannot be used to measure temporal variations of muscle force or energy 
consumption. Also, validity of this method to measure muscular activity has been proven 
only for aerobic tasks. Most importantly, FDG-PET requires specialized equipment and 
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involves a low dose of radiation, hence it is difficult to perform repeated measurements on 
the same subject because of ethical issues. 
Conclusions
In conclusion, the high to very high correlation between the measured %FDG and the 
predicted %Em that was found when analyzing each individual subject and when analyzing 
averaged results gives great confidence on the validity of the model outcomes when analyzing 
muscle function during gait. However, significant improvements in the subject-specific 
models compared to generic models were not proven. Given its advantages and limitations, 
FDG-PET should be considered as a complimentary tool to EMG when validating MS 
models.
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Appendix 7.1: %FDG uptake - Ten healthy subjects
Subject
1 2 3 4 5 6 7 8 9 10 mean std median min max
H
ip
 re
gi
on
Gemellus Inferior 0,1% 0,0% 0,0% 0,1% 0,1% 0,1% 0,1% 0,1% 0,1% 0,1% 0,1% 0,0% 0,1% 0,0% 0,1%
Gemellus Superior 0,2% 0,0% 0,0% 0,0% 0,0% 0,1% 0,1% 0,0% 0,1% 0,1% 0,1% 0,0% 0,0% 0,0% 0,2%
Gluteus Maximus 4,1% 4,6% 7,2% 6,7% 7,0% 11,5% 7,9% 11,6% 7,4% 6,7% 7,5% 2,3% 7,1% 4,1% 11,6%
Gluteus Medius 2,5% 2,5% 4,0% 3,0% 5,5% 4,8% 4,3% 19,5% 6,1% 4,5% 5,7% 4,8% 4,4% 2,5% 19,5%
Gluteus Minimus 1,1% 0,6% 1,5% 1,2% 3,9% 3,0% 2,8% 4,8% 6,2% 1,2% 2,6% 1,8% 2,2% 0,6% 6,2%
Iliacus 1,3% 1,5% 2,0% 2,1% 2,3% 3,0% 2,6% 1,2% 2,7% 1,3% 2,0% 0,6% 2,0% 1,2% 3,0%
Obturator Externus 0,5% 0,4% 0,3% 0,3% 0,3% 0,4% 0,4% 0,2% 0,2% 0,3% 0,3% 0,1% 0,3% 0,2% 0,5%
Obturator Internus 2,0% 0,3% 0,9% 1,4% 0,5% 0,7% 0,4% 0,3% 0,5% 0,4% 0,7% 0,5% 0,5% 0,3% 2,0%
Pectineus 0,5% 0,5% 0,8% 0,8% 0,4% 0,5% 0,8% 0,4% 0,7% 0,4% 0,6% 0,2% 0,5% 0,4% 0,8%
Piriformis 2,7% 0,4% 1,1% 0,5% 0,2% 0,3% 0,5% 1,4% 0,6% 0,3% 0,8% 0,7% 0,5% 0,2% 2,7%
Psoas Major 1,1% 1,0% 1,4% 1,3% 1,6% 1,7% 1,7% 0,8% 1,7% 1,5% 1,4% 0,3% 1,4% 0,8% 1,7%
Quadratus Femoris 0,2% 0,2% 0,4% 0,2% 0,3% 0,5% 0,5% 0,2% 0,7% 0,3% 0,3% 0,2% 0,3% 0,2% 0,7%
Tensor Fasciae Latae 0,3% 0,4% 0,4% 0,4% 0,5% 0,6% 0,6% 0,9% 0,5% 0,3% 0,5% 0,2% 0,5% 0,3% 0,9%
SUM 16,5% 12,4% 20,1% 18,0% 22,5% 27,3% 22,7% 41,3% 27,3% 17,3% 22,6% 7,7% 21,3% 12,4% 41,3%
Th
ig
h 
re
gi
on
Adductor Brevis 2,0% 1,4% 1,2% 1,6% 1,0% 1,3% 1,3% 3,4% 1,9% 1,7% 1,7% 0,6% 1,5% 1,0% 3,4%
Adductor Longus 1,2% 1,2% 1,5% 5,1% 1,2% 2,2% 2,1% 3,9% 3,5% 1,1% 2,3% 1,3% 1,8% 1,1% 5,1%
Adductor Magnus 4,0% 3,6% 5,7% 5,3% 5,4% 6,9% 5,7% 3,7% 5,5% 3,6% 4,9% 1,1% 5,4% 3,6% 6,9%
Biceps Femoris Caput Breve 0,4% 0,7% 0,9% 0,8% 1,2% 1,0% 1,2% 0,5% 1,4% 0,5% 0,9% 0,3% 0,8% 0,4% 1,4%
Biceps Femoris Caput Longum 1,2% 0,9% 1,4% 1,9% 1,4% 1,9% 1,8% 0,8% 2,1% 2,3% 1,6% 0,5% 1,6% 0,8% 2,3%
Gracilis 0,3% 0,6% 0,7% 0,8% 0,6% 0,6% 0,7% 0,6% 0,6% 0,6% 0,6% 0,1% 0,6% 0,3% 0,8%
Rectus Femoris 1,5% 1,3% 2,1% 1,8% 1,9% 2,0% 2,8% 1,0% 2,4% 2,0% 1,9% 0,5% 1,9% 1,0% 2,8%
Sartorius 0,6% 1,0% 1,5% 1,4% 1,1% 1,5% 1,6% 4,4% 1,4% 0,8% 1,5% 1,0% 1,4% 0,6% 4,4%
Semimembranosus 2,6% 1,2% 1,7% 1,7% 1,3% 3,6% 1,8% 1,2% 2,7% 2,8% 2,0% 0,8% 1,7% 1,2% 3,6%
Semitendinosus 1,2% 1,0% 1,2% 1,3% 1,3% 1,1% 0,9% 0,6% 1,6% 1,8% 1,2% 0,3% 1,2% 0,6% 1,8%
Vastus Intermedius 2,5% 3,0% 5,9% 4,6% 4,9% 6,0% 5,4% 2,8% 4,0% 3,2% 4,2% 1,3% 4,3% 2,5% 6,0%
Vastus Lateralis 3,6% 3,8% 6,7% 6,4% 6,4% 7,6% 7,4% 3,8% 4,7% 5,3% 5,6% 1,5% 5,8% 3,6% 7,6%
Vastus Medialis 2,4% 2,3% 5,4% 4,7% 4,2% 5,3% 4,2% 2,7% 4,2% 3,2% 3,9% 1,1% 4,2% 2,3% 5,4%
SUM 23,5% 22,0% 36,0% 37,2% 31,8% 40,9% 36,8% 29,5% 35,9% 29,0% 32,3% 5,9% 33,8% 22,0% 40,9%
Lo
we
r l
eg
Extensor Digitorum Longus 0,7% 4,6% 1,2% 3,4% 1,1% 0,9% 1,6% 1,7% 1,8% 1,3% 1,8% 1,2% 1,5% 0,7% 4,6%
Extensor Hallucis Longus 1,5% 1,9% 0,8% 1,7% 1,0% 0,8% 0,8% 1,0% 1,3% 1,4% 1,2% 0,4% 1,2% 0,8% 1,9%
Flexor Digitorum Longus 0,2% 0,9% 0,7% 0,4% 1,5% 0,9% 1,5% 0,6% 0,9% 0,4% 0,8% 0,4% 0,8% 0,2% 1,5%
Flexor Hallucis Longus 0,6% 4,6% 0,7% 0,7% 1,2% 1,4% 2,3% 1,2% 0,8% 1,8% 1,5% 1,1% 1,2% 0,6% 4,6%
Gastrocnemius Lateralis 2,3% 1,0% 4,0% 1,3% 1,4% 1,8% 1,7% 4,6% 2,0% 3,1% 2,3% 1,1% 1,9% 1,0% 4,6%
Gastrocnemius Medialis 5,1% 1,9% 8,6% 6,6% 13,7% 4,8% 4,0% 4,9% 6,1% 9,9% 6,6% 3,2% 5,6% 1,9% 13,7%
Peroneus Brevis 0,8% 0,6% 0,8% 1,4% 1,2% 0,5% 0,6% 0,3% 0,5% 4,8% 1,2% 1,3% 0,7% 0,3% 4,8%
Peroneus Longus 0,5% 2,6% 1,2% 4,4% 0,7% 0,8% 1,1% 0,6% 1,0% 3,2% 1,6% 1,3% 1,0% 0,5% 4,4%
Plantaris 0,2% 0,1% 0,1% 0,1% 0,1% 0,1% 0,4% 0,2% 0,1% 0,1% 0,1% 0,1% 0,1% 0,1% 0,4%
Popliteus 0,5% 0,3% 0,4% 0,2% 0,5% 0,4% 0,5% 0,4% 0,7% 0,4% 0,4% 0,1% 0,4% 0,2% 0,7%
Soleus 39,5% 40,5% 17,3% 17,0% 15,2% 13,5% 21,2% 8,8% 11,5% 21,5% 20,6% 10,4% 17,1% 8,8% 40,5%
Tibialis Anterior 7,0% 5,0% 4,6% 6,4% 7,1% 2,9% 2,8% 3,7% 5,2% 4,4% 4,9% 1,5% 4,8% 2,8% 7,1%
Tibialis Posterior 1,1% 1,7% 3,4% 1,2% 1,1% 2,9% 2,0% 1,2% 4,7% 1,3% 2,1% 1,2% 1,5% 1,1% 4,7%
SUM 59,9% 65,6% 43,8% 44,8% 45,8% 31,8% 40,5% 29,2% 36,7% 53,6% 45,2% 11,1% 44,3% 29,2% 65,6%
158
Chapter 7
Appendix 7.2: %Em metabolic energy consumption - Ten healthy subjects - Gene-
ric musculoskeletal models
Subject
1 2 3 4 5 6 7 8 9 10 mean std median min max
H
ip
 re
gi
on
Gemellus Inferior 0,0% 0,0% 0,1% 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 0,1%
Gemellus Superior 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 0,1% 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 0,1%
Gluteus Maximus 3,3% 5,2% 4,8% 2,6% 1,3% 5,6% 2,7% 5,6% 4,7% 5,0% 4,1% 1,4% 4,7% 1,3% 5,6%
Gluteus Medius 9,3% 7,7% 5,1% 8,8% 5,4% 8,3% 7,8% 5,5% 9,0% 7,9% 7,5% 1,5% 7,8% 5,1% 9,3%
Gluteus Minimus 4,3% 3,4% 3,1% 4,1% 2,8% 3,8% 3,9% 3,4% 3,7% 4,4% 3,7% 0,5% 3,8% 2,8% 4,4%
Iliacus 3,7% 2,5% 2,4% 3,5% 2,1% 3,1% 3,8% 3,1% 2,7% 3,3% 3,0% 0,6% 3,1% 2,1% 3,8%
Obturator Externus 0,4% 0,4% 0,3% 0,6% 0,3% 0,3% 0,4% 0,7% 0,4% 0,5% 0,4% 0,1% 0,4% 0,3% 0,7%
Obturator Internus 0,1% 0,2% 0,3% 0,2% 0,1% 0,3% 0,2% 0,4% 0,2% 0,2% 0,2% 0,1% 0,2% 0,1% 0,4%
Pectineus 0,5% 0,3% 0,3% 0,6% 0,4% 0,5% 0,8% 0,7% 0,4% 0,5% 0,5% 0,2% 0,5% 0,3% 0,8%
Piriformis 0,4% 0,2% 0,4% 0,2% 0,2% 0,5% 0,3% 0,7% 0,5% 0,6% 0,4% 0,2% 0,4% 0,2% 0,7%
Psoas Major 3,0% 2,0% 1,9% 2,9% 1,6% 2,7% 3,2% 3,0% 2,2% 2,9% 2,5% 0,5% 2,8% 1,6% 3,2%
Quadratus Femoris 0,1% 0,1% 0,2% 0,1% 0,0% 0,1% 0,1% 0,1% 0,1% 0,1% 0,1% 0,1% 0,1% 0,0% 0,2%
Tensor Fasciae Latae 2,1% 1,9% 1,7% 2,5% 1,8% 1,8% 2,0% 1,7% 2,0% 2,1% 2,0% 0,2% 1,9% 1,7% 2,5%
SUM 27,2% 24,0% 20,6% 26,1% 16,1% 27,0% 25,2% 25,0% 25,9% 27,6% 24,5% 3,4% 25,6% 16,1% 27,6%
Th
ig
h 
re
gi
on
Adductor Brevis 0,2% 0,1% 0,1% 0,3% 0,1% 0,1% 0,5% 0,5% 0,1% 0,3% 0,2% 0,2% 0,2% 0,1% 0,5%
Adductor Longus 1,4% 0,7% 0,5% 1,5% 0,6% 1,2% 2,2% 1,7% 0,8% 1,4% 1,2% 0,5% 1,3% 0,5% 2,2%
Adductor Magnus 2,5% 1,8% 1,7% 2,8% 5,6% 0,6% 2,1% 2,8% 2,2% 1,9% 2,4% 1,2% 2,1% 0,6% 5,6%
Biceps Femoris Caput Breve 1,5% 1,2% 0,9% 1,6% 1,0% 1,2% 1,3% 1,3% 1,6% 1,8% 1,3% 0,3% 1,3% 0,9% 1,8%
Biceps Femoris Caput Longum 2,5% 3,1% 2,3% 2,4% 1,1% 2,1% 2,4% 1,5% 3,5% 3,6% 2,4% 0,7% 2,4% 1,1% 3,6%
Gracilis 0,8% 0,5% 0,5% 1,0% 0,5% 0,7% 1,1% 1,3% 0,8% 0,7% 0,8% 0,3% 0,7% 0,5% 1,3%
Rectus Femoris 2,5% 3,8% 2,9% 3,6% 0,4% 2,6% 3,5% 2,9% 3,0% 3,9% 2,9% 1,0% 3,0% 0,4% 3,9%
Sartorius 5,2% 3,4% 3,1% 4,4% 2,0% 4,2% 4,9% 3,9% 3,8% 4,9% 4,0% 0,9% 4,0% 2,0% 5,2%
Semimembranosus 2,3% 2,2% 1,6% 2,4% 4,7% 2,0% 2,1% 2,1% 2,3% 2,3% 2,4% 0,8% 2,2% 1,6% 4,7%
Semitendinosus 2,6% 2,1% 1,3% 2,3% 4,9% 1,3% 2,1% 2,0% 2,0% 2,2% 2,3% 1,0% 2,1% 1,3% 4,9%
Vastus Intermedius 0,2% 0,4% 0,5% 0,6% 0,7% 0,4% 0,3% 0,4% 0,2% 0,1% 0,4% 0,2% 0,4% 0,1% 0,7%
Vastus Lateralis 3,0% 5,4% 6,8% 7,7% 9,8% 6,0% 4,9% 5,4% 3,3% 1,2% 5,4% 2,3% 5,4% 1,2% 9,8%
Vastus Medialis 1,0% 1,7% 2,1% 2,5% 3,0% 1,8% 1,7% 1,7% 1,3% 0,5% 1,7% 0,7% 1,7% 0,5% 3,0%
SUM 25,8% 26,5% 24,4% 33,1% 34,4% 24,3% 28,9% 27,5% 25,0% 24,7% 27,4% 3,4% 26,1% 24,3% 34,4%
Lo
we
r l
eg
Extensor Digitorum Longus 0,3% 0,2% 0,2% 0,3% 0,3% 0,2% 0,3% 0,4% 0,3% 0,3% 0,3% 0,0% 0,3% 0,2% 0,4%
Extensor Hallucis Longus 0,1% 0,1% 0,1% 0,2% 0,1% 0,1% 0,1% 0,2% 0,2% 0,2% 0,1% 0,0% 0,1% 0,1% 0,2%
Flexor Digitorum Longus 0,2% 0,0% 0,1% 0,1% 0,1% 0,1% 0,2% 0,0% 0,1% 0,1% 0,1% 0,0% 0,1% 0,0% 0,2%
Flexor Hallucis Longus 1,0% 0,2% 0,2% 0,6% 0,3% 0,7% 0,9% 0,4% 0,4% 0,5% 0,5% 0,3% 0,5% 0,2% 1,0%
Gastrocnemius Lateralis 5,6% 5,7% 7,2% 5,0% 6,0% 6,4% 5,4% 5,8% 5,8% 5,3% 5,8% 0,6% 5,7% 5,0% 7,2%
Gastrocnemius Medialis 16,8% 17,5% 19,9% 15,2% 16,2% 17,6% 15,6% 16,2% 17,9% 17,2% 17,0% 1,3% 17,0% 15,2% 19,9%
Peroneus Brevis 0,2% 0,0% 0,2% 0,1% 0,1% 0,1% 0,1% 0,1% 0,0% 0,0% 0,1% 0,0% 0,1% 0,0% 0,2%
Peroneus Longus 0,8% 0,4% 0,3% 0,6% 0,5% 0,8% 0,7% 0,5% 0,6% 0,5% 0,6% 0,2% 0,6% 0,3% 0,8%
Plantaris 0,2% 0,2% 0,2% 0,1% 0,2% 0,2% 0,1% 0,2% 0,2% 0,2% 0,2% 0,0% 0,2% 0,1% 0,2%
Popliteus 0,2% 0,2% 0,2% 0,3% 0,3% 0,2% 0,3% 0,2% 0,3% 0,2% 0,2% 0,0% 0,2% 0,2% 0,3%
Soleus 17,8% 23,2% 25,0% 14,5% 23,8% 19,4% 18,6% 20,2% 19,4% 19,3% 20,1% 3,0% 19,4% 14,5% 25,0%
Tibialis Anterior 2,0% 1,8% 1,3% 3,2% 1,4% 2,0% 1,9% 3,1% 3,5% 3,0% 2,3% 0,8% 2,0% 1,3% 3,5%
Tibialis Posterior 2,0% 0,1% 0,1% 0,7% 0,2% 1,0% 1,7% 0,4% 0,4% 1,0% 0,8% 0,6% 0,6% 0,1% 2,0%
SUM 47,1% 49,6% 55,1% 40,8% 49,6% 48,8% 45,9% 47,6% 49,1% 47,7% 48,1% 3,4% 48,2% 40,8% 55,1%
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Appendix 7.3: %Em metabolic energy consumption - Ten healthy subjects - Sub-
ject-specific musculoskeletal models
Subject
1 2 3 4 5 6 7 8 9 10 mean std median min max
H
ip
 re
gi
on
Gemellus Inferior 0,0% 0,2% 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 0,2% 0,1% 0,1% 0,0% 0,0% 0,2%
Gemellus Superior 0,1% 0,1% 0,0% 0,0% 0,0% 0,0% 0,1% 0,1% 0,0% 0,1% 0,1% 0,0% 0,1% 0,0% 0,1%
Gluteus Maximus 6,1% 8,8% 4,5% 6,7% 7,8% 3,3% 3,6% 10,9% 9,3% 7,6% 6,9% 2,4% 7,2% 3,3% 10,9%
Gluteus Medius 10,8% 9,5% 5,8% 8,8% 8,3% 10,3% 8,7% 8,0% 10,6% 10,5% 9,1% 1,5% 9,1% 5,8% 10,8%
Gluteus Minimus 4,8% 2,4% 2,4% 5,8% 3,0% 6,0% 3,9% 1,3% 3,3% 3,2% 3,6% 1,4% 3,3% 1,3% 6,0%
Iliacus 5,3% 3,2% 3,9% 5,5% 2,1% 3,8% 5,2% 3,7% 2,8% 3,9% 3,9% 1,0% 3,8% 2,1% 5,5%
Obturator Externus 0,1% 0,2% 0,0% 0,3% 0,1% 0,2% 0,4% 0,5% 0,2% 0,2% 0,2% 0,1% 0,2% 0,0% 0,5%
Obturator Internus 0,7% 1,6% 0,5% 0,2% 0,0% 0,7% 0,0% 0,5% 0,7% 0,2% 0,5% 0,4% 0,5% 0,0% 1,6%
Pectineus 0,5% 0,4% 0,8% 1,1% 0,3% 0,3% 0,1% 0,3% 0,5% 0,4% 0,5% 0,3% 0,4% 0,1% 1,1%
Piriformis 1,2% 0,6% 0,9% 0,3% 0,0% 0,7% 1,0% 1,2% 2,5% 1,2% 1,0% 0,7% 0,9% 0,0% 2,5%
Psoas Major 2,2% 2,2% 0,2% 2,9% 1,5% 2,3% 2,7% 5,0% 1,9% 4,1% 2,5% 1,3% 2,3% 0,2% 5,0%
Quadratus Femoris 0,0% 0,1% 0,0% 0,0% 0,0% 0,0% 0,0% 1,1% 0,9% 0,7% 0,3% 0,4% 0,0% 0,0% 1,1%
Tensor Fasciae Latae 1,9% 2,2% 1,6% 0,9% 1,3% 1,6% 2,7% 4,6% 2,8% 1,7% 2,1% 1,0% 1,8% 0,9% 4,6%
SUM 33,7% 31,5% 20,7% 32,4% 24,3% 29,2% 28,5% 37,2% 35,7% 34,3% 30,8% 4,9% 32,0% 20,7% 37,2%
Th
ig
h 
re
gi
on
Adductor Brevis 0,0% 0,2% 0,1% 0,6% 0,3% 0,1% 0,4% 0,5% 0,2% 0,1% 0,3% 0,2% 0,2% 0,0% 0,6%
Adductor Longus 0,4% 0,6% 0,7% 2,0% 1,1% 0,5% 3,5% 0,5% 1,0% 0,5% 1,1% 0,9% 0,7% 0,4% 3,5%
Adductor Magnus 2,3% 3,0% 7,8% 3,9% 5,6% 3,5% 2,2% 3,3% 4,0% 0,9% 3,7% 1,8% 3,4% 0,9% 7,8%
Biceps Femoris Caput Breve 2,6% 2,6% 0,4% 2,3% 1,5% 2,2% 3,1% 0,3% 2,3% 1,9% 1,9% 0,9% 2,2% 0,3% 3,1%
Biceps Femoris Caput Longum 1,5% 2,0% 2,5% 1,4% 2,2% 4,8% 3,9% 1,8% 1,1% 1,8% 2,3% 1,1% 1,9% 1,1% 4,8%
Gracilis 0,4% 0,4% 0,1% 0,7% 0,2% 0,2% 0,6% 0,3% 0,7% 0,2% 0,4% 0,2% 0,4% 0,1% 0,7%
Rectus Femoris 4,1% 3,2% 2,9% 7,8% 2,2% 4,6% 3,2% 2,2% 4,0% 4,9% 3,9% 1,5% 3,6% 2,2% 7,8%
Sartorius 2,3% 1,0% 0,2% 1,1% 0,3% 0,3% 1,1% 1,6% 1,9% 1,1% 1,1% 0,7% 1,1% 0,2% 2,3%
Semimembranosus 1,7% 2,1% 1,5% 1,7% 0,6% 1,3% 0,3% 4,7% 0,3% 1,8% 1,6% 1,2% 1,6% 0,3% 4,7%
Semitendinosus 2,3% 3,4% 1,9% 4,3% 1,8% 0,1% 2,4% 0,1% 1,1% 1,8% 1,9% 1,2% 1,9% 0,1% 4,3%
Vastus Intermedius 0,4% 4,7% 0,4% 0,2% 4,9% 2,1% 0,0% 1,1% 1,1% 0,0% 1,5% 1,8% 0,7% 0,0% 4,9%
Vastus Lateralis 1,3% 0,4% 0,3% 1,4% 1,9% 3,7% 4,2% 0,3% 0,4% 0,3% 1,4% 1,4% 0,9% 0,3% 4,2%
Vastus Medialis 1,4% 0,4% 5,7% 2,1% 2,2% 1,0% 1,9% 3,4% 1,3% 0,3% 2,0% 1,5% 1,6% 0,3% 5,7%
SUM 20,9% 24,0% 24,7% 29,3% 25,0% 24,7% 26,9% 20,2% 19,3% 15,6% 23,1% 3,8% 24,3% 15,6% 29,3%
Lo
we
r l
eg
Extensor Digitorum Longus 0,3% 1,2% 0,4% 1,0% 0,2% 0,7% 1,5% 1,0% 1,2% 0,4% 0,8% 0,4% 0,8% 0,2% 1,5%
Extensor Hallucis Longus 0,1% 0,3% 0,3% 0,3% 0,2% 0,2% 1,4% 0,5% 0,1% 0,2% 0,3% 0,4% 0,2% 0,1% 1,4%
Flexor Digitorum Longus 0,0% 0,1% 0,4% 0,0% 0,0% 0,1% 0,0% 0,9% 0,1% 0,0% 0,2% 0,3% 0,0% 0,0% 0,9%
Flexor Hallucis Longus 1,3% 3,7% 3,7% 1,2% 2,7% 3,0% 1,3% 2,5% 1,3% 1,9% 2,3% 1,0% 2,2% 1,2% 3,7%
Gastrocnemius Lateralis 11,8% 4,8% 7,1% 6,4% 5,6% 5,2% 0,7% 5,8% 11,6% 6,6% 6,6% 3,1% 6,1% 0,7% 11,8%
Gastrocnemius Medialis 3,2% 4,0% 15,0% 13,3% 14,4% 6,0% 14,3% 8,5% 2,4% 19,1% 10,0% 5,6% 10,9% 2,4% 19,1%
Peroneus Brevis 0,4% 0,0% 0,5% 0,7% 0,2% 0,1% 0,1% 0,3% 0,1% 0,1% 0,2% 0,2% 0,2% 0,0% 0,7%
Peroneus Longus 0,2% 0,4% 0,3% 0,8% 0,1% 0,3% 0,9% 0,7% 0,5% 0,1% 0,4% 0,3% 0,4% 0,1% 0,9%
Plantaris 0,1% 0,0% 0,1% 0,3% 0,3% 0,1% 0,4% 0,2% 0,4% 0,2% 0,2% 0,1% 0,2% 0,0% 0,4%
Popliteus 1,0% 0,1% 0,3% 0,1% 0,1% 0,4% 0,8% 0,2% 0,5% 0,7% 0,4% 0,3% 0,4% 0,1% 1,0%
Soleus 24,4% 27,0% 22,2% 11,0% 25,4% 27,9% 20,9% 19,5% 23,2% 15,1% 21,7% 5,0% 22,7% 11,0% 27,9%
Tibialis Anterior 1,8% 1,8% 1,3% 3,0% 1,3% 1,6% 1,7% 1,1% 3,3% 4,2% 2,1% 1,0% 1,7% 1,1% 4,2%
Tibialis Posterior 0,8% 1,0% 3,1% 0,3% 0,3% 0,4% 0,5% 1,3% 0,4% 1,5% 1,0% 0,8% 0,7% 0,3% 3,1%
SUM 45,4% 44,5% 54,6% 38,3% 50,7% 46,1% 44,6% 42,5% 45,1% 50,1% 46,2% 4,4% 45,2% 38,3% 54,6%
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Appendix 7.4: Em metabolic energy consumption (J/kg)- Ten healthy subjects - 
Generic musculoskeletal models
Subject
1 2 3 4 5 6 7 8 9 10 mean std median min max
H
ip
 re
gi
on
Gemellus Inferior 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Gemellus Superior 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Gluteus Maximus 0,15 0,20 0,21 0,09 0,05 0,24 0,12 0,23 0,17 0,18 0,16 0,06 0,17 0,05 0,24
Gluteus Medius 0,44 0,29 0,22 0,32 0,23 0,35 0,34 0,23 0,32 0,28 0,30 0,06 0,30 0,22 0,44
Gluteus Minimus 0,20 0,13 0,14 0,15 0,12 0,16 0,17 0,14 0,13 0,16 0,15 0,02 0,15 0,12 0,20
Iliacus 0,18 0,09 0,10 0,13 0,09 0,13 0,17 0,13 0,09 0,12 0,12 0,03 0,12 0,09 0,18
Obturator Externus 0,02 0,01 0,01 0,02 0,01 0,01 0,02 0,03 0,01 0,02 0,02 0,00 0,02 0,01 0,03
Obturator Internus 0,00 0,01 0,01 0,01 0,01 0,01 0,01 0,02 0,01 0,01 0,01 0,00 0,01 0,00 0,02
Pectineus 0,03 0,01 0,01 0,02 0,02 0,02 0,04 0,03 0,01 0,02 0,02 0,01 0,02 0,01 0,04
Piriformis 0,02 0,01 0,02 0,01 0,01 0,02 0,01 0,03 0,02 0,02 0,02 0,01 0,02 0,01 0,03
Psoas Major 0,14 0,08 0,08 0,11 0,07 0,11 0,14 0,13 0,08 0,11 0,10 0,02 0,11 0,07 0,14
Quadratus Femoris 0,00 0,00 0,01 0,00 0,00 0,00 0,00 0,01 0,00 0,00 0,00 0,00 0,00 0,00 0,01
Tensor Fasciae Latae 0,10 0,07 0,07 0,09 0,08 0,08 0,08 0,07 0,07 0,08 0,08 0,01 0,08 0,07 0,10
SUM 1,28 0,90 0,90 0,95 0,68 1,15 1,09 1,04 0,92 0,99 0,99 0,16 0,97 0,68 1,28
Th
ig
h 
re
gi
on
Adductor Brevis 0,01 0,00 0,00 0,01 0,01 0,01 0,02 0,02 0,00 0,01 0,01 0,01 0,01 0,00 0,02
Adductor Longus 0,07 0,03 0,02 0,06 0,03 0,05 0,10 0,07 0,03 0,05 0,05 0,02 0,05 0,02 0,10
Adductor Magnus 0,12 0,07 0,08 0,10 0,23 0,03 0,09 0,12 0,08 0,07 0,10 0,05 0,08 0,03 0,23
Biceps Femoris Caput Breve 0,07 0,05 0,04 0,06 0,04 0,05 0,06 0,06 0,06 0,06 0,05 0,01 0,06 0,04 0,07
Biceps Femoris Caput Longum 0,12 0,12 0,10 0,09 0,05 0,09 0,10 0,06 0,12 0,13 0,10 0,03 0,10 0,05 0,13
Gracilis 0,04 0,02 0,02 0,04 0,02 0,03 0,05 0,05 0,03 0,03 0,03 0,01 0,03 0,02 0,05
Rectus Femoris 0,12 0,14 0,13 0,13 0,02 0,11 0,15 0,12 0,11 0,14 0,12 0,04 0,12 0,02 0,15
Sartorius 0,25 0,13 0,13 0,16 0,08 0,18 0,21 0,16 0,14 0,18 0,16 0,04 0,16 0,08 0,25
Semimembranosus 0,11 0,08 0,07 0,09 0,20 0,08 0,09 0,09 0,08 0,08 0,10 0,03 0,09 0,07 0,20
Semitendinosus 0,12 0,08 0,06 0,08 0,21 0,06 0,09 0,08 0,07 0,08 0,09 0,04 0,08 0,06 0,21
Vastus Intermedius 0,01 0,01 0,02 0,02 0,03 0,02 0,01 0,02 0,01 0,00 0,02 0,01 0,02 0,00 0,03
Vastus Lateralis 0,14 0,20 0,30 0,28 0,41 0,25 0,21 0,22 0,12 0,04 0,22 0,10 0,22 0,04 0,41
Vastus Medialis 0,05 0,06 0,09 0,09 0,13 0,08 0,07 0,07 0,05 0,02 0,07 0,03 0,07 0,02 0,13
SUM 1,22 0,99 1,07 1,21 1,45 1,03 1,25 1,15 0,89 0,89 1,11 0,17 1,11 0,89 1,45
Lo
we
r l
eg
Extensor Digitorum Longus 0,01 0,01 0,01 0,01 0,01 0,01 0,01 0,01 0,01 0,01 0,01 0,00 0,01 0,01 0,01
Extensor Hallucis Longus 0,01 0,00 0,00 0,01 0,01 0,00 0,01 0,01 0,01 0,01 0,01 0,00 0,01 0,00 0,01
Flexor Digitorum Longus 0,01 0,00 0,00 0,00 0,00 0,00 0,01 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,01
Flexor Hallucis Longus 0,05 0,01 0,01 0,02 0,01 0,03 0,04 0,02 0,01 0,02 0,02 0,01 0,02 0,01 0,05
Gastrocnemius Lateralis 0,26 0,21 0,31 0,18 0,25 0,27 0,23 0,24 0,21 0,19 0,24 0,04 0,24 0,18 0,31
Gastrocnemius Medialis 0,79 0,66 0,87 0,56 0,68 0,75 0,68 0,68 0,64 0,62 0,69 0,09 0,68 0,56 0,87
Peroneus Brevis 0,01 0,00 0,01 0,00 0,01 0,00 0,01 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,01
Peroneus Longus 0,04 0,01 0,01 0,02 0,02 0,03 0,03 0,02 0,02 0,02 0,02 0,01 0,02 0,01 0,04
Plantaris 0,01 0,01 0,01 0,01 0,01 0,01 0,01 0,01 0,01 0,01 0,01 0,00 0,01 0,01 0,01
Popliteus 0,01 0,01 0,01 0,01 0,01 0,01 0,01 0,01 0,01 0,01 0,01 0,00 0,01 0,01 0,01
Soleus 0,84 0,87 1,10 0,53 1,00 0,82 0,80 0,84 0,69 0,69 0,82 0,15 0,83 0,53 1,10
Tibialis Anterior 0,09 0,07 0,06 0,12 0,06 0,09 0,08 0,13 0,12 0,11 0,09 0,02 0,09 0,06 0,13
Tibialis Posterior 0,09 0,00 0,01 0,03 0,01 0,04 0,07 0,02 0,01 0,04 0,03 0,03 0,02 0,00 0,09
SUM 2,22 1,86 2,41 1,49 2,09 2,08 1,98 1,98 1,74 1,72 1,96 0,25 1,98 1,49 2,41
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Appendix 7.5: Em metabolic energy consumption (J/kg)- Ten healthy subjects - 
Subject-specific musculoskeletal models
Subject
1 2 3 4 5 6 7 8 9 10 mean std median min max
H
ip
 re
gi
on
Gemellus Inferior 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,01 0,00 0,00 0,00 0,00 0,01
Gemellus Superior 0,01 0,00 0,00 0,00 0,00 0,00 0,00 0,01 0,00 0,00 0,00 0,00 0,00 0,00 0,01
Gluteus Maximus 0,29 0,28 0,20 0,24 0,32 0,13 0,15 0,47 0,31 0,28 0,27 0,09 0,28 0,13 0,47
Gluteus Medius 0,51 0,30 0,25 0,32 0,34 0,43 0,36 0,34 0,35 0,39 0,36 0,07 0,35 0,25 0,51
Gluteus Minimus 0,23 0,08 0,10 0,21 0,12 0,25 0,16 0,06 0,11 0,12 0,14 0,06 0,12 0,06 0,25
Iliacus 0,25 0,10 0,17 0,20 0,09 0,16 0,21 0,16 0,09 0,15 0,16 0,05 0,16 0,09 0,25
Obturator Externus 0,00 0,01 0,00 0,01 0,00 0,01 0,02 0,02 0,01 0,01 0,01 0,01 0,01 0,00 0,02
Obturator Internus 0,04 0,05 0,02 0,01 0,00 0,03 0,00 0,02 0,02 0,01 0,02 0,02 0,02 0,00 0,05
Pectineus 0,03 0,01 0,04 0,04 0,01 0,01 0,00 0,01 0,02 0,02 0,02 0,01 0,01 0,00 0,04
Piriformis 0,06 0,02 0,04 0,01 0,00 0,03 0,04 0,05 0,08 0,05 0,04 0,02 0,04 0,00 0,08
Psoas Major 0,10 0,07 0,01 0,11 0,06 0,10 0,11 0,22 0,06 0,15 0,10 0,05 0,10 0,01 0,22
Quadratus Femoris 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,05 0,03 0,03 0,01 0,02 0,00 0,00 0,05
Tensor Fasciae Latae 0,09 0,07 0,07 0,03 0,05 0,07 0,11 0,20 0,09 0,06 0,09 0,04 0,07 0,03 0,20
SUM 1,61 1,00 0,91 1,17 1,00 1,21 1,17 1,60 1,19 1,28 1,21 0,22 1,18 0,91 1,61
Th
ig
h 
re
gi
on
Adductor Brevis 0,00 0,00 0,00 0,02 0,01 0,00 0,02 0,02 0,01 0,00 0,01 0,01 0,01 0,00 0,02
Adductor Longus 0,02 0,02 0,03 0,07 0,05 0,02 0,15 0,02 0,03 0,02 0,04 0,04 0,03 0,02 0,15
Adductor Magnus 0,11 0,10 0,34 0,14 0,23 0,15 0,09 0,14 0,13 0,03 0,15 0,08 0,14 0,03 0,34
Biceps Femoris Caput Breve 0,13 0,08 0,02 0,08 0,06 0,09 0,13 0,01 0,08 0,07 0,08 0,04 0,08 0,01 0,13
Biceps Femoris Caput Longum 0,07 0,06 0,11 0,05 0,09 0,20 0,16 0,08 0,04 0,07 0,09 0,05 0,07 0,04 0,20
Gracilis 0,02 0,01 0,00 0,02 0,01 0,01 0,03 0,01 0,02 0,01 0,02 0,01 0,01 0,00 0,03
Rectus Femoris 0,20 0,10 0,13 0,28 0,09 0,19 0,13 0,10 0,13 0,18 0,15 0,06 0,13 0,09 0,28
Sartorius 0,11 0,03 0,01 0,04 0,01 0,01 0,04 0,07 0,06 0,04 0,04 0,03 0,04 0,01 0,11
Semimembranosus 0,08 0,07 0,07 0,06 0,03 0,06 0,01 0,20 0,01 0,07 0,07 0,05 0,06 0,01 0,20
Semitendinosus 0,11 0,11 0,08 0,15 0,07 0,01 0,10 0,01 0,04 0,07 0,07 0,05 0,08 0,01 0,15
Vastus Intermedius 0,02 0,15 0,02 0,01 0,20 0,09 0,00 0,05 0,04 0,00 0,06 0,07 0,03 0,00 0,20
Vastus Lateralis 0,06 0,01 0,01 0,05 0,08 0,15 0,17 0,01 0,01 0,01 0,06 0,06 0,03 0,01 0,17
Vastus Medialis 0,07 0,01 0,25 0,08 0,09 0,04 0,08 0,15 0,04 0,01 0,08 0,07 0,07 0,01 0,25
SUM 1,00 0,76 1,09 1,06 1,03 1,02 1,11 0,87 0,64 0,59 0,92 0,18 1,01 0,59 1,11
Lo
we
r l
eg
Extensor Digitorum Longus 0,01 0,04 0,02 0,04 0,01 0,03 0,06 0,04 0,04 0,02 0,03 0,02 0,03 0,01 0,06
Extensor Hallucis Longus 0,01 0,01 0,01 0,01 0,01 0,01 0,06 0,02 0,00 0,01 0,01 0,01 0,01 0,00 0,06
Flexor Digitorum Longus 0,00 0,00 0,02 0,00 0,00 0,00 0,00 0,04 0,00 0,00 0,01 0,01 0,00 0,00 0,04
Flexor Hallucis Longus 0,06 0,12 0,16 0,04 0,11 0,13 0,05 0,11 0,04 0,07 0,09 0,04 0,09 0,04 0,16
Gastrocnemius Lateralis 0,56 0,15 0,31 0,23 0,23 0,21 0,03 0,25 0,39 0,25 0,26 0,13 0,24 0,03 0,56
Gastrocnemius Medialis 0,15 0,13 0,66 0,48 0,59 0,25 0,59 0,37 0,08 0,72 0,40 0,23 0,42 0,08 0,72
Peroneus Brevis 0,02 0,00 0,02 0,02 0,01 0,01 0,00 0,01 0,00 0,00 0,01 0,01 0,01 0,00 0,02
Peroneus Longus 0,01 0,01 0,02 0,03 0,00 0,01 0,04 0,03 0,02 0,00 0,02 0,01 0,01 0,00 0,04
Plantaris 0,00 0,00 0,00 0,01 0,01 0,00 0,02 0,01 0,01 0,01 0,01 0,01 0,01 0,00 0,02
Popliteus 0,05 0,00 0,01 0,00 0,00 0,02 0,03 0,01 0,02 0,03 0,02 0,01 0,01 0,00 0,05
Soleus 1,16 0,86 0,98 0,40 1,04 1,15 0,86 0,84 0,77 0,57 0,86 0,23 0,86 0,40 1,16
Tibialis Anterior 0,08 0,06 0,06 0,11 0,05 0,07 0,07 0,05 0,11 0,16 0,08 0,03 0,07 0,05 0,16
Tibialis Posterior 0,04 0,03 0,13 0,01 0,01 0,02 0,02 0,06 0,01 0,05 0,04 0,04 0,03 0,01 0,13
SUM 2,16 1,42 2,41 1,38 2,08 1,90 1,84 1,83 1,50 1,88 1,84 0,31 1,86 1,38 2,41
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Summary of key findings: Part I
The first goal of this thesis was to provide insight into the current status and challenges 
regarding functional outcome after three different orthopedic interventions: total hip 
arthroplasty, triple innominate osteotomy, and limb salvage surgery of the lower limb. In 
chapter 2, we aimed to answer the question ‘What is the current level of functional outcome 
after total hip arthroplasty, assessed with objective measurement methods, during gait and 
gait-related activities of daily living?’. To this end, we performed a systematic review of 
the literature using broad search terms in the MEDLINE database. The inclusion criteria 
were as follows: primary osteoarthritis as indication, comparison with healthy controls or 
comparison between the operated and the non-operated limbs, and a follow-up period 
of at least six months after surgery. The search yielded 2177 citations, of which 35 articles 
were included. It was found that in the operated hip, patients had reduced sagittal range of 
motion, peak extension, sagittal power generation, abduction moment, and external rotation 
moment compared to healthy controls during gait. Most of these findings (sagittal hip range 
of motion, hip abduction moment, hip external rotation moment) could not be attributed 
to a difference in walking speed, as they were also present in studies that matched walking 
speed between the groups. Stair ascent and descent did not magnify the impairments found 
during level walking, although deficits in hip kinetics in all three planes were present during 
ascent. One of the most consistent findings during walking and stair ascent was a lower hip 
abduction moment, which also appeared to be independent of the surgical approach. 
In chapters 3a and 3b, we sought to answer the question ‘To what extent is the functional 
outcome in terms of gait and lower limb strength after triple innominate osteotomy and 
total hip arthroplasty with femoral shortening similar to healthy controls and comparable 
between the limbs?’. In chapter 3a, the long-term effects of triple innominate osteotomy 
on gait and muscle strength were investigated. Gait analyses and isometric strength tests 
were performed in twelve women (age 34±12 years) who had undergone unilateral triple 
innominate osteotomy (80±18 months before the study). Results were compared with an age- 
(33±10 years) and gender-matched control group of eight healthy women. In general, the 
gait of women who had undergone triple innominate osteotomy was similar to their healthy 
peers, but subtle differences were found between the operated and non-operated limbs. The 
abduction moment pattern during stance was significantly different between the operated 
and non-operated limbs. Furthermore, the muscle strength measurements revealed that 
the abduction strength in both limbs was significantly reduced compared to controls. We 
concluded that the patients generally recovered well from their operation in terms of gait, 
with only small asymmetries detected between the limbs. The bilateral abductor strength 
deficit implies that the patients walked at a higher percentage of their maximum capacity. 
This may eventually lead to alterations in gait when the patients become fatigued, which is 
relevant for these young patients who may still want to engage in sports or other strenuous 
activities for many years to come. 
In chapter 3b, we aimed to quantify the functional outcome of total hip arthroplasty with 
acetabular reconstruction and femoral shortening in congenital hip dysplasia patients. Gait 
analyses and isometric strength tests were performed in seven women after surgery (age: 
39±13 years, time post-surgery: 45±52 months) as well as in seven healthy peers (age: 31±10 
165
Summary and General Discussion
8
years). It was found that the adduction angle in the operated limb was significantly larger 
than in the non-operated limb. Furthermore, the abduction moment was significantly lower 
compared to controls. In terms of strength, the operated limb was significantly weaker 
compared with controls in hip abduction, hip extension, knee flexion and knee extension. 
The operated limb was weaker than the non-operated limb in all measurements, except for 
knee flexion. We concluded that the observed gait deviations in the frontal plane point to 
Trendelenburg’s sign to compensate for abductor weakness; this finding was supported by 
the abductor strength measurements. The potential for improving the abductor strength and 
gait is unclear, since structural changes in the muscle tissue may have taken place during the 
many years of functioning at non-optimal lengths before the surgery. 
In chapter 4, the purpose was to answer the question ‘Are orthopedic oncologists able to 
accurately predict the functional effects of limb salvage surgery in the lower limb?’. To this 
end, 23 patients (between six months and ten years after surgery) and five independent 
orthopedic oncologists completed the Toronto Extremity Salvage Score (TESS) and the 
RAND-36 physical functioning subscale (RAND-36 PFS). The surgeons made their 
predictions based on patient case descriptions (including MRI scans) that reflected the pre-
operative status. We found “very poor” to “poor” correlations between patient-reported 
outcomes and surgeon-predicted outcomes on both scales, with a tendency for the surgeons 
to underestimate the patient-reported functional outcome. Furthermore, the inter-surgeon 
agreement on most RAND-36 PFS questions was “poor,” indicating that there was a high 
variability in the predictions to the questions. Thus, it was difficult for the participating 
surgeons to accurately predict the patient-reported functional outcome of limb salvage 
surgery. This warrants research into objective tools that could help the orthopedic oncologists 
in the decision making process. These tools could include musculoskeletal models, which 
prospectively calculate whether the patient will have enough residual muscle strength after 
the operation to perform activities of daily living. 
Summary of key findings: Part II
The second goal of this thesis was to explore the possibilities of FDG-PET in providing 
fundamental insight into the musculoskeletal system, and its potential as a supporting 
technique to help in solving some of the identified challenges surrounding functional 
outcome. In chapter 5, the aim was to answer the question ‘Which muscles in the lower limb 
are of primary importance during walking?’. In that chapter, positron emission tomography 
(PET) with [18F]-fluorodeoxyglucose (FDG) was used, which is a novel methodology based 
on the increased uptake of glucose and FDG in exercising muscles. Ten healthy subjects 
walked on a treadmill at self-selected comfortable walking speed for 85 min, 55 min before 
and 30 min after intravenous injection of 50 MBq FDG. Thereafter, a PET/CT scan of the 
lower limb was made. The three-dimensional contours of 39 muscles in the left lower limb 
were semi-automatically determined from magnetic resonance imaging scans, using newly 
developed advanced algorithms in the Mimics Innovation Suite (Materialise N.V., Leuven, 
Belgium). After non-rigidly registering the magnetic resonance imaging to the computerized 
tomography scans, the muscle contours were superimposed on the PET scans. We found that 
the most active muscles during walking were the soleus, gluteus maximus, vastus lateralis, 
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gastrocnemius medialis, and adductor magnus. The range of FDG uptake values was large 
between subjects, including in some of the most important muscles involved in walking 
(e.g., soleus, gluteus medius, gastrocnemius medialis). The most active muscles identified 
in the study generally corresponded well with literature that used other methods, such as 
inverse dynamics and electromyography. Several muscles (e.g., adductor magnus, gluteus 
minimus) that have previously remained difficult to measure with traditional methods (e.g., 
surface EMG) because of their large size, or their deep-lying position in the body, were 
found by FDG-PET to be very active during gait. Compared with traditional methods used 
in the field, which involve measuring the FDG uptake in only a single slice of the scan, the 
three-dimensional analysis that was performed yielded different results in many of the most 
active muscles. This illustrates the added value of our extensive three-dimensional analysis 
of muscle activity with FDG-PET. 
In chapter 6, the questions we aimed to answer were ‘Are the muscles in the lower limb active 
symmetrically during walking?’ and ‘Is muscle activity homogeneous or region-specific 
during walking?’. The methodology was largely the same as in chapter 5, with the exception 
that the right lower limb was also segmented in this study. The lower leg muscles exhibited 
particularly large asymmetries (e.g., median 42% asymmetry in the gastrocnemius medialis). 
Asymmetries were also identified in the gluteus medius (15% asymmetry) and gluteus 
minimus (30% asymmetry), whereas the uptake in the thighs was relatively symmetrical 
between the limbs (<6% asymmetry). The FDG distribution was not distributed normally; 
most voxels had a relatively low standardized uptake value (SUV), and a minority of voxels 
had a relatively high SUV. The areas of higher FDG uptake were not distributed randomly 
throughout the muscles, but were clustered together in virtually all muscles. The findings 
of the study challenge the common assumption that muscle activation between the limbs 
is symmetrical in healthy subjects. The clustering of voxels with high uptake indicates that 
even in this prolonged repetitive task, certain regions of muscles contribute more to walking 
than other regions. 
In chapter 7, we sought to answer the question ‘Can FDG-PET be used to validate healthy 
subject-specific musculoskeletal models?’. Validation of musculoskeletal models is an 
important but challenging step towards their application in a clinical setting, such as in 
surgical planning. The FDG-PET methodology presented in chapters 5 and 6 could be a 
solution to this problem. Subject-specific musculoskeletal models of the same ten healthy 
subjects were constructed, using advanced techniques such as muscle anatomy segmented 
from MRI scans and functional scaling based on joint strength measurements. The muscles 
that were most active during walking as identified in chapter 5 (soleus, gluteus maximus, 
vastus lateralis, gastrocnemius medialis, and adductor magnus) were also generally the most 
active muscles in the models in terms of the amount of energy used. The measured muscle 
glucose uptake from the PET scan in each individual subject exhibited ‘good’ to ‘very good’ 
correlations with the model estimate of metabolic energy consumption (Spearman’s ρ = 
0.87±0.04, Pearson’s r = 0.77±0.10). When the uptake values of each muscle were averaged 
over the ten subjects, higher correlations were found (Spearman’s ρ = 0.96, Pearson’s r =0.91). 
We concluded that FDG-PET appears to be a valuable complimentary method in addition to 
electromyography for validating musculoskeletal models. 
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General Discussion
This general discussion reflects on the work described in this thesis. It will also be explored 
how the findings further enhance our understanding of how the musculoskeletal system 
behaves in healthy persons, and in patients treated with the selected orthopedic interventions. 
Furthermore, limitations that should be considered are discussed, and directions for 
future research will be highlighted. Finally, the current status and potential future role of 
musculoskeletal modeling in evaluating and predicting functional outcome after orthopedic 
surgery will be discussed. 
Part I: New perspectives on functional assessment in 
orthopedic surgery
Gait and hip muscle strength after total hip arthroplasty and triple innomi-
nate osteotomy
After each of the hip surgeries discussed in chapters 2, 3a, and 3b, a common observation 
was that the hip kinetics in the frontal plane deviated from healthy controls, or from the 
non-operated hip. Lifting the foot on the non-operated side to perform swing removes the 
support for that side of the pelvis, as the body weight is medial to the supporting (operated) 
hip. This leads to an adduction moment that needs to be stabilized by the hip abductors 
(i.e. primarily the gluteus medius and minimus). We indeed identified the hip abductors as 
being weaker than controls after triple innominate osteotomy and total hip arthroplasty with 
femoral shortening. The consequences of a reduced hip abduction strength and abduction 
moment during gait may not be immediately apparent in the frontal plane hip kinematics. 
Based on the studies in this thesis, the severity of the abduction deficit appeared to scale 
with the severity of the disease, and the extent of the surgical intervention. In the patients 
who underwent triple innominate osteotomy, no deviations in frontal plane hip kinematics 
from controls were found. After total hip arthroplasty for primary osteoarthritis, out of a 
total of 35 studies, only four studies reported frontal plane hip kinematics (Beaulieu et al. 
2010; Bennett et al. 2008; Madsen et al. 2004; Varin et al. 2013). Of those, only two reported 
hip adduction angles, and both found it reduced compared to controls (Beaulieu et al. 
2010; Varin et al. 2013). Finally, the most severely affected patients, who underwent total 
hip arthroplasty with femoral shortening, exhibited increased adduction angles during gait 
compared to the contralateral side, indicative of pelvic drop. Recommendations that can be 
made for all three patient categories are that rehabilitation protocols, surgical approaches, 
and musculoskeletal modeling efforts should focus on the hip abductors. The abductors are 
already focused on in rehabilitation protocols for all three types of hip surgery, but this may 
need to be intensified if the patients are to reach normal hip kinetics.
When it comes to abductor muscle strength, even in the patients who underwent triple 
innominate osteotomy and were affected the least by abduction deficits during gait, the 
abductor muscles were weaker bilaterally by about 35% compared to controls. Studies that 
used musculoskeletal simulations have found that in some healthy subjects, gait deviations 
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emerged already at 60% loss of muscle strength of the gluteus medius (van der Krogt et al. 
2012). Although the abductor weakness that we identified in our study affected gait only 
mildly, this does imply that patients walked at a higher percentage of their capacity. As a 
result, they may alter their gait in a potentially harmful way when walking long distances, 
or as they get older and their muscles get weaker. Anecdotally, almost all women who had 
undergone triple innominate osteotomy indicated during the measurement session that they 
felt tired sooner than their family and friends, when shopping or going for a walk. Given that 
the abductor weakness was bilateral in our patient cohort (which was operated unilaterally), 
it is unlikely that the weakness in that muscle group was due to soft tissue damage inflicted 
during the operation itself. Instead, it might be due to a general reduction in activity level in 
the patients compared to their healthy peers. To test this hypothesis, future work could focus 
on also measuring general activity level in both groups; for example, using wearable activity 
monitors (Jantunen et al. 2016; Sprint et al. 2016).
For patients suffering from congenital hip dysplasia, pain and limitations in activities of 
daily living are more severe than for patients with primary osteoarthritis or with earlier 
stages of hip dysplasia, especially in the case of high luxation of the femoral head. In that 
case, the pre-operative anatomical deformity is much larger, and the muscles around the 
hip, particularly the abductors, have been functioning at non-optimal lengths for years. 
Therefore, the expected functional outcome after total hip arthroplasty with acetabular 
reconstruction and femoral shortening can be expected to be less good than for the other 
patients. Our results for frontal plane hip kinetics are in line with the limited literature that 
exists on the subject (Lai et al. 2001). The other studies that have been published in this 
field have been limited to spatiotemporal parameters (Kyriazis et al. 2002), sagittal plane 
kinematics (Marangoz et al. 2010), or pre-operative gait analysis (Romano et al. 1996). 
Future work in this patient group could focus on prospectively including patients with hip 
dysplasia and tracing how their gait develops from before until after total hip arthroplasty 
with femoral shortening, in order to fully map causes for gait abnormalities and to develop 
targeted muscle strengthening exercises or gait retraining. We remark that nowadays, in the 
Netherlands and most other countries in the western world, there is extensive screening for 
congenital hip dysplasia in infants, and the disease can be effectively treated during infancy 
using a brace, which  has greatly reduced the prevalence of this condition in adulthood. 
Still, the treatment with a brace is not always successful, and patients with an immigration 
background were frequently not screened as babies and left untreated. For the patients 
that suffer from the consequences of untreated congenital hip dysplasia, it is perhaps even 
more important than in primary osteoarthritis patients to restore functional outcome to the 
highest possible level, since they are, on average, much younger (usually 35-55 years) than 
patients who undergo surgery for primary osteoarthritis (usually above 60 years). Aiming 
to achieve the optimal functional outcome for every patient is not an easy task, as the goal 
of achieving normal walking mechanics may be unattainable for many patients. Factors 
including surgical approach (Madsen et al. 2004) and persisting pre-operative impairments 
(Bennett et al. 2008; Foucher et al. 2007; Lugade et al. 2010) may predispose patients to 
restricted possible outcomes. 
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Influence of surgical approach
Any orthopedic intervention on the hip inherently includes some form of temporary 
or permanent damage to muscles, tendons, or ligaments. Therefore, it is reasonable to 
anticipate that the surgical approach has some effect on the objectively measured gait 
parameters assessed in this thesis, and that this effect might be different for each surgical 
approach. Surprisingly, this could not be firmly established. For example, in total hip 
arthroplasty for primary osteoarthritis (chapter 2), studies that included patients operated 
with the potentially abductor-harming lateral or anterolateral approach did not find reduced 
abductor moments more consistently than studies that used the posterior approach (which 
spares the abductor musculature) (e.g., Beaulieu et al. 2010; Mont et al. 2007; Perron et al. 
2000; Varin et al. 2013). Similarly, studies that included patients operated with the posterior 
approach (in which the external rotators are released) did not find reduced external rotation 
moments more consistently than the ones that used other approaches (e.g., Beaulieu et al. 
2010; Foucher et al. 2011). Firm conclusions cannot be drawn on this basis, however, since 
the magnitude of differences between patients and controls was not taken into account 
in chapter 2. To firmly establish the effect of each surgical approach on post-operative 
kinematics and kinetics, several dedicated studies that included patients operated with 
different surgical approaches have been performed (Foucher et al. 2011; Kiss et al. 2012; 
Leuchte et al. 2007; Madsen et al. 2004). All of those studies and several clinical studies (e.g., 
Graves et al. 2016; Leunig et al. 2013) that used patient-reported outcomes found no or small 
differences between approaches. For triple innominate osteotomy and Ganz’s osteotomy, 
which are functionally rather similar osteotomies but which employ different approaches 
to the hip, the surgical approach also did not appear to significantly influence the post-
operative functional outcome as measured by gait analyses (Janssen et al. 2009; Karam et al. 
2011; Pedersen et al. 2006; Sucato et al. 2010). Thus, the surgical approach to the hip appears 
to play only a modest role in the recovery of gait after surgery. In spite of this seemingly 
limited effect on functional outcome, new approaches to the hip are still being investigated 
for various reasons. For example, a new medial inguinal approach for total hip arthroplasty 
in the treatment of primary osteoarthritis was presented at the International Society for 
Technology in Arthroplasty 2016 (Lucente 2016). The new approach led to reduced surgery 
times, lower blood loss, lower complication rates, significantly faster recovery times, and 
a more aesthetically pleasing scar compared to conventional approaches. Moreover, the 
muscles of the hip were claimed to remain totally unharmed. However, long term follow-
up and functional outcome data were not yet available. It will be interesting to see how this 
particular approach and other surgical approaches and assistive techniques develop in the 
coming years, and whether positive effects on objective functional outcome parameters can 
be demonstrated. 
Persistence of pre-operative deviations
The gait deficits that we identified in chapters 2, 3a and 3b might be remnants of the gait 
pattern that developed pre-operatively as a result of pain-avoiding compensation strategies 
(Beaulieu et al. 2010; Foucher et al. 2007; Foucher et al. 2011). Specifically, several of the 
most important deficits identified in chapter 2, the sagittal range of hip motion, and the 
abduction and external rotation moments about the operated hip after total hip arthroplasty 
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have previously been found to be persisting from before the operation (Foucher et al. 2007). 
Patients may not be able to reverse the losses of muscle strength due to disuse to avoid 
pain preceding the surgery, a period which takes several years in most cases. It has indeed 
been shown that although hip muscle strength (abduction, extension, and flexion) increases 
significantly around the operated hip after one year compared to the pre-operative situation, 
it still does not reach the level of the contralateral side (Shih et al. 1994). Because of this 
persistence, increased muscle strengthening regimens, both before and after surgery, appear 
justified. In more severely affected patients, such as those with congenital hip dysplasia, 
one might expect gait to be worse pre-operatively than post-operatively; for example, in the 
form of an increased adduction angle and a reduced abduction moment. However, this is 
not necessarily the case: some studies found that some of their less severely affected patients 
actually had an increased hip abduction moment compared to controls (Romano et al. 1996). 
We can only speculate about the notion that this might be explained by the progression of 
the disease over the years. Initially, patients may attempt to achieve as much joint surface 
area in the affected hip as possible, through an increased hip abduction moment leading to 
less pelvic drop. Then, as they develop luxation and it becomes more and more painful to 
produce a high abduction moment, they may gradually be forced to switch to a different 
strategy of lower abduction moments and resulting pelvic drop, and higher adduction angles.
Musculoskeletal modeling of hip patients
When looking at the current level of functional outcome achieved by hip patients, as shown 
in chapters 2, 3a, and 3b, it is important to remark that, in general, the patients were doing 
well. With total hip arthroplasty being a very successful surgery in general (Learmonth 
et al. 2007), even for severely affected patients with hip dysplasia (Colo et al. 2016), and 
triple innominate osteotomy being an intervention that leads to ‘very good’ or ‘excellent’ 
outcomes (de Kleuver et al. 1997; Janssen et al. 2009), one may wonder if there is room 
for added value through supportive analyses such as obtained through musculoskeletal 
modeling. What might such analyses yield that can improve the functional status of the 
patients post-operatively? Recommendations on the surgical approach to the hip could be 
one, but this has only a modest role in recovery, and this is something that depends on 
the preference of the surgeon (in primary osteoarthritis), or that is largely dictated by the 
surgical requirements of the intervention (in patients with hip dysplasia), such as exposure 
of the joint. Recommendations on the optimal location of the reconstructed center of 
rotation of the hip, the femoral offset and the degree of anteversion could be another aspect 
to analyze with musculoskeletal models. For example, more favorable abductor moment 
arms could be achieved by medialization of the reconstructed acetabulum and choosing 
an implant with a larger femoral offset. It is important to note that even such seemingly 
simple recommendations are difficult to make, as there are also downsides associated with 
medialization, including additional loss of medial acetabular bone stock, increased joint 
reaction forces, and proprioceptive changes (Lenaerts et al. 2008; Terrier et al. 2014). This 
trade-off that might not pay off in each patient (Terrier et al. 2014), coupled with the already 
very good outcomes observed in patients after total hip arthroplasty and triple innominate 
osteotomy, limit the added value that musculoskeletal models can bring. Furthermore, the 
group of patients who could potentially benefit most from improved functional outcome and 
from elaborate musculoskeletal analyses (the severely affected patients with hip dysplasia) 
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is, as mentioned previously, becoming smaller and smaller due to improved screening and 
treatment in infancy. Therefore, it is reasonable to conclude that musculoskeletal models 
probably have a modest added value in hip patients, and that their value might be larger in 
other patient categories.
Towards improving the functional outcome of limb salvage surgery
In spite of considerable progress in the treatment of patients suffering from sarcoma of 
the lower limb (Veth et al. 2003), patients who have undergone limb salvage surgery will 
generally have a reduced level of functioning of the affected limb as a result of resections 
of bone, muscle, nerve, or combinations of those. This was not different in the population 
examined in this thesis, as measured by the Toronto Extremity Salvage Score (TESS) and 
the RAND-36 physical functioning subscale (RAND-36 PFS) scales. The most important 
finding was that the post-operative level of functioning was difficult to predict, even for 
experienced orthopedic oncologists. The low level of inter-surgeon agreement on most 
questions of the RAND-36 PFS indicates the high variability in the surgeons’ predictions, 
and suggests that also treatment decisions may vary between surgeons. Of course, this 
can be expected for treating almost any disease with a low prevalence, and even more so 
for limb salvage surgery, which is one of the most complicated orthopedic interventions. 
Nonetheless, the poor predictive capability and the variations identified between surgeons 
warrant future work, which could proceed along several avenues. The first would be to 
also take general activity level and expected adaptive capacity of the patient into account 
when predicting functional outcome. This is challenging to quantify, but it is known to play 
a large role in functional recovery (De Visser et al. 2000). Second, instead of measuring 
functional outcome with questionnaires, more comprehensive objective means (such as 
gait analysis) could be employed as an additional outcome measure to reduce the inherent 
subjectivity in questionnaires (Lindemann et al. 2006). Indeed, until now, it is still unknown 
if the questionnaires we used are related to objective gait parameters. Third, tools could be 
developed that aim to assist the orthopedic oncologists in the decision making process, such 
as musculoskeletal models (Fluit 2015). Musculoskeletal models could be a powerful tool 
to analyze the complex biomechanical problems associated with limb salvage surgery, and 
provide a pre-operative prediction of the functional effects of the surgery or identify target 
areas for rehabilitation. It can be expected that image-based, patient-specific musculoskeletal 
models are more suitable than generic models to study the functional outcome after limb 
salvage surgery, due to the wide variability in location and shape of the tumors. Fluit et 
al. (2015) performed explorative work in this area. They described a method to develop 
patient-specific musculoskeletal models for patients after limb salvage surgery, based on 
image data from MRI, combined with information from the surgical log (Figure 8.1). 
The models were animated using traditional inverse dynamics and a novel predictive 
gait model (Fluit et al. 2014), and subsequently validated using marker trajectories (for 
the kinematics) and electromyography (for the muscle activity levels) obtained post-
operatively. The patient-specific models indeed tended to be more accurate for predicting 
kinematics and muscle activity levels than generic models of the patients (Fluit 2015). 
However, there is still a lot of work to be done before these models can become more widely 
used. For instance, although work has been done to investigate which parameters of the 
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musculoskeletal models are most crucial to characterize (e.g., tendon slack length, optimal 
fiber length, origin and insertion points of prime movers, and maximal isometric muscle 
force (Carbone 2016; Carbone et al. 2012; Van Campen et al. 2014)), these parameters are 
still hard to truly personalize. They require detailed (i.e. lengthy) MRI scans with specific 
scan settings that allow the geometric parameters to be extracted, and extensive (thus 
burdensome) measurements of isometric maximum joint torques for the measurement 
of muscle parameters. Once those measurements are obtained, analyzing the data and the 
personalization process still takes a lot of time, even in the case of a healthy person. When 
creating a musculoskeletal model of a patient post-operatively and using that model to make 
predictions, assumptions about what will happen during the intervention may play an even 
larger role than the most crucial parameters for healthy persons. Therefore, future work 
is needed to disentangle the effects of step-by-step personalization of the musculoskeletal 
models on the predicted functional outcome, and the supporting role that these models 
might play in the treatment decision making process for limb salvage surgery. Such work 
would need to include extensive validation measurements before it can be applied to aid in 
clinical decision making. Part II of this thesis focused on one of the most promising new 
validation techniques.
                                 
Figure 8.1. A: Example of the results of semi-automatic segmentation of muscles from MRI scans. B: 
Three-dimensional visualization of the segmented bones and muscles. C: Image-based post-operative 
subject-specific musculoskeletal model that has been based on the segmented bones and muscles from 
the MRI scan and the surgical log. Only the muscles of the right limb are shown.
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Part II: New perspectives on functional assessment in 
musculoskeletal research
Muscle activity during walking measured using FDG-PET: Implications for 
research
Over the course of the last two decades, the use of FDG-PET in studying the musculoskeletal 
system during various activities has increased. This is not surprising given some major 
benefits of this technique, such as the ability to investigate a large number of muscles 
simultaneously (including the muscles that lie deep in the body that are almost inaccessible 
with electromyography), the ability to measure muscular activity in entire muscles rather 
than a limited (often superficial) region, and the freedom of movement for participants to 
perform a task unhindered by wires or by physical limitations of an experimental area. In 
spite of these benefits, up to now, studies that used FDG-PET have been limited to examining 
FDG uptake in discrete slices of the muscle (e.g., Fujimoto et al. 2003; Gondoh et al. 2009; 
Oi et al. 2003; Shimada et al. 2009a; Shimada et al. 2009b; Shimada et al. 2007). The reason 
for this is twofold: first, segmentation of the muscles to allow for quantification of FDG 
uptake in every individual muscle was labor-intensive. To illustrate this, assuming analysis 
of a single slice per muscle, if one wants to segment all ~40 muscles (excluding the feet) in 
both the left and right lower limbs in ten subjects, there are already 800 muscle boundaries 
that need to be drawn manually. If entire muscle volumes are to be examined, and assuming 
a slice thickness of 2 mm, there would be well over 100.000 regions of interest to manually 
delineate. Second, and more importantly, it was assumed in the past that the FDG uptake 
measured in a discrete slice containing part of the muscle would be representative for the 
uptake in the entire muscle. The work presented in this thesis contributed to this knowledge 
by showing that this is not the case. There were several muscles that are important for 
walking (e.g., the gluteus medius and minimus and the thigh muscles) in which the uptake 
was grossly under or overestimated when merely examining single slices. This highlights 
how novel image analysis techniques can be utilized to advance our understanding of the 
musculoskeletal system, and it also opens doors to a better understanding of patients with 
different pathologies.
Clinical applications
Although FDG-PET has mainly been applied in a research context in healthy persons, the 
prospect of using the technique in patients with different pathologies is appealing. The 
technique offers the perspective of being able to show which muscles are activated less than 
‘normal’, and which are more active and might be compensating for other muscles or for 
underlying pathology. This would be useful information; for example, in patients who have 
undergone joint replacement, who have had an anterior cruciate ligament reconstruction, 
or who are suffering from neurological disease. The findings obtained through FDG-PET 
could provide clues for therapies targeted at reducing those differences from ‘normal’ that 
could be harmful. It could be used pre- and post-operatively to evaluate the adaptation of 
the musculature before and after certain surgical interventions with a level of inter- and 
intramuscular detail that is higher than possible with other methods. For example, the 
asymmetric activation of the individual muscles in the quadriceps could be measured 
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before and after anterior cruciate ligament reconstruction to determine the success of the 
surgery, since such asymmetries are known to exist in the quadriceps as a whole (Lepley 
2015; Palmieri-Smith et al. 2015). Similarly, FDG-PET could also be used for examining 
the effects of different rehabilitation protocols. For the patients who have undergone limb 
salvage surgery as discussed in part I of this thesis, FDG-PET analysis could increase our 
fundamental understanding of muscle adaptation after such an extensive intervention. For 
example, it is clinically known that if the gastrocnemii are released from the femur in case of 
a tumor in the distal femur area, they partially re-attach themselves onto the muscle belly of 
the soleus. This fascinating adaptive capacity of the musculoskeletal system could be studied 
in more detail with FDG-PET. The mechanisms by which the adaptations occur and to 
what degree the gastrocnemii and other muscles around the knee are activated after surgery 
are largely unknown, and this knowledge could aid the pre-surgical planning process. It 
could also be used in the validation of predictions made by musculoskeletal models. The 
measurement protocol may need to be shortened if patients are to be studied. Note that other 
techniques, such as electromyography, could also be used to measure muscle adaptations 
after surgery; but in the case used as an example, it might prove difficult to distinguish 
the signal of the reattached gastrocnemii from that originating from the cranial part of the 
soleus due to crosstalk.
The role of FDG-PET in validating musculoskeletal models
In spite of significant progress in the capabilities of musculoskeletal models over the past 
decades, like any other type of model, they still rely on simplifications and assumptions. 
These include, amongst others, the behavior of musculotendon units (Zajac 1989), the 
cost function used to calculate muscle activity (Praagman et al. 2006) and, for healthy 
subjects, the symmetry between the left and right limbs with regard to both anatomy and 
function (Ackermann et al. 2010; Anderson et al. 2001). The work presented in chapters 
6 and 7 of this thesis demonstrated that there was a wide variety of FDG uptake between 
subjects, between the left and right limb, and even within muscles. This has implications for 
musculoskeletal modeling in that the models will need to reflect those uptake differences 
between subjects, limbs, and within muscles as well as possible. It seems obvious that most of 
the variety will never be possible to predict using generic musculoskeletal models, and that 
subject-specific parameters such as muscle volumes, segment lengths, joint models, muscle 
compartments, fiber types, and perhaps even the way a person moves, will need to be taken 
into consideration when constructing the models. The work presented in chapter 8 aimed 
to determine if the simulated muscle activity of generic and subject-specific musculoskeletal 
models would correspond with the FDG uptake from PET on the level of the entire limb, 
segments (pelvis, thigh and lower leg), and muscles. In the entire limb, the predicted 
metabolic power (3.82 W/kg for generic models and 3.73 W/kg for subject-specific models) 
was similar to measured values from the literature (4.67 W/kg (Inman et al. 1981)), taking 
into account the fact that the measured value included the entire upper body and resting 
metabolism of the whole body. The W/kg-values could not be directly compared to the FDG-
PET measurements, but indicate that the methodology of calculating power with the muscle 
model introduced in chapter 8 appears to be valid. On the level of lower limb segments, the 
measured percentage FDG values and simulated percentage Energy values of both generic 
and subject-specific models corresponded reasonably well, at 45-50% in the lower leg, and 
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20-30% in both pelvis and thigh. On the level of muscles, the most important observation 
was that the most active muscles, as identified in chapter 6 (soleus, gluteus maximus, vastus 
lateralis, gastrocnemius medialis, and adductor magnus), also tended to be the most active 
ones in the model predictions for most subjects. Furthermore, correlations calculated taking 
all muscles into account and averaged over all subjects were high (Spearman’s ρ = 0.91, 
Pearson’s r = 0.84 for generic models, ρ = 0.95, Pearson’s r = 0.92 for subject-specific models). 
Whilst these correlations are certainly very high and show the potential of FDG-PET for the 
validation of musculoskeletal models, there are still a few important limitations to consider 
when interpreting the results. 
The first is that correlations were low in the thigh (mean ρ = 0.24±0.22, r = 0.24±0.26 for 
generic models, mean ρ = 0.20±0.31, r = 0.18±0.27 for subject-specific models). The activity 
in the vasti was generally underestimated by the models, whereas that of the rectus femoris 
was overestimated. This might have been due to the type of knee joint in the model, which 
was a simple hinge joint that did not require any lateral stabilization from the vasti. A second 
limitation is that, whilst the models were ‘subject-specific’ in terms of anatomy and functional 
scaling based on dynamometry, they were not made subject-specific in terms of muscle 
physiology. One of the factors that plays a role in muscle glucose uptake and efficiency is the 
muscle’s fiber type distribution (Henriksen et al. 1990; Johnson et al. 1973), whereas the cost 
function used in the static optimization process (in which the muscle activities are calculated), 
was always the same. The cost function used in our study was a simple minimization of the 
cubed muscle activities (Crowninshield et al. 1981), using a normalization factor based on 
the muscle volume according to Happee et al. (Happee et al. 1995). Other, energy-based 
cost-functions have been proposed (Praagman et al. 2006), which might be more suitable 
to reflect the complex interplay between muscles. A third ‘limitation’ is that subject-specific 
models had only slightly higher correlations with the FDG-PET measurements than generic 
models for most measures. This could be due to two problems: the subject-specific models 
were not that much more representative of real-life physiology than the generic ones, or the 
FDG-PET measurements did not reflect the true muscle energy consumption for the models 
to be compared to. In the prior case, this would be unfortunate, since a lot of time and effort 
was performed in creating subject-specific models (Carbone 2016), which seemingly did not 
yield a large benefit in the comparisons with FDG-PET. On the other hand, one might argue 
that most of the correlations between models and simulations were already very high for the 
generic models (order of 0.8-0.9), and that there was not much room for improvement. In 
the latter case, while it is known that the FDG-PET measurements certainly do not represent 
the whole truth in terms of energy consumption (e.g., the role of alternative energy sources 
is not included in the measurements), its concurrent validity for studying walking has been 
demonstrated (Oi et al. 2003 and chapter 5).
Limitations of FDG-PET
An aspect that makes it difficult to use PET images on a stand-alone basis is the absence of 
anatomic structures in the images. Therefore, a CT or MRI scan that provides information 
on the location of anatomical structures is necessary. Muscle boundaries, which were of 
particular interest in the work presented in this thesis, are hard to distinguish on CT scans, 
since their attenuation coefficient is similar to that of the surrounding muscle tissue. In 
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contrast, certain specific T1-weighted MRI imaging protocols provide excellent visibility 
of muscle boundaries (Kolk et al. 2014; Scheys 2009). Ideally, the MRI scan would be made 
concurrently with the PET scan (in the same machine at the same time) in order to maintain 
co-registration. In the work presented in this thesis, there were a few weeks between the 
PET-CT scan and the MRI scan. A crude PET-MRI co-registration was accomplished by 
placing the subject on the scan bed using rulers and angle measurements, but this needed to 
be refined in an additional step. The MRI scans (including the muscle regions-of-interest) 
had to be transposed and morphed to correspond with the PET and CT scans. The latter 
two scans were made while the patient was lying on the scan bed in an unchanged position 
between the scans, negating the need to transpose or morph those two scans onto each other. 
A limitation specific to the use of FDG to measure muscle glucose uptake is that the 
relation between FDG uptake and the actual work performed or force exerted by a muscle 
is unknown. Various alternative energy sources are available to the muscle cells, including 
plasma free fatty acids, triglyceride stores, and internal glycogen. The combination of 
substrates that was used by each muscle in each subject might have varied in our study, even 
during the exercise. To limit the effects of varying substrates as much as possible, the exercise 
intensity was kept low, at a constant level, and maintained for a long time with the aim of 
maintaining a steady state in glucose uptake from the blood. Ideally, we would also have 
measured the FDG uptake in the subjects after a period of rest on a day separate from the 
walking exercise. Working this way, subjects could serve as their own controls to establish 
a baseline metabolism of FDG uptake in each subject. Unfortunately, this was not possible 
due to ethical constraints regarding the radiation dose imposed on these healthy subjects. 
Recommendations and future perspectives for using FDG-PET
Recently (following FDA approval in 2011), the first PET-MRI scanners have been introduced 
into clinics. This type of scanner has, for example, been used in studying the heart (Ferda et 
al. 2016; Lau et al. 2016), the brain (Schutz et al. 2016), predicting radiotherapy treatment 
response (Wong et al. 2016), and in staging cancer (Paspulati et al. 2015). It has not yet 
been applied in the study of muscle activity. Future work should aim to assess the feasibility 
of hybrid PET-MRI scanners in studying muscle activity for three main reasons. First, the 
technique obliterates the need for transposing and morphing to obtain co-registration, 
thereby simplifying the image analysis process and potentially improving its accuracy. 
Second, the ‘one-stop-shop’ PET-MRI scanner saves time, since a separate MRI scanning 
session is no longer required. Third, it avoids the CT scan altogether, which reduces the level 
of radiation exposure to the subject. It is important to note that PET-MRI also has several 
important disadvantages with respect to PET-CT, which include difficulties in determining 
the attenuation correction for the PET data. To generate artifact-free, quantitatively accurate 
PET images, attenuation and scatter correction are crucial (Bailey 1998; Zaidi et al. 2003). In 
PET-CT scanners, these attenuation maps are obtained by the CT scan. If such a scan is not 
available, as in PET-MRI, the attenuation map needs to be estimated based on the MRI scan, 
which may introduce errors (Lee et al. 2016).
One of the most promising capabilities of FDG-PET in the context of measuring muscle 
activity, as demonstrated in this thesis, is the ability to detect spatial distribution of FDG 
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within a muscle. The reconstruction of an image from a modern PET scanner typically has 
a voxel size of about 1-2 mm. This is roughly similar to the size of a muscle biopsy, but 
in contrast to a biopsy sample, the PET scan offers information about the activity in the 
entire volume of the muscle. From multi-channel electromyography studies, it is known 
that the spatial activation of muscle fibers in a muscle is not uniform; it is influenced by at 
least the contraction intensity and fatigue (Farina et al. 2008; Kleine et al. 2000). An FDG-
PET measurement offers an additional, and in many ways improved, measurement of the 
spatial distribution of activity within muscles (given the already stated disadvantages of 
electromyography) (Pappas et al. 2001). Measuring the intramuscular distribution of FDG, 
in theory, also allows musculoskeletal modelers to validate their models not just on the level 
of whole muscles, but to go much further and also validate muscle activity levels for each 
individual muscle-tendon element within muscles. For example, the recent TLEM 2.0 model 
as presented by Carbone and Fluit et al. (2015), based on cadaver measurements on a single 
specimen, contains no less than 166 of these elements per leg (e.g., the adductor magnus 
consists of 13 muscle-tendon elements in the model). Muscle activation in all of these 
elements might be individually compared to the FDG-PET measurements. Note that PET 
using FDG as the tracer is not suitable as the sole validation technique in musculoskeletal 
modeling, because it only measures cumulative muscle activity over periods of time, rather 
than the timing of each muscle’s activation within the gait cycle or other exercise. It should, 
therefore, be considered as a complimentary technique to other, time-sensitive techniques 
such as electromyography, ultrasound, or near-infrared spectroscopy.
An alternative and interesting way of using PET is not by using FDG and static imaging 
(as was done in this thesis), but by using tracers that decay faster and dynamic imaging. 
This entails imaging a tracer’s kinetics within the tissues as it is being taken up by those 
tissues. In a way, this technique is able to provide ‘live’ insight into the metabolism. The 
most frequently used isotope in this context is [15O], either as oxygen or water molecules. 
These tracers can be used to form a measure of the amount of tissue perfusion. As such, 
it also measures aerobic metabolism like with FDG. Unlike [18F], however, there is no 
trapping process, and the half-life time is also much shorter (122 seconds), allowing an 
almost instantaneous measurement of blood flow in a tissue. The feasibility of using [15O]-
H2O in combination with PET has already been demonstrated for a simple knee extension 
exercise (Kalliokoski et al. 2000). Two clear disadvantages of using this technique are that 
the exercises that can be performed are limited because of the participant’s position in the 
scanner tunnel (as opposed to being able to move around freely such as in walking), and that 
if the limb under investigation is moving during the scan (or even if muscles are contracting 
and changing shape), this hampers the accurate capture of the image. These disadvantages 
have led to tracers with longer half-life times (such as [18F]-FDG), becoming more popular 
in the study of muscle activity during exercise. 
The cumulative nature of the FDG accumulation in cells, due to the trapping process as 
explained in the introduction of this thesis, has both advantages and disadvantages. The 
participants in our study walked for a long time (90 minutes) and, therefore, it is tempting 
to state that the metabolic uptake data can be considered to be reliable because of the steady 
state of walking (particularly, the FDG uptake into the cells) that surely would have occurred 
during such a long walk. However, since the PET images were captured after the exercise 
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and contain no temporal information at all, it was impossible to see if the distribution of 
FDG changed during the exercise. Subjects could have switched between several muscle 
recruitment strategies during the 90 minutes of exercise. Future work could elucidate this 
aspect in several ways. First, several PET scans could be made during the exercise bout. For 
example, a PET scan of only one bed position, focusing on either the lower leg muscles, the 
thigh muscles, or the hip muscles, could be repeated at certain intervals during an exercise. 
If 15 min of exercise, followed by 3-5 min of scanning would be repeated several times 
(e.g., four times), the FDG’s distribution within muscles in the region of interest could be 
examined temporally. Second, a method that is sensitive to temporal changes in muscle 
activity, such as multi-channel electromyography (Holtermann et al. 2005; Staudenmann 
et al. 2009), could be used concurrently during the ongoing exercise, to image temporal 
shifts in regional muscle activity. Due to the inherent superficial nature of multi-channel 
electromyography, this would likely be feasible only for the lower leg muscles. If, from either 
of these proposed methods it is found that there are no temporal changes in the activity levels 
of muscle regions, this would provide a way to validate the use of the FDG-PET technique 
for measuring spatial distribution of muscle activity during prolonged exercise. It might also 
provide guidelines for future studies aiming to shorten the exercise time as much as possible, 
for example in the case of studying pathology.
Concluding remarks
This thesis offers several new insights in the functional outcome after different types of 
orthopedic surgery, as well as in musculoskeletal research and modeling. Through literature 
review, gait analyses, and strength measurements, we identified that the largest deficit in 
patients who had undergone any of the three investigated forms of hip surgery concerned 
the loss of hip abduction moment (not always limited to the operated side). This was 
the case during gait and stair ascent, as well as during strength measurements, with the 
magnitude of the deficit depending on the type of surgery performed. This highlights the 
need for rehabilitation protocols, surgical approaches, and musculoskeletal modeling efforts 
to focus on the hip abductors. Another insight was that the post-operative level of functional 
outcome after limb salvage surgery was difficult to predict, even for experienced orthopedic 
oncologists, warranting research into musculoskeletal models that might be able to help 
them in the pre-operative decision making process. The first promising steps have already 
been taken in that direction, during the TLEMsafe project (Fluit 2015; Verdonschot 2014).
In the second part of this thesis, we used a combination of FDG-PET and advanced three-
dimensional MRI segmentation techniques to determine muscle activity in all muscles 
of the hip, thigh, and lower leg in healthy subjects. The benefits of our three-dimensional 
segmentation techniques became clear when we compared the volumetric muscle activity 
results to those obtained using single slice-based analysis techniques that had been used in 
the field up to that point. The findings also challenged the common notion of symmetry 
in muscle activity between both limbs in healthy subjects, which could have important 
implications in musculoskeletal modeling. The intramuscular uptake data offers the potential 
next step in validation of musculoskeletal models; namely, validation not only on the level 
of whole muscle, but also on the level of the musculotendon units that comprise the muscle. 
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Finally, we already performed the first comparison of energy consumption measured with 
FDG-PET with the energy consumption predicted by personalized musculoskeletal models 
and found ‘good’ to ‘very good’ correlations, although additional work to achieve further 
personalization remains to be done (Carbone 2016), in order to explain the many remaining 
differences between the measurements and the models. In spite of drawbacks, such as ethical 
constraints and the relative novelty and unknowns associated with FDG-PET in measuring 
muscle activity, it remains important to acknowledge its greatest strengths compared to 
techniques such as surface electromyography. It can be used to obtain information from 
deep-lying muscles, it can measure all muscles simultaneously, it does not require reference 
contractions, and it does not suffer from reduced signal quality due to adipose tissue and 
crosstalk from other muscles. Therefore, we pose that FDG-PET should be considered as a 
valuable addition to the validation techniques available in musculoskeletal modeling, and 
that it holds great promise in studying and quantifying pathological conditions in patients 
suffering from various types of musculoskeletal disease. 
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Appendices
Nederlandse Samenvatting: Deel I
Het eerste doel van dit proefschrift was om inzicht te verkrijgen in de huidige status en 
uitdagingen aangaande de functionele uitkomst na drie verschillende orthopedische 
operaties: totale heupvervanging, drievoudige heuposteotomie en een beensparende operatie. 
In hoofdstuk 2 was ons doel om de vraag ‘Wat is het huidige niveau van functionaliteit na 
totale heupvervanging tijdens lopen en loopgerelateerde activiteiten van het dagelijks leven, 
gemeten met objectieve meetmethoden?’ te beantwoorden. We hebben de wetenschappelijke 
literatuur bestudeerd, gebruikmakend van veelomvattende zoektermen in de MEDLINE 
database. De inclusiecriteria waren als volgt: primaire osteoartritis als indicatie, waarbij een 
vergelijking werd gemaakt tussen patiënten en gezonde controles, of een vergelijking tussen de 
geopereerde en niet geopereerde zijde, en een opvolgingstijd van tenminste zes maanden na 
de operatie. De literatuurstudie leidde tot 2177 artikelen, waarvan er 35 werden geïncludeerd. 
In de geopereerde heup hadden de patiënten tijdens het lopen een verminderd saggitaal 
bewegingsbereik en maximale extensie, en genereerden ze een lager saggitaal vermogen, 
een lager abductiemoment en een lager extern rotatiemoment vergeleken met gezonde 
controles. De meeste van deze bevindingen (saggitaal bewegingsbereik, abductiemoment, 
extern rotatiemoment) waren niet te wijten aan een verlaagde loopsnelheid, aangezien deze 
bevindingen ook werden gevonden in studies die de loopsnelheid gelijk hielden tussen 
patiënten en controles. Bij traplopen (zowel omhoog als naar beneden) werden de verschillen 
tussen patiënten en controles niet uitvergroot ten opzichte van tijdens het lopen, hoewel de 
patiënten wel lagere heupmomenten genereerden tijdens het omhoog traplopen. Een van 
de meeste consistente bevindingen tijdens zowel lopen op vlakke ondergrond als tijdens het 
omhoog traplopen, was een verminderd abductiemoment dat bovendien onafhankelijk leek 
te zijn van de chirurgische benadering van het heupgewricht. 
In de hoofdstukken 3a en 3b zochten we naar een antwoord op de vraag ‘In welke mate 
is de functionele uitkomst met betrekking tot het lopen en de kracht in de benen na een 
drievoudige heuposteotomie en na totale heupvervanging met femorale inkorting gelijk 
aan gezonde controles en vergelijkbaar tussen de benen?’. In hoofdstuk 3a hebben we de 
langetermijn gevolgen van drievoudige heuposteotomie op het lopen en op de kracht in de 
benen onderzocht. Dit hebben we gedaan met behulp van gangbeeldanalyse en isometrische 
krachtmetingen bij twaalf vrouwen (leeftijd 34±12 jaar) die de operatie 80±18 maanden 
geleden hadden ondergaan. De resultaten vergeleken we met een controlegroep bestaande 
uit acht vrouwen die even oud waren als de studiegroep (33±10 jaar). Over het algemeen was 
het looppatroon van de vrouwen die een drievoudige heuposteotomie hadden ondergaan 
gelijk aan dat van de controlegroep, maar er werden wel kleine verschillen gevonden tussen 
de geopereerde en de niet geopereerde zijde. Het patroon van het abductiemoment in de 
standfase was significant verschillend tussen de geopereerde en de niet geopereerde zijde. 
Verder toonden de krachtmetingen aan dat de abductiekracht significant was verminderd 
in beide zijden ten opzichte van de gezonde controles. We concludeerden dat de patiënten 
over het algemeen goed waren hersteld van hun operatie op het gebied van het lopen, en dat 
er slechts kleine verschillen werden gevonden tussen de geopereerde en de niet geopereerde 
zijde. Het tweezijdige krachtsverschil in de abductoren impliceert dat de patiënten op een 
hoger percentage van hun maximale kracht liepen. Dit zou uiteindelijk kunnen leiden tot 
aanpassingen van het looppatroon als de patiënten moe worden, hetgeen relevant is voor 
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deze jonge patiënten die wellicht nog vele jaren willen kunnen sporten en andere zware 
activiteiten willen kunnen uitvoeren. 
In hoofdstuk 3b hadden we als doel om de functionele uitkomst van totale heupvervanging 
met heupkomreconstructie en femorale inkorting te meten bij patiënten met erfelijke 
heupdysplasie. Dit hebben we gedaan met behulp van gangbeeldanalyses en isometrische 
krachtmetingen bij zeven vrouwen die deze operatie hadden ondergaan (leeftijd: 39±13 
jaar, tijd na operatie: 45±52 maanden), en ook bij zeven gezonde vrouwen (leeftijd: 
31±10 jaar). Een van de bevindingen was dat de adductiehoek in de geopereerde heup 
significant groter was tijdens het lopen dan die in de niet geopereerde heup. Verder was het 
abductiemoment significant lager dan dat van de gezonde controles. Bij de krachtmetingen 
bleek dat de geopeerde zijde significant zwakker was dan de controles tijdens heupabductie, 
heupextensie, knieflexie en knieextensie. De geopereerde zijde was bovendien zwakker 
dan de niet geopeerde zijde tijdens alle metingen behalve knieflexie. De afwijkingen in 
het looppatroon in het frontale vlak duidden op een zogenaamd teken van Trendelenburg, 
wat een compensatiemechanisme is voor zwakte in de abductoren. Deze bevinding 
werd ondersteund door de metingen van de abductiekracht. Het is nog de vraag of er 
verbeteringspotentieel is voor de abductiekracht en het looppatroon, aangezien er mogelijk 
structurele veranderingen hebben opgetreden in de spieren tijdens de vele jaren voorafgaand 
aan de operatie, waarin de spieren hebben moeten functioneren op een niet optimale lengte.
In hoofdstuk 4 hadden we als doel om de vraag ‘Zijn orthopedisch oncologen in staat om 
de functionele effecten van een beensparende operatie te voorspellen?’ te beantwoorden. We 
hebben drieëntwintig patiënten (tussen zes en tien jaar na operatie) en vijf onafhankelijke 
orthopedisch oncologen gevraagd om twee vragenlijsten te beantwoorden. Dit waren de 
zogenaamde ‘Toronto Extremity Salvage Score (TESS)’ en de ‘RAND-36 physical functioning 
subscale (RAND-36 PFS)’. De orthopedisch oncologen baseerden hun voorspellingen van 
de functionele uitkomst op een casus beschrijving van iedere patiënt die hun status (inclusief 
MRI scans) voor de operatie weergaf. We vonden “zeer lage” to “lage” correlaties tussen de 
uitkomsten zoals weergegeven door de patiënten en die van de orthopedisch oncologen op 
beide vragenlijsten, en de orthopedisch oncologen hadden de neiging om de uitkomsten 
die waren gerapporteerd door de patiënten te onderschatten. Verder waren de orthopedisch 
oncologen het vaak niet met elkaar eens: de overeenkomst op de meeste vragen in de RAND-
36 PFS was “laag”, hetgeen erop duidt dat er een hoge variabiliteit was tussen de antwoorden 
van de orthopedisch oncologen. Het bleek dus lastig voor de deelnemende orthopedisch 
oncologen om de functionele uitkomst van beensparende operaties te voorspellen. Dit toont 
aan dat er meer onderzoek gedaan zou moeten worden naar objectieve methoden die de 
orthopedisch oncologen kunnen helpen tijdens het kiezen van de beste behandeling. Een 
van die methoden zou het gebruikmaken van spierskeletmodellen kunnen zijn. Met zulke 
modellen zou op voorhand kunnen worden berekend of de patiënt nog genoeg spierkracht 
over zal hebben na de operatie om activiteiten van het dagelijks leven uit te voeren.  
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Nederlandse Samenvatting: Deel II
Het tweede doel van dit proefschrift was om te ontdekken wat de mogelijkheden van FDG-
PET zijn om fundamenteel inzicht te verkrijgen in het spierskeletsysteem tijdens lopen, en 
ook om te weten te komen wat de potentie van de techniek is om de eerder geïdentificeerde 
uitdagingen met betrekking tot functionele uitkomst op te lossen. Hoofdstuk 5 had als doel 
om de vraag ‘Welke spieren in de onderste extremiteit zijn het meest belangrijk tijdens het 
lopen?’. In dat hoofdstuk werd positron emissie tomografie (PET) in combinatie met [18F]-
fluodeoxyglucose (FDG) gebruikt. Dit is een nieuwe methodologie die gebaseerd is op de 
toename van de opname van glucose en FDG in spieren die actief zijn. Hiertoe liepen tien 
gezonde proefpersonen op een loopband op zelfgekozen snelheid gedurende 85 minuten; 
55 minuten voor en 30 minuten na een intraveneuze injectie met 50 MBq FDG. Daarna 
werd er een PET/CT scan gemaakt van de onderste extremiteit. De driedimensionale 
contouren van 39 spieren in de linker onderste extremiteit werden halfautomatisch bepaald 
met behulp van MRI scans en nieuwe geavanceerde algoritmes in de Mimics Innovation 
Suite (Materialise N.V., Leuven, Belgium). Nadat de MRI scans op een niet rigide manier 
waren geregistreerd op de CT scans, werden de spiercontouren op de PET scans gelegd. 
Het bleek dat de meest actieve spieren tijdens het lopen de soleus, gluteus maximus, vastus 
lateralis, gastrocnemius medialis en adductor magnus waren. Er waren wel grote verschillen 
tussen proefpersonen, ook in enkele van de meest belangrijke spieren tijdens het lopen 
(bijvoorbeeld de soleus, gluteus medius en gastrocnemius medialis). De spieren die we 
identificeerden als zijnde meest actief, waren over het algemeen dezelfde spieren die ook 
al in eerdere studies waren geïdentificeerd met behulp van andere methoden zoals inverse 
dynamica en elektromyografie. Een aantal spieren (bijvoorbeeld de adductor magnus en 
de gluteus minimus) die voorheen lastig te meten waren met bestaande technieken zoals 
oppervlakte elektromyografie vanwege hun grootte of hun diep liggende positie in het 
lichaam, werden door FDG-PET geïdentificeerd als zeer actief tijdens het lopen. Vergeleken 
met bestaande methoden voor het analyseren van de hoeveelheid FDG in spieren waarbij 
slechts in één plakje van de scan wordt gemeten, leidde onze driedimensionale analyse tot 
een ander resultaat in veel van de meest actieve spieren. Dit toont de toegevoegde waarde 
van onze uitgebreide driedimensionale analyse van spieractiviteit met behulp van FDG-PET. 
In hoofdstuk 6 zochten we antwoorden op de vragen ‘Zijn de spieren van de linker en rechter 
onderste extremiteit symmetrisch actief tijdens het lopen?’ en ‘Zijn de spieren homogeen 
actief of zijn er specifieke regio's binnen spieren die actiever zijn dan andere tijdens lopen?’. 
De methodologie was grotendeels gelijk aan die van hoofdstuk 5, met de toevoeging dat 
ditmaal ook het rechterbeen werd geanalyseerd. De spieren van de onderbenen vertoonden 
forse asymmetrieën (bijvoorbeeld een mediane asymmetrie van 42% in de gastrocnemius 
medialis). Er werden ook asymmetrieën gevonden in de gluteus medius (15% asymmetrie) 
en gluteus minimus (30% asymmetrie), terwijl de FDG opname in de spieren van het 
dijbeen relatief symmetrisch was tussen beide benen (<6% asymmetrie). De FDG opname 
was niet normaal verdeeld binnen spieren; de meeste voxels hadden een relatief lage SUV 
(gestandaardiseerde opname waarde), terwijl een kleine hoeveelheid voxels juist een 
relatief hoge SUV vertoonde. De gebieden waar de FDG opname hoger was, waren niet 
willekeurig verdeeld binnen de spieren, maar vormden clusters in vrijwel alle spieren. De 
bevindingen van deze studie demonstreren dat het niet vanzelfsprekend is dat spieractiviteit 
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altijd symmetrisch is tussen de beide benen in gezonde proefpersonen. Het feit dat er 
clusters werden gevormd van voxels met hoge uptake toont aan dat zelfs in een langdurige, 
repetitieve handeling als lopen, bepaalde regio's van spieren een hogere bijdrage leveren aan 
de loopbeweging dan anderen.
In hoofdstuk 7 zochten we naar een antwoord op de vraag ‘Kan FDG-PET worden gebruikt 
voor het valideren van spierskeletmodellen van gezonde proefpersonen?’. De validatie van 
spierskeletmodellen is een belangrijke maar moeilijk te nemen horde richting het gebruik 
van dit soort modellen in de klinische praktijk, zoals bij het plannen van orthopedische 
operaties. Het gebruiken van FDG-PET zoals getoond in de hoofdstukken 5 en 6 zou 
een oplossing kunnen zijn voor dit probleem. We construeerden proefpersoonspecifieke 
spierskeletmodellen van dezelfde tien gezonde proefpersonen met geavanceerde technieken 
zoals spieranatomie gesegmenteerd op MRI scans en functionele schaling gebaseerd 
op krachtmetingen. De spieren die in hoofdstuk 5 reeds waren geïdentificeerd als zijnde 
meest actief tijdens het lopen (soleus, gluteus maximus, vastus lateralis, gastrocnemius 
medialis en adductor magnus), waren over het algemeen ook het meeste actief in de 
spierskeletmodellen. De met behulp van PET gemeten FDG opname in de spieren in elke 
proefpersoon had een ‘goede’ to ‘zeer goede’ correlatie met het energieverbruik in de spier, 
berekend met de spierskeletmodellen (Spearman’s ρ = 0.87±0.04, Pearson’s r = 0.77±0.10). 
Toen de gemiddelde FDG opname van elke spier over alle tien proefpersonen werd berekend, 
werden de correlaties hoger (Spearman’s ρ = 0.96, Pearson’s r =0.91). We concludeerden dat 
FDG-PET een waardevolle nieuwe techniek lijkt als aanvulling op elektromyografie voor het 
valideren van spierskeletmodellen.  
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Dankwoord
Er hebben veel mensen geholpen bij de totstandkoming van dit proefschrift, die ik op 
deze plek wil bedanken. Ten eerste wil ik alle patiënten en gezonde proefpersonen danken 
voor hun bereidheid om mee te doen aan de verschillende studies. De data die ik daarbij 
verzameld heb is van grote waarde, getuige de niet één, maar drie proefschriften die mijn 
projectgenoten en ik erop hebben gebaseerd. 
Dan wil ik graag mijn (co-)promotoren bedanken: Nico, Vivian en Sander. Wat waren jullie 
een sterk team, en wat was het een voorrecht om met jullie samen te werken! Nico, bedankt 
voor je frisse blik en waardevolle inzichten die mij vaak nog eens deden nadenken over 
de resultaten. Ondanks je overvolle agenda had je altijd tijd voor mij en dat waardeer ik 
zeer. Ik vind het erg leuk dat we nog altijd samenwerken en elkaar regelmatig tegenkomen 
op congressen. Vivian, ik zal nooit vergeten dat je me belde om me te vertellen dat ik 
was aangenomen. Dit is misschien wel het beste telefoontje dat ik ooit heb gehad! Onze 
samenwerking voelde meteen heel vertrouwd en we klikten erg goed met elkaar. Tijdens 
mijn promotie stond je deur als dagelijks begeleider altijd open en had je vaak goede ideeën 
om nuances aan te brengen, of om een studie net iets anders op te stellen en daardoor sterk te 
verbeteren, of zelfs hele studies te conceptualiseren. Ik heb ook veel geleerd van je inzichten 
over mijn conceptartikelen, bedankt daarvoor. Sander, hartelijk bedankt voor je waardevolle 
opmerkingen en feedback op mijn artikelen. Je wist altijd bruikbare aanwijzingen te geven, 
met niet alleen wát je zou veranderen, maar ook waarom. Vervolgens heb ik die kennis 
direct toegepast op alle volgende artikelen. Ik kan nog steeds niet geloven hoe zoveel talent 
voor wetenschap en klinisch werk in één persoon kan samenkomen. 
Dear TLEMsafe partners, thank you for the privilege of working with you all. Starting from 
different perspectives, it was amazing to see the synergy between the partners develop over 
the years. We are still harvesting the fruits of this labor (e.g. TLEM 2.0 in AnyBody's model 
repository, and the Muscle Segmentation module in Materialise's Mimics Innovation Suite). 
Vincenzo and René, as fellow PhD students in the project we have been through thick and 
thin. Where it was up to me to collect all data in the project, it was up to you to extensively 
use that data to build and validate musculoskeletal models. I think that collaboration 
worked out very well, with three successful PhD theses as a result. Thank you for all the 
years of pleasant collaboration and that you are my paranimfs! I will also never forget our 
trips together with Pim, Hielke, and Steven to the various European consortium meetings, 
including stops in Hamburg (waking up like the movie 'The Hangover'), Kattegat (where 
penguins live), and Munich (Octoberfest exactly during our consortium meeting, what a 
coincidence!). 
Graag wil ik ook alle stagiaires bedanken die hebben bijgedragen aan dit proefschrift. Olga, 
we hebben samen de gezonde proefpersonen gemeten met behulp van FDG-PET en jij hebt 
de eerste analyses uitgevoerd op de data. Dit heeft twee congrespresentaties opgeleverd, 
Bedankt! Michiel, bedankt voor je zoekwerk in de literatuur. Dit heeft de basis gelegd voor 
de studie over patiënten na een totale heupvervanging. Jim, dankzij jou verliep de studie met 
triple osteotomie patiënten heel vlot, bedankt! Kevin, je hebt grotendeels de vragenlijststudie 
uitgevoerd en de patiënten bevraagd naar hun functionele status. Bedankt hiervoor! Edzo, je 
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hebt bergen werk verzet om de FDG-PET data te koppelen aan de MRI beelden en dat heeft 
zich vertaald in meerdere fraaie artikelen. Bedankt voor al je inzet. Daphne, bedankt voor je 
inzichten bij het interpreteren van de FDG-PET data, en ook voor de gezelligheid en om af 
en toe te tennissen na werktijd.
Wim Schreurs, Wim Rijnen, Ingrid en Gerjon, bedankt voor jullie input vanuit Orthopedie 
en de prettige samenwerking. Petra, de samenwerking met jou en de Sint Maartenskliniek 
verliep erg goed, bedankt daarvoor. Eric en Martin, bedankt voor jullie adviezen over de 
PET studie. Bregina en Mark, met jullie was het altijd aangenaam om metingen te doen op 
de afdeling Anatomie en Fysiologie. Kristian, we hebben vele MRI scans gemaakt! Op een 
bepaald moment kwam ik meerdere keren per week langs met proefpersonen om scans te 
maken. Bedankt voor al jullie hulp!
Mijn dank gaat ook uit naar mijn collega onderzoekers van de afdeling: Digna, Jorik, Noortje, 
Mark, Roos, Lotte, Mariska, Arjen, Ellen, Merel, Joyce, Milou, Bas, Frank, Jolanda, Lotte, 
Mark, Hanneke, Anita, Chantal, Jos en Mariëlle. Roomies Noortje, Jorik en Digna, jullie in 
het bijzonder bedankt voor de gezelligheid en dat we altijd lief en leed konden delen. Jullie 
zorgden voor een goede sfeer, onder andere wanneer we vrijdagmiddag naar de Aesculaaf 
gingen om nog even een pintje te pakken, en natuurlijk bij de SYTYCC competities. 
Roland, bedankt voor alle technische ondersteuning. Vaak gingen we op strooptocht door 
het hele Radboud, op zoek naar de juiste apparatuur bij verschillende afdelingen. Op een 
bepaald moment vonden we onder het stof een stoel uit begin jaren '90 om spierkrachten 
mee te meten. Die werkte nog op diskettes en stond al zeker tien jaar stil. Misschien 
hadden we het elektrisch circuit toch beter even na kunnen kijken vóórdat we hem op het 
stopcontact aansloten, want op een bepaald moment kwamen de vonken eruit en was er een 
kleine brand. Never a dull moment! Geert, jij ook enorm bedankt voor de ondersteuning 
in verschillende vormen in de loop der jaren. Naast technische ondersteuning heb je ook 
geholpen bij het doen van metingen en met het uitvoeren van de literatuur review. 
Mede leden van de NCEBP PhD council, Tessel, Lotte, Nathalie, Jan, Jorik, Saskia en Sanaz, 
het was leuk en leerzaam om samen aan iets te werken naast onze promotietrajecten. 
Jorik, Arjen, Geert en Roland, bedankt voor de gezellige klaverjasavonden. We hebben heel 
wat legendarische handjes gespeeld! Sommige daarvan zijn zelfs voor eeuwig op de gevoelige 
plaat vastgelegd en zullen we onze kleinkinderen nog over vertellen. 
Gijs, Sander en Sten, bedankt voor de vele gezellige klaverjasavonden. We hadden onszelf als 
doel gesteld om elke keer in een andere kroeg af te spreken; ik denk dat dit goed is gelukt! 
Sten, onze Magic avonden waren ook altijd geslaagd en een mooie gelegenheid om nog eens 
lekker te nerden en onze studententijd in Sjeepee langzaam af te bouwen.
Pim, Lianne, Gijs, Sabine, Sten, Miriam, Hannes, Marjolein, Kitty, Arris, Gert-Jan, Alexandra, 
Karen, Emiel, Han, Ellen, Joost, ik geniet altijd van ons jaarlijkse kerstdinerweekend en 
hoop dat we dit nog vele jaren voortzetten! Maaike, bedankt voor je gezelschap, de stabiliteit 
tijdens vele jaren, en alle leuke dingen die we hebben meegemaakt. 
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Gert-Jan en Jurgen, we kennen elkaar al lang en maken vaak mooie trips. Van Terschelling 
to Transnistrië, het ene land nog exotischer dan het andere. Het wordt alweer hoog tijd om 
weer eens een mooie trip in te plannen.
Collega's en vrienden van Materialise, dankzij jullie voelde ik me direct thuis in België. 
Hartelijk bedankt om me steeds tijdens de lunchpauzes te vragen of ik al een datum voor de 
verdediging heb. Inmiddels ben ik fier dat ik het Vlaamse vocabulaire al aardig onder de knie 
heb, met woorden als kuisen (=schoonmaken), proper (=schoon), schoon (=mooi), lopen 
(=hardlopen) en natuurlijk de Bicky burger. Marnic, bedankt voor het samen bezoeken van 
vele festivals, game edities, fitness sessies, eten bij de frituur, en dat we een epic DJ-duo 
vormen bij de parties van Materialise. Onze doorbraak buiten het bedrijf zal vast niet lang 
meer op zich laten wachten! 
Lieve pap en mam en zussie, bedankt voor jullie onvoorwaardelijke steun en liefde. Het is 
niet in woorden uit te drukken hoeveel ik om jullie geef en hoe dankbaar ik ben voor jullie. 
Ik lijk wel steeds verder van jullie weg te verhuizen (eerst Nijmegen, nu Leuven). Gelukkig 
spreken we elkaar vaak en komen jullie wel eens bij me langs in België. 
Lieve Kati, bedankt voor je steun in de laatste fase van het afmaken van dit proefschrift. We 
hebben het erg fijn samen en ik denk dat we elkaar perfect aanvullen. Voor zover je het nog 
niet wist: ik hou van je en sa täidad mu südame rõõmuga! 
Sjoerd Kolk, December 2017
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